TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
R-HSA-1280215	Cytokine Signaling in Immune system	2.58196535327602e-27	-61.2212466370656	756	109	0.223360655737705	488	10287	56300,10125,6288,90865,1440,27189,3559,3669,943,3684,4791,4318,4940,3659,3055,3934,64127,10148,1435,2633,54739,3557,4938,4939,3575,26281,3593,2069,8809,11009,1848,9235,5743,1847,4314,8638,2668,2247,7133,50604,4233,3586,2903,2537,4982,1326,3561,6708,3592,1839,3976,6352,595,3601,23586,1437,2919,3383,8503,3569,3429,5971,4843,8767,4312,8995,3552,6364,27177,115362,3589,3627,115361,3604,6351,2635,146433,4790,3394,5699,2634,330,5698,3576,91543,1844,6348,941,29949,11213,6363,3455,9636,23529,5292,2920,4067,149233,3687,5721,1850,970,51561,3553,3162,6347,960,3460,3656	IL36G,RASGRP1,SAA1,IL33,CSF3,IL17C,IL2RA,ISG20,TNFRSF8,ITGAM,NFKB2,MMP9,OAS3,IRF1,HCK,LCN2,NOD2,EBI3,CSF1,GBP1,XAF1,IL1RN,OAS1,OAS2,IL7R,FGF20,IL12B,EREG,IL18R1,IL24,DUSP6,IL32,PTGS2,DUSP5,MMP3,OASL,GDNF,FGF2,TNFRSF1B,IL20,MET,IL10,GRIN2A,IFI6,TNFRSF11B,MAP3K8,IL2RG,SPTA1,IL12A,HBEGF,LIF,CCL5,CCND1,IL15RA,DDX58,CSF2,CXCL1,ICAM1,PIK3R3,IL6,IFI27,RELB,NOS2,RIPK2,MMP1,TNFSF18,IL1A,CCL20,IL36B,GBP5,IL11,CXCL10,GBP4,TNFRSF9,CCL4,GBP3,IL34,NFKB1,IRF8,PSMB10,GBP2,BIRC3,PSMB9,CXCL8,RSAD2,DUSP2,CCL3,CD80,IL19,IRAK3,CCL19,IFNAR2,ISG15,CLCF1,PIM1,CXCL2,LYN,IL23R,ITGAX,PSME2,DUSP8,CD70,IL23A,IL1B,HMOX1,CCL2,CD44,IFNGR2,IRAK2
R-HSA-449147	Signaling by Interleukins	4.76231079124036e-22	-49.0961390350788	525	81	0.165983606557377	488	10287	1440,3559,27189,3684,10125,56300,6288,90865,3557,3575,26281,3593,2069,4791,4318,3055,64127,3934,1435,10148,2668,2247,7133,8809,11009,1848,9235,5743,1847,4314,3561,1326,6708,3592,1839,3976,6352,595,3601,50604,4233,3586,2903,8503,3569,1437,2919,3383,3627,6351,146433,4790,5699,4843,8767,4312,3552,27177,6364,3589,6348,941,29949,11213,6363,5698,3576,1844,1850,51561,6347,3553,3162,3656,23529,5292,2920,4067,149233,5721,3687	CSF3,IL2RA,IL17C,ITGAM,RASGRP1,IL36G,SAA1,IL33,IL1RN,IL7R,FGF20,IL12B,EREG,NFKB2,MMP9,HCK,NOD2,LCN2,CSF1,EBI3,GDNF,FGF2,TNFRSF1B,IL18R1,IL24,DUSP6,IL32,PTGS2,DUSP5,MMP3,IL2RG,MAP3K8,SPTA1,IL12A,HBEGF,LIF,CCL5,CCND1,IL15RA,IL20,MET,IL10,GRIN2A,PIK3R3,IL6,CSF2,CXCL1,ICAM1,CXCL10,CCL4,IL34,NFKB1,PSMB10,NOS2,RIPK2,MMP1,IL1A,IL36B,CCL20,IL11,CCL3,CD80,IL19,IRAK3,CCL19,PSMB9,CXCL8,DUSP2,DUSP8,IL23A,CCL2,IL1B,HMOX1,IRAK2,CLCF1,PIM1,CXCL2,LYN,IL23R,PSME2,ITGAX
R-HSA-6783783	Interleukin-10 signaling	9.60996906949823e-21	-46.0914859484725	49	25	0.0512295081967213	488	10287	3593,3557,3976,6351,6352,6347,3592,3553,3627,1435,3552,3586,6364,2920,7133,6363,1440,6348,941,3569,3383,5743,2919,3576,1437	IL12B,IL1RN,LIF,CCL4,CCL5,CCL2,IL12A,IL1B,CXCL10,CSF1,IL1A,IL10,CCL20,CXCL2,TNFRSF1B,CCL19,CSF3,CCL3,CD80,IL6,ICAM1,PTGS2,CXCL1,CXCL8,CSF2
R-HSA-168256	Immune System	3.03273015064908e-17	-38.034483327252	2101	178	0.364754098360656	488	10287	4586,4688,255488,4067,2920,5292,6279,3460,970,3553,6347,960,5698,9636,6363,64135,3455,941,6348,11213,29949,3552,285852,55521,3386,4312,4843,6351,146433,3604,1540,3394,3937,10584,5971,8503,3569,3429,221687,2903,3586,6278,4982,2537,4233,6352,3976,7498,1839,3601,595,245973,3725,1604,6616,3561,5266,6708,1847,9235,154664,6891,8809,342510,1848,7097,29126,2247,57823,2207,7133,23308,2668,55008,3055,3659,3934,4791,4939,3575,4938,114770,3593,26281,5004,54739,26253,90865,56300,10125,943,7128,27189,1440,3669,644150,4794,149233,5721,3687,23529,3656,1850,1118,3162,54210,51561,10071,91543,1844,330,2634,5806,3576,23327,5005,6280,27177,6364,719,6890,8995,3589,115362,8767,53831,2635,5068,79930,5699,4790,3627,629,1520,115361,3383,4033,5317,23586,1437,92369,2919,6317,50617,718,50604,7087,117157,1326,11119,3592,127544,5743,4314,11009,7295,2268,10517,2495,8638,84676,8876,10148,1435,64127,4318,4940,5329,3557,2069,7130,2633,272,3710,4792,6288,3684,3559	MUC5AC,NCF2,RNF144B,LYN,CXCL2,PIM1,S100A8,IFNGR2,CD70,IL1B,CCL2,CD44,PSMB9,ISG15,CCL19,IFIH1,IFNAR2,CD80,CCL3,IRAK3,IL19,IL1A,TREML4,TRIM36,ICAM4,MMP1,NOS2,CCL4,IL34,TNFRSF9,CYLD,IRF8,LCP2,COLEC10,RELB,PIK3R3,IL6,IFI27,RNF182,GRIN2A,IL10,S100A7,TNFRSF11B,IFI6,MET,CCL5,LIF,XDH,HBEGF,IL15RA,CCND1,ATP6V1C2,JUN,CD55,SNAP25,IL2RG,PI3,SPTA1,DUSP5,IL32,ABCA13,TAP2,IL18R1,CD300E,DUSP6,TLR2,CD274,FGF2,SLAMF7,FCER1G,TNFRSF1B,ICOSLG,GDNF,HERC6,HCK,IRF1,LCN2,NFKB2,OAS2,IL7R,OAS1,PGLYRP2,IL12B,FGF20,ORM1,XAF1,CLEC4E,IL33,IL36G,RASGRP1,TNFRSF8,TNFAIP3,IL17C,CSF3,ISG20,WIPF3,NFKBIE,IL23R,PSME2,ITGAX,CLCF1,IRAK2,DUSP8,CHIT1,HMOX1,TREM1,IL23A,MUC12,RSAD2,DUSP2,BIRC3,GBP2,PTX3,CXCL8,NEDD4L,ORM2,S100A9,IL36B,CCL20,C3AR1,TAP1,TNFSF18,IL11,GBP5,RIPK2,GPR84,GBP3,REG3A,DOK3,PSMB10,NFKB1,CXCL10,CFB,CTSS,GBP4,ICAM1,LRMP,PKP1,DDX58,CSF2,SPSB4,CXCL1,SERPINB3,ATP6V0A4,C3,IL20,ICAM5,SH2D1B,MAP3K8,BTN3A1,IL12A,RNF19B,PTGS2,MMP3,IL24,TXN,FGR,FBXW10,FTH1,OASL,TRIM63,VNN1,EBI3,CSF1,NOD2,MMP9,OAS3,PLAUR,IL1RN,EREG,TNFAIP6,GBP1,AMPD3,ITPR3,NFKBIA,SAA1,ITGAM,IL2RA
R-HSA-380108	Chemokine receptors bind chemokines	1.59712437808128e-13	-29.4654014603922	48	19	0.0389344262295082	488	10287	9034,3627,7852,6352,2920,6346,57007,6364,6374,6363,2921,6372,6373,6376,3576,1236,2919,4283,643	CCRL2,CXCL10,CXCR4,CCL5,CXCL2,CCL1,ACKR3,CCL20,CXCL5,CCL19,CXCL3,CXCL6,CXCL11,CX3CL1,CXCL8,CCR7,CXCL1,CXCL9,CXCR5
R-HSA-6785807	Interleukin-4 and 13 signaling	1.05461721600623e-12	-27.5778432432688	111	27	0.055327868852459	488	10287	4314,5743,3383,6288,3576,7133,3684,2247,3569,3934,3687,149233,3552,3586,4312,5292,4843,4318,3593,595,3976,3553,6347,3162,3592,51561,3561	MMP3,PTGS2,ICAM1,SAA1,CXCL8,TNFRSF1B,ITGAM,FGF2,IL6,LCN2,ITGAX,IL23R,IL1A,IL10,MMP1,PIM1,NOS2,MMP9,IL12B,CCND1,LIF,IL1B,CCL2,HMOX1,IL12A,IL23A,IL2RG
R-HSA-375276	Peptide ligand-binding receptors	4.0330497262736e-09	-19.328742991284	188	30	0.0614754098360656	488	10287	6288,2847,2919,3576,1236,5021,6752,4283,643,623,1910,2921,6374,6363,6373,6376,6372,2920,9283,57007,6346,718,719,6364,10887,9034,3627,7852,6352,2151	SAA1,MCHR1,CXCL1,CXCL8,CCR7,OXTR,SSTR2,CXCL9,CXCR5,BDKRB1,EDNRB,CXCL3,CXCL5,CCL19,CXCL11,CX3CL1,CXCL6,CXCL2,GPR37L1,ACKR3,CCL1,C3,C3AR1,CCL20,PROKR1,CCRL2,CXCL10,CXCR4,CCL5,F2RL2
R-HSA-373076	Class A/1 (Rhodopsin-like receptors)	1.36197814675348e-06	-13.5065723953337	322	36	0.0737704918032787	488	10287	2863,6346,57007,6364,719,7852,135,9034,10887,3627,643,2919,6288,2847,4283,6752,6373,6376,718,9283,2920,8111,147,2151,6352,5021,3576,1236,6374,6363,2921,6372,150,134864,1910,623	GPR39,CCL1,ACKR3,CCL20,C3AR1,CXCR4,ADORA2A,CCRL2,PROKR1,CXCL10,CXCR5,CXCL1,SAA1,MCHR1,CXCL9,SSTR2,CXCL11,CX3CL1,C3,GPR37L1,CXCL2,GPR68,ADRA1B,F2RL2,CCL5,OXTR,CXCL8,CCR7,CXCL5,CCL19,CXCL3,CXCL6,ADRA2A,TAAR1,EDNRB,BDKRB1
R-HSA-909733	Interferon alpha/beta signaling	3.3845219780641e-06	-12.5962978792785	69	14	0.0286885245901639	488	10287	54739,3669,8638,3429,4938,4939,3455,9636,3394,2634,4940,3659,91543,2537	XAF1,ISG20,OASL,IFI27,OAS1,OAS2,IFNAR2,ISG15,IRF8,GBP2,OAS3,IRF1,RSAD2,IFI6
R-HSA-418594	G alpha (i) signalling events	3.78187943771079e-06	-12.485289466155	242	29	0.0594262295081967	488	10287	5996,643,2847,6288,3576,5999,1236,2919,6752,2918,4283,2921,9628,6363,6374,6373,6372,150,623,57007,718,6364,719,2920,2914,7852,6352,6004,3627	RGS1,CXCR5,MCHR1,SAA1,CXCL8,RGS4,CCR7,CXCL1,SSTR2,GRM8,CXCL9,CXCL3,RGS6,CCL19,CXCL5,CXCL11,CXCL6,ADRA2A,BDKRB1,ACKR3,C3,CCL20,C3AR1,CXCL2,GRM4,CXCR4,CCL5,RGS16,CXCL10
R-HSA-500792	GPCR ligand binding	4.26362968438981e-06	-12.3653897218727	453	44	0.0901639344262295	488	10287	6346,2863,57007,719,6364,2914,7852,135,9034,10887,3627,643,2919,6288,2847,4283,6752,9340,90226,7474,6373,6376,718,9283,2920,8111,147,6352,2151,1604,11211,1236,3576,5021,2918,6374,6363,2921,6372,150,134864,623,1910,2642	CCL1,GPR39,ACKR3,C3AR1,CCL20,GRM4,CXCR4,ADORA2A,CCRL2,PROKR1,CXCL10,CXCR5,CXCL1,SAA1,MCHR1,CXCL9,SSTR2,GLP2R,UCN2,WNT5A,CXCL11,CX3CL1,C3,GPR37L1,CXCL2,GPR68,ADRA1B,CCL5,F2RL2,CD55,FZD10,CCR7,CXCL8,OXTR,GRM8,CXCL5,CCL19,CXCL3,CXCL6,ADRA2A,TAAR1,BDKRB1,EDNRB,GCGR
R-HSA-168249	Innate Immune System	1.42994651399655e-05	-11.1552884241975	1285	93	0.190573770491803	488	10287	272,5004,3710,5329,26281,7130,2069,114770,4318,4791,3659,3055,3934,64127,3559,644150,3684,7128,4792,10125,6288,26253,1326,6616,3561,5266,1604,6708,1839,245973,3725,4233,2903,718,6278,50617,8876,2668,7295,2268,2247,7097,7133,2207,2495,154664,1848,342510,1847,10584,3937,1520,629,1540,5068,4790,79930,5699,4843,53831,8767,719,8503,5971,23586,1437,2919,6317,4033,5317,1118,1850,54210,3553,960,6279,3656,4688,4067,4586,5721,3687,941,6280,5005,11213,64135,9636,5698,330,5806,10071,1844	AMPD3,ORM1,ITPR3,PLAUR,FGF20,TNFAIP6,EREG,PGLYRP2,MMP9,NFKB2,IRF1,HCK,LCN2,NOD2,IL2RA,WIPF3,ITGAM,TNFAIP3,NFKBIA,RASGRP1,SAA1,CLEC4E,MAP3K8,SNAP25,IL2RG,PI3,CD55,SPTA1,HBEGF,ATP6V1C2,JUN,MET,GRIN2A,C3,S100A7,ATP6V0A4,VNN1,GDNF,TXN,FGR,FGF2,TLR2,TNFRSF1B,FCER1G,FTH1,ABCA13,DUSP6,CD300E,DUSP5,COLEC10,LCP2,CTSS,CFB,CYLD,REG3A,NFKB1,DOK3,PSMB10,NOS2,GPR84,RIPK2,C3AR1,PIK3R3,RELB,DDX58,CSF2,CXCL1,SERPINB3,LRMP,PKP1,CHIT1,DUSP8,TREM1,IL1B,CD44,S100A8,IRAK2,NCF2,LYN,MUC5AC,PSME2,ITGAX,CD80,S100A9,ORM2,IRAK3,IFIH1,ISG15,PSMB9,BIRC3,PTX3,MUC12,DUSP2
R-HSA-109582	Hemostasis	6.24969406063935e-05	-9.68039295271773	632	52	0.10655737704918	488	10287	5055,1437,10125,8140,857,8503,3559,55619,23657,9056,3684,9162,4312,5152,4843,23764,4602,3659,83953,3937,5004,3710,5329,5270,6401,2152,7273,3053,150,5197,5341,5005,2268,2207,5552,2888,11343,3779,5880,4067,10938,3687,6385,3561,54210,490,960,2151,5327,9732,6547,2886	SERPINB2,CSF2,RASGRP1,SLC7A5,CAV1,PIK3R3,IL2RA,DOCK10,SLC7A11,SLC7A7,ITGAM,DGKI,MMP1,PDE9A,NOS2,MAFF,MYB,IRF1,FCAMR,LCP2,ORM1,ITPR3,PLAUR,SERPINE2,SELE,F3,TTN,SERPIND1,ADRA2A,PF4V1,PLEK,ORM2,FGR,FCER1G,SRGN,GRB14,MGLL,KCNMB1,RAC2,LYN,EHD1,ITGAX,SDC4,IL2RG,TREM1,ATP2B1,CD44,F2RL2,PLAT,DOCK4,SLC8A3,GRB7
R-HSA-6799990	Metal sequestration by antimicrobial proteins	6.95352327760497e-05	-9.57367698742947	6	4	0.00819672131147541	488	10287	6279,3934,6278,6280	S100A8,LCN2,S100A7,S100A9
R-HSA-877300	Interferon gamma signaling	0.000128397743095457	-8.96037774400108	94	14	0.0286885245901639	488	10287	2634,4940,3659,3383,115362,2633,960,8638,115361,4939,2635,3460,4938,3394	GBP2,OAS3,IRF1,ICAM1,GBP5,GBP1,CD44,OASL,GBP4,OAS2,GBP3,IFNGR2,OAS1,IRF8
R-HSA-448706	Interleukin-1 processing	0.000156158521747564	-8.76463890161246	7	4	0.00819672131147541	488	10287	3552,4790,4791,3553	IL1A,NFKB1,NFKB2,IL1B
R-HSA-1474244	Extracellular matrix organization	0.000164616851292358	-8.71188989772967	296	29	0.0594262295081967	488	10287	3386,4312,4318,3687,169044,650,3918,1520,960,6385,63923,1305,375790,3914,7087,10516,9507,4314,3383,4316,1294,4319,4322,4321,27302,9378,56999,2247,3684	ICAM4,MMP1,MMP9,ITGAX,COL22A1,BMP2,LAMC2,CTSS,CD44,SDC4,TNN,COL13A1,AGRN,LAMB3,ICAM5,FBLN5,ADAMTS4,MMP3,ICAM1,MMP7,COL7A1,MMP10,MMP13,MMP12,BMP10,NRXN1,ADAMTS9,FGF2,ITGAM
R-HSA-913531	Interferon Signaling	0.000214806203535056	-8.44577431522958	201	22	0.0450819672131148	488	10287	4940,3659,2537,115362,2633,115361,54739,960,4938,3460,4939,2635,3394,23586,2634,91543,3383,8638,3429,3669,3455,9636	OAS3,IRF1,IFI6,GBP5,GBP1,GBP4,XAF1,CD44,OAS1,IFNGR2,OAS2,GBP3,IRF8,DDX58,GBP2,RSAD2,ICAM1,OASL,IFI27,ISG20,IFNAR2,ISG15
R-HSA-71240	Tryptophan catabolism	0.000220563526808156	-8.41932480113285	13	5	0.0102459016393443	488	10287	8942,6999,3620,8140,8564	KYNU,TDO2,IDO1,SLC7A5,KMO
R-HSA-202733	Cell surface interactions at the vascular wall	0.000232335067225956	-8.36732997294724	136	17	0.0348360655737705	488	10287	5197,23657,9056,3684,2207,2888,8140,857,6385,960,54210,6401,2886,4312,4067,83953,3687	PF4V1,SLC7A11,SLC7A7,ITGAM,FCER1G,GRB14,SLC7A5,CAV1,SDC4,CD44,TREM1,SELE,GRB7,MMP1,LYN,FCAMR,ITGAX
R-HSA-446652	Interleukin-1 signaling	0.000258806422283133	-8.25943018002281	46	9	0.0184426229508197	488	10287	1326,3553,11213,3557,4790,3656,8767,3552,64127	MAP3K8,IL1B,IRAK3,IL1RN,NFKB1,IRAK2,RIPK2,IL1A,NOD2
R-HSA-445989	TAK1 activates NFkB by phosphorylation and activation of IKKs complex	0.000324831130126122	-8.03220511028513	29	7	0.014344262295082	488	10287	64127,4790,3656,8767,6288,4791,4792	NOD2,NFKB1,IRAK2,RIPK2,SAA1,NFKB2,NFKBIA
R-HSA-1442490	Collagen degradation	0.000485945216921444	-7.62941466280129	40	8	0.0163934426229508	488	10287	1305,4321,4322,4318,4312,4316,4319,4314	COL13A1,MMP12,MMP13,MMP9,MMP1,MMP7,MMP10,MMP3
R-HSA-1474228	Degradation of the extracellular matrix	0.000741155626088608	-7.20729993300764	111	14	0.0286885245901639	488	10287	3918,1520,960,4321,1305,4322,3914,56999,4312,4318,9507,4314,4316,4319	LAMC2,CTSS,CD44,MMP12,COL13A1,MMP13,LAMB3,ADAMTS9,MMP1,MMP9,ADAMTS4,MMP3,MMP7,MMP10
R-HSA-933542	TRAF6 mediated NF-kB activation	0.000904437711231773	-7.00819712091565	25	6	0.0122950819672131	488	10287	4790,64135,4792,23586,4791,6288	NFKB1,IFIH1,NFKBIA,DDX58,NFKB2,SAA1
R-HSA-168898	Toll-Like Receptors Cascades	0.000923499415994156	-6.98734039070833	153	17	0.0348360655737705	488	10287	6279,3656,3725,4790,1326,1520,64127,4791,8767,3684,7097,11213,6280,4792,330,6288,1848	S100A8,IRAK2,JUN,NFKB1,MAP3K8,CTSS,NOD2,NFKB2,RIPK2,ITGAM,TLR2,IRAK3,S100A9,NFKBIA,BIRC3,SAA1,DUSP6
R-HSA-6783589	Interleukin-6 family signaling	0.00139459633192971	-6.57515027337607	27	6	0.0122950819672131	488	10287	3976,3589,10148,3569,23529,3592	LIF,IL11,EBI3,IL6,CLCF1,IL12A
R-HSA-5689896	Ovarian tumor domain proteases	0.00154248631171283	-6.47435967631627	37	7	0.014344262295082	488	10287	64135,64127,7128,79931,8767,23586,10318	IFIH1,NOD2,TNFAIP3,TNIP3,RIPK2,DDX58,TNIP1
R-HSA-168179	Toll Like Receptor TLR1:TLR2 Cascade	0.00171515904706879	-6.36824946384859	95	12	0.0245901639344262	488	10287	64127,4791,4792,1848,6288,8767,7097,3725,4790,3656,1326,11213	NOD2,NFKB2,NFKBIA,DUSP6,SAA1,RIPK2,TLR2,JUN,NFKB1,IRAK2,MAP3K8,IRAK3
R-HSA-168188	Toll Like Receptor TLR6:TLR2 Cascade	0.00171515904706879	-6.36824946384859	95	12	0.0245901639344262	488	10287	64127,1848,8767,6288,4791,4792,4790,3725,3656,7097,11213,1326	NOD2,DUSP6,RIPK2,SAA1,NFKB2,NFKBIA,NFKB1,JUN,IRAK2,TLR2,IRAK3,MAP3K8
R-HSA-166058	MyD88:Mal cascade initiated on plasma membrane	0.00171515904706879	-6.36824946384859	95	12	0.0245901639344262	488	10287	1326,11213,7097,3656,3725,4790,4792,4791,6288,8767,1848,64127	MAP3K8,IRAK3,TLR2,IRAK2,JUN,NFKB1,NFKBIA,NFKB2,SAA1,RIPK2,DUSP6,NOD2
R-HSA-181438	Toll Like Receptor 2 (TLR2) Cascade	0.00171515904706879	-6.36824946384859	95	12	0.0245901639344262	488	10287	64127,4792,4791,6288,8767,1848,7097,3656,4790,3725,1326,11213	NOD2,NFKBIA,NFKB2,SAA1,RIPK2,DUSP6,TLR2,IRAK2,NFKB1,JUN,MAP3K8,IRAK3
R-HSA-6788467	IL-6-type cytokine receptor ligand interactions	0.00201625109568052	-6.20651538510007	20	5	0.0102459016393443	488	10287	23529,3592,3589,10148,3976	CLCF1,IL12A,IL11,EBI3,LIF
R-HSA-425407	SLC-mediated transmembrane transport	0.00244464917916813	-6.01385365135307	287	25	0.0512295081967213	488	10287	8671,6534,6513,84102,6547,64116,80736,124935,3099,64078,115019,6542,51458,6523,23657,64849,9056,6506,6580,28231,8140,11182,28232,51296,23382	SLC4A4,SLC6A7,SLC2A1,SLC41A2,SLC8A3,SLC39A8,SLC44A4,SLC43A2,HK2,SLC28A3,SLC26A9,SLC7A2,RHCG,SLC5A1,SLC7A11,SLC13A3,SLC7A7,SLC1A2,SLC22A1,SLCO4A1,SLC7A5,SLC2A6,SLCO3A1,SLC15A3,AHCYL2
R-HSA-5669034	TNFs bind their physiological receptors	0.0024795083292827	-5.99969499278172	30	6	0.0122950819672131	488	10287	970,7133,4982,943,3604,8995	CD70,TNFRSF1B,TNFRSF11B,TNFRSF8,TNFRSF9,TNFSF18
R-HSA-75205	Dissolution of Fibrin Clot	0.00253909697190942	-5.97594678403524	13	4	0.00819672131147541	488	10287	5329,5327,5270,5055	PLAUR,PLAT,SERPINE2,SERPINB2
R-HSA-166016	Toll Like Receptor 4 (TLR4) Cascade	0.00254242575347912	-5.97463663263939	126	14	0.0286885245901639	488	10287	330,4792,4791,8767,6288,1848,64127,1326,11213,3684,7097,3656,3725,4790	BIRC3,NFKBIA,NFKB2,RIPK2,SAA1,DUSP6,NOD2,MAP3K8,IRAK3,ITGAM,TLR2,IRAK2,JUN,NFKB1
R-HSA-166054	Activated TLR4 signalling	0.00307117857994505	-5.78569388879242	115	13	0.0266393442622951	488	10287	8767,6288,1848,330,4792,4791,64127,11213,1326,3656,3725,4790,7097	RIPK2,SAA1,DUSP6,BIRC3,NFKBIA,NFKB2,NOD2,IRAK3,MAP3K8,IRAK2,JUN,NFKB1,TLR2
R-HSA-5603029	IkBA variant leads to EDA-ID	0.003217979228597	-5.73900168518822	7	3	0.00614754098360656	488	10287	4792,4791,4790	NFKBIA,NFKB2,NFKB1
R-HSA-1592389	Activation of Matrix Metalloproteinases	0.00349235967003342	-5.65717764801738	32	6	0.0122950819672131	488	10287	4312,4322,4318,4314,4319,4316	MMP1,MMP13,MMP9,MMP3,MMP10,MMP7
R-HSA-168638	NOD1/2 Signaling Pathway	0.00349235967003342	-5.65717764801738	32	6	0.0122950819672131	488	10287	330,8767,1540,64127,7128,3656	BIRC3,RIPK2,CYLD,NOD2,TNFAIP3,IRAK2
R-HSA-114604	GPVI-mediated activation cascade	0.00367738872786397	-5.60555236349534	54	8	0.0163934426229508	488	10287	2207,3561,8503,3937,3559,5880,4067,1437	FCER1G,IL2RG,PIK3R3,LCP2,IL2RA,RAC2,LYN,CSF2
R-HSA-5668541	TNFR2 non-canonical NF-kB pathway	0.0036936638244621	-5.60113640717688	104	12	0.0245901639344262	488	10287	970,7133,5699,3604,943,5971,4791,330,5698,5721,4982,8995	CD70,TNFRSF1B,PSMB10,TNFRSF9,TNFRSF8,RELB,NFKB2,BIRC3,PSMB9,PSME2,TNFRSF11B,TNFSF18
R-HSA-881907	Gastrin-CREB signalling pathway via PKC and MAPK	0.00374642512600208	-5.58695319341177	443	34	0.069672131147541	488	10287	1847,4314,1844,5698,1848,5021,2247,2642,623,1910,2668,2903,5721,8111,4233,11343,1839,2151,147,3561,1850,6708,1437,10125,6288,2847,9162,8503,3559,26281,5699,2069,10887,3710	DUSP5,MMP3,DUSP2,PSMB9,DUSP6,OXTR,FGF2,GCGR,BDKRB1,EDNRB,GDNF,GRIN2A,PSME2,GPR68,MET,MGLL,HBEGF,F2RL2,ADRA1B,IL2RG,DUSP8,SPTA1,CSF2,RASGRP1,SAA1,MCHR1,DGKI,PIK3R3,IL2RA,FGF20,PSMB10,EREG,PROKR1,ITPR3
R-HSA-112409	RAF-independent MAPK1/3 activation	0.00389070480119984	-5.54916495493569	23	5	0.0102459016393443	488	10287	1844,1847,1848,1850,3569	DUSP2,DUSP5,DUSP6,DUSP8,IL6
R-HSA-193807	Synthesis of bile acids and bile salts via 27-hydroxycholesterol	0.00449456912409264	-5.40488547236219	15	4	0.00819672131147541	488	10287	9420,1646,1645,1581	CYP7B1,AKR1C2,AKR1C1,CYP7A1
R-HSA-5603027	IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR)	0.00496839949058928	-5.30465752482437	8	3	0.00614754098360656	488	10287	4790,4791,4792	NFKB1,NFKB2,NFKBIA
R-HSA-975871	MyD88 cascade initiated on plasma membrane	0.0062144708428284	-5.08087469958658	84	10	0.0204918032786885	488	10287	6288,8767,1848,4792,4791,64127,1326,3656,3725,4790	SAA1,RIPK2,DUSP6,NFKBIA,NFKB2,NOD2,MAP3K8,IRAK2,JUN,NFKB1
R-HSA-168142	Toll Like Receptor 10 (TLR10) Cascade	0.0062144708428284	-5.08087469958658	84	10	0.0204918032786885	488	10287	3725,4790,3656,1326,64127,4791,4792,1848,8767,6288	JUN,NFKB1,IRAK2,MAP3K8,NOD2,NFKB2,NFKBIA,DUSP6,RIPK2,SAA1
R-HSA-168176	Toll Like Receptor 5 (TLR5) Cascade	0.0062144708428284	-5.08087469958658	84	10	0.0204918032786885	488	10287	3656,3725,4790,1326,64127,8767,6288,1848,4792,4791	IRAK2,JUN,NFKB1,MAP3K8,NOD2,RIPK2,SAA1,DUSP6,NFKBIA,NFKB2
R-HSA-168928	RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways	0.0062144708428284	-5.08087469958658	84	10	0.0204918032786885	488	10287	1540,9636,7128,4790,64135,3659,4792,23586,4791,6288	CYLD,ISG15,TNFAIP3,NFKB1,IFIH1,IRF1,NFKBIA,DDX58,NFKB2,SAA1
R-HSA-351200	Interconversion of polyamines	0.00652579493017166	-5.03199250481506	3	2	0.00409836065573771	488	10287	6303,54498	SAT1,SMOX
R-HSA-210991	Basigin interactions	0.00676558728417793	-4.99590620897983	26	5	0.0102459016393443	488	10287	23657,4312,857,9056,8140	SLC7A11,MMP1,CAV1,SLC7A7,SLC7A5
R-HSA-168643	Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	0.00704436393257627	-4.95552742407004	48	7	0.014344262295082	488	10287	330,8767,1540,7295,64127,7128,3656	BIRC3,RIPK2,CYLD,TXN,NOD2,TNFAIP3,IRAK2
R-HSA-2022090	Assembly of collagen fibrils and other multimeric structures	0.0070617774098234	-4.9530585013973	60	8	0.0163934426229508	488	10287	3914,4322,1520,3918,4316,1294,4314,4318	LAMB3,MMP13,CTSS,LAMC2,MMP7,COL7A1,MMP3,MMP9
R-HSA-168164	Toll Like Receptor 3 (TLR3) Cascade	0.00708530093071926	-4.94973293239863	99	11	0.0225409836065574	488	10287	8767,6288,1848,330,4792,4791,64127,1326,3656,4790,3725	RIPK2,SAA1,DUSP6,BIRC3,NFKBIA,NFKB2,NOD2,MAP3K8,IRAK2,NFKB1,JUN
R-HSA-937061	TRIF-mediated TLR3/TLR4 signaling	0.00708530093071926	-4.94973293239863	99	11	0.0225409836065574	488	10287	64127,6288,8767,1848,4792,330,4791,3656,3725,4790,1326	NOD2,SAA1,RIPK2,DUSP6,NFKBIA,BIRC3,NFKB2,IRAK2,JUN,NFKB1,MAP3K8
R-HSA-166166	MyD88-independent TLR3/TLR4 cascade	0.00708530093071926	-4.94973293239863	99	11	0.0225409836065574	488	10287	64127,330,4792,4791,8767,6288,1848,3656,3725,4790,1326	NOD2,BIRC3,NFKBIA,NFKB2,RIPK2,SAA1,DUSP6,IRAK2,JUN,NFKB1,MAP3K8
R-HSA-111453	BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members	0.00719217171839661	-4.93476210579132	9	3	0.00614754098360656	488	10287	27113,637,5366	BBC3,BID,PMAIP1
R-HSA-2214320	Anchoring fibril formation	0.00719217171839661	-4.93476210579132	9	3	0.00614754098360656	488	10287	3918,1294,3914	LAMC2,COL7A1,LAMB3
R-HSA-8854691	Interleukin-19, 20, 22, 24	0.00719217171839661	-4.93476210579132	9	3	0.00614754098360656	488	10287	11009,29949,50604	IL24,IL19,IL20
R-HSA-193639	p75NTR signals via NF-kB	0.00726824649365205	-4.92424021410145	17	4	0.00819672131147541	488	10287	8767,4792,4790,4803	RIPK2,NFKBIA,NFKB1,NGF
R-HSA-2871796	FCERI mediated MAPK activation	0.0075877566045745	-4.88121930378459	265	22	0.0450819672131148	488	10287	6708,3937,1850,3561,5699,2069,26281,3725,1839,4067,4233,5721,2903,2668,3559,2247,1848,10125,5698,1437,1844,1847	SPTA1,LCP2,DUSP8,IL2RG,PSMB10,EREG,FGF20,JUN,HBEGF,LYN,MET,PSME2,GRIN2A,GDNF,IL2RA,FGF2,DUSP6,RASGRP1,PSMB9,CSF2,DUSP2,DUSP5
R-HSA-382551	Transmembrane transport of small molecules	0.00830472766418805	-4.79093032824406	677	46	0.0942622950819672	488	10287	6542,6523,23327,115019,2495,266675,5698,28232,11182,490,3162,4645,245973,6547,6534,64078,5721,50617,3099,124935,6446,64849,23657,51458,6506,9056,366,28231,6580,23382,51296,26154,8140,8671,24,84102,1080,6338,5699,4363,8989,6513,80736,64116,3934,8714	SLC7A2,SLC5A1,NEDD4L,SLC26A9,FTH1,BEST4,PSMB9,SLCO3A1,SLC2A6,ATP2B1,HMOX1,MYO5B,ATP6V1C2,SLC8A3,SLC6A7,SLC28A3,PSME2,ATP6V0A4,HK2,SLC43A2,SGK1,SLC13A3,SLC7A11,RHCG,SLC1A2,SLC7A7,AQP9,SLCO4A1,SLC22A1,AHCYL2,SLC15A3,ABCA12,SLC7A5,SLC4A4,ABCA4,SLC41A2,CFTR,SCNN1B,PSMB10,ABCC1,TRPA1,SLC2A1,SLC44A4,SLC39A8,LCN2,ABCC3
R-HSA-5621481	C-type lectin receptors (CLRs)	0.00838228828382117	-4.78163433686845	144	14	0.0286885245901639	488	10287	4067,5698,4792,4791,5721,26253,4586,10071,3710,3553,5699,2207,4790,5971	LYN,PSMB9,NFKBIA,NFKB2,PSME2,CLEC4E,MUC5AC,MUC12,ITPR3,IL1B,PSMB10,FCER1G,NFKB1,RELB
R-HSA-5621480	Dectin-2 family	0.00935178032198774	-4.67218854503825	28	5	0.0102459016393443	488	10287	4067,4586,10071,2207,26253	LYN,MUC5AC,MUC12,FCER1G,CLEC4E
R-HSA-512988	Interleukin-3, 5 and GM-CSF signaling	0.00974817606713319	-4.63067508150978	271	22	0.0450819672131148	488	10287	5721,3055,2903,4067,4233,2069,5699,26281,1839,6708,1850,3561,1844,1847,10125,1848,5698,1437,2247,2668,3559,8503	PSME2,HCK,GRIN2A,LYN,MET,EREG,PSMB10,FGF20,HBEGF,SPTA1,DUSP8,IL2RG,DUSP2,DUSP5,RASGRP1,DUSP6,PSMB9,CSF2,FGF2,GDNF,IL2RA,PIK3R3
R-HSA-2454202	Fc epsilon receptor (FCERI) signaling	0.0104604434068118	-4.56015443053524	372	28	0.0573770491803279	488	10287	3561,1850,3937,6708,3710,1839,26281,3725,4790,2069,5699,4233,4067,2903,5721,941,8503,3559,2668,2247,2207,1437,5698,4792,1848,10125,1847,1844	IL2RG,DUSP8,LCP2,SPTA1,ITPR3,HBEGF,FGF20,JUN,NFKB1,EREG,PSMB10,MET,LYN,GRIN2A,PSME2,CD80,PIK3R3,IL2RA,GDNF,FGF2,FCER1G,CSF2,PSMB9,NFKBIA,DUSP6,RASGRP1,DUSP5,DUSP2
R-HSA-975138	TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation	0.0107901909475244	-4.5291178031565	91	10	0.0204918032786885	488	10287	1326,3656,3725,4790,4792,4791,6288,8767,1848,64127	MAP3K8,IRAK2,JUN,NFKB1,NFKBIA,NFKB2,SAA1,RIPK2,DUSP6,NOD2
R-HSA-372790	Signaling by GPCR	0.0109136659886271	-4.51773951462381	1299	79	0.161885245901639	488	10287	2914,53831,6364,719,2863,3627,9034,135,5699,6752,4283,1437,2919,8503,6373,9340,11343,2920,64108,9283,5721,1850,6004,147,5698,2918,3576,5999,5021,1844,1910,6372,6374,6363,57007,26230,6346,3710,10887,2069,7852,26281,6288,2847,10125,5996,283365,643,3559,6376,9162,7474,9628,90226,26575,8111,4233,5880,2903,718,1604,3561,6708,2151,6352,1839,1236,1848,1847,11211,5142,4314,623,2642,134864,150,2668,2247,2921	GRM4,GPR84,CCL20,C3AR1,GPR39,CXCL10,CCRL2,ADORA2A,PSMB10,SSTR2,CXCL9,CSF2,CXCL1,PIK3R3,CXCL11,GLP2R,MGLL,CXCL2,RTP4,GPR37L1,PSME2,DUSP8,RGS16,ADRA1B,PSMB9,GRM8,CXCL8,RGS4,OXTR,DUSP2,EDNRB,CXCL6,CXCL5,CCL19,ACKR3,TIAM2,CCL1,ITPR3,PROKR1,EREG,CXCR4,FGF20,SAA1,MCHR1,RASGRP1,RGS1,OR6C6,CXCR5,IL2RA,CX3CL1,DGKI,WNT5A,RGS6,UCN2,RGS17,GPR68,MET,RAC2,GRIN2A,C3,CD55,IL2RG,SPTA1,F2RL2,CCL5,HBEGF,CCR7,DUSP6,DUSP5,FZD10,PDE4B,MMP3,BDKRB1,GCGR,TAAR1,ADRA2A,GDNF,FGF2,CXCL3
R-HSA-913709	O-linked glycosylation of mucins	0.0113457117142527	-4.47891542898044	65	8	0.0163934426229508	488	10287	6482,79623,51301,10164,50614,10071,6484,4586	ST3GAL1,GALNT14,GCNT4,CHST4,GALNT9,MUC12,ST3GAL4,MUC5AC
R-HSA-425393	Transport of inorganic cations/anions and amino acids/oligopeptides	0.012432768962758	-4.38741963376599	107	11	0.0225409836065574	488	10287	6547,9056,6506,6542,23657,115019,8671,51296,124935,23382,8140	SLC8A3,SLC7A7,SLC1A2,SLC7A2,SLC7A11,SLC26A9,SLC4A4,SLC15A3,SLC43A2,AHCYL2,SLC7A5
R-HSA-1474290	Collagen formation	0.0124774798786511	-4.38382986923242	93	10	0.0204918032786885	488	10287	4316,1294,169044,4314,4318,3914,1305,4322,1520,3918	MMP7,COL7A1,COL22A1,MMP3,MMP9,LAMB3,COL13A1,MMP13,CTSS,LAMC2
R-HSA-975155	MyD88 dependent cascade initiated on endosome	0.0124774798786511	-4.38382986923242	93	10	0.0204918032786885	488	10287	4791,4792,1848,8767,6288,64127,1326,3725,4790,3656	NFKB2,NFKBIA,DUSP6,RIPK2,SAA1,NOD2,MAP3K8,JUN,NFKB1,IRAK2
R-HSA-168181	Toll Like Receptor 7/8 (TLR7/8) Cascade	0.0124774798786511	-4.38382986923242	93	10	0.0204918032786885	488	10287	1326,3725,4790,3656,4791,4792,1848,8767,6288,64127	MAP3K8,JUN,NFKB1,IRAK2,NFKB2,NFKBIA,DUSP6,RIPK2,SAA1,NOD2
R-HSA-428542	Regulation of Commissural axon pathfinding by Slit and Robo	0.0126420784223443	-4.37072447163341	4	2	0.00409836065573771	488	10287	6092,9353	ROBO2,SLIT2
R-HSA-447115	Interleukin-12 signaling	0.0126420784223443	-4.37072447163341	4	2	0.00409836065573771	488	10287	3592,3593	IL12A,IL12B
R-HSA-173736	Alternative complement activation	0.0126420784223443	-4.37072447163341	4	2	0.00409836065573771	488	10287	629,718	CFB,C3
R-HSA-162582	Signal Transduction	0.0143671344885184	-4.24281200806479	2548	142	0.290983606557377	488	10287	2919,6752,1437,27121,10252,1645,284654,8767,2914,53831,8828,719,6364,92737,6658,3627,5699,4790,3576,5021,330,2918,1844,23327,3624,83595,1910,1030,9283,5721,6004,1850,147,2886,3914,6288,4792,283365,3559,90226,6376,91010,64220,4318,26230,3710,10887,24,7852,2069,1080,195814,723790,1236,4314,11211,2642,2921,5880,26575,50617,718,375790,2151,4283,113878,2986,8503,3569,83478,9340,6373,84870,2863,9938,9034,135,1540,5999,5698,64321,941,6374,6363,6372,11343,4067,2920,64108,4688,6385,5327,2847,5957,10125,5996,857,643,644150,9628,7128,7474,4803,9162,23767,4023,57007,23286,6346,650,51176,26281,116984,1848,4629,6461,1847,5142,150,2668,134864,54567,10046,7185,623,2247,8111,4233,23002,658,2903,6484,8313,3918,6708,1604,3561,3725,245973,595,6352,1839	CXCL1,SSTR2,CSF2,DKK4,SPRY1,AKR1C1,RSPO1,RIPK2,GRM4,GPR84,NRP2,C3AR1,CCL20,DNER,SOX3,CXCL10,PSMB10,NFKB1,CXCL8,OXTR,BIRC3,GRM8,DUSP2,NEDD4L,INHBA,SOX7,EDNRB,CDKN2B,GPR37L1,PSME2,RGS16,DUSP8,ADRA1B,GRB7,LAMB3,SAA1,NFKBIA,OR6C6,IL2RA,UCN2,CX3CL1,FMNL3,STRA6,MMP9,TIAM2,ITPR3,PROKR1,ABCA4,CXCR4,EREG,CFTR,SDR16C5,HIST2H2AA4,CCR7,MMP3,FZD10,GCGR,CXCL3,RAC2,RGS17,ATP6V0A4,C3,AGRN,F2RL2,CXCL9,DTX2,GUCY2F,PIK3R3,IL6,ARHGAP24,GLP2R,CXCL11,RSPO3,GPR39,ARHGAP25,CCRL2,ADORA2A,CYLD,RGS4,PSMB9,SOX17,CD80,CXCL5,CCL19,CXCL6,MGLL,LYN,CXCL2,RTP4,NCF2,SDC4,PLAT,MCHR1,RCVRN,RASGRP1,RGS1,CAV1,CXCR5,WIPF3,RGS6,TNFAIP3,WNT5A,NGF,DGKI,FLRT3,LPL,ACKR3,WWC1,CCL1,BMP2,LEF1,FGF20,ARAP2,DUSP6,MYH11,SHB,DUSP5,PDE4B,ADRA2A,GDNF,TAAR1,DLL4,MAMLD1,TRAF1,BDKRB1,FGF2,GPR68,MET,DAAM1,BMPR1B,GRIN2A,ST3GAL4,AXIN2,LAMC2,SPTA1,CD55,IL2RG,JUN,ATP6V1C2,CCND1,CCL5,HBEGF
R-HSA-352230	Amino acid transport across the plasma membrane	0.0143930098374912	-4.24101261821047	31	5	0.0102459016393443	488	10287	124935,8140,9056,23657,6542	SLC43A2,SLC7A5,SLC7A7,SLC7A11,SLC7A2
R-HSA-216083	Integrin cell surface interactions	0.0146962347454222	-4.22016395777404	68	8	0.0163934426229508	488	10287	3386,3687,3383,960,1305,7087,375790,3684	ICAM4,ITGAX,ICAM1,CD44,COL13A1,ICAM5,AGRN,ITGAM
R-HSA-187706	Signalling to p38 via RIT and RIN	0.0148521452830852	-4.20961096065985	249	20	0.040983606557377	488	10287	4803,2247,2668,3559,1844,1847,10125,1848,5698,1437,2069,5699,26281,1839,6708,3561,1850,5721,2903,4233	NGF,FGF2,GDNF,IL2RA,DUSP2,DUSP5,RASGRP1,DUSP6,PSMB9,CSF2,EREG,PSMB10,FGF20,HBEGF,SPTA1,IL2RG,DUSP8,PSME2,GRIN2A,MET
R-HSA-170984	ARMS-mediated activation	0.0148521452830852	-4.20961096065985	249	20	0.040983606557377	488	10287	6708,3561,1850,2069,5699,26281,1839,4233,5721,2903,2668,3559,2247,4803,1848,10125,5698,1437,1844,1847	SPTA1,IL2RG,DUSP8,EREG,PSMB10,FGF20,HBEGF,MET,PSME2,GRIN2A,GDNF,IL2RA,FGF2,NGF,DUSP6,RASGRP1,PSMB9,CSF2,DUSP2,DUSP5
R-HSA-6798695	Neutrophil degranulation	0.0150619307773872	-4.19558485915823	487	34	0.069672131147541	488	10287	4318,53831,719,3934,5004,272,1520,5329,4790,7130,79930,6317,2919,4033,5317,3684,718,3687,6278,6616,1118,1604,960,6279,154664,5806,5005,8876,6280,7097,2268,7133,2207,2495	MMP9,GPR84,C3AR1,LCN2,ORM1,AMPD3,CTSS,PLAUR,NFKB1,TNFAIP6,DOK3,SERPINB3,CXCL1,LRMP,PKP1,ITGAM,C3,ITGAX,S100A7,SNAP25,CHIT1,CD55,CD44,S100A8,ABCA13,PTX3,ORM2,VNN1,S100A9,TLR2,FGR,TNFRSF1B,FCER1G,FTH1
R-HSA-194068	Bile acid and bile salt metabolism	0.0151578382864622	-4.18923750217658	43	6	0.0122950819672131	488	10287	9023,1645,8714,1581,1646,9420	CH25H,AKR1C1,ABCC3,CYP7A1,AKR1C2,CYP7B1
R-HSA-170968	Frs2-mediated activation	0.0154571860319867	-4.16968126843205	250	20	0.040983606557377	488	10287	4233,2903,5721,3561,1850,6708,1839,2069,5699,26281,5698,1437,1848,10125,1847,1844,3559,2668,2247,4803	MET,GRIN2A,PSME2,IL2RG,DUSP8,SPTA1,HBEGF,EREG,PSMB10,FGF20,PSMB9,CSF2,DUSP6,RASGRP1,DUSP5,DUSP2,IL2RA,GDNF,FGF2,NGF
R-HSA-6803204	TP53 Regulates Transcription of Genes Involved in Cytochrome C Release	0.0157349274851106	-4.1518723569854	21	4	0.00819672131147541	488	10287	8626,27113,5366,637	TP63,BBC3,PMAIP1,BID
R-HSA-381426	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)	0.0157349274851106	-4.1518723569854	21	4	0.00819672131147541	488	10287	5069,3484,4312,60676	PAPPA,IGFBP1,MMP1,PAPPA2
R-HSA-1810476	RIP-mediated NFkB activation via ZBP1	0.0157349274851106	-4.1518723569854	21	4	0.00819672131147541	488	10287	4790,4791,4792,6288	NFKB1,NFKB2,NFKBIA,SAA1
R-HSA-5684996	MAPK1/MAPK3 signaling	0.0160814600845638	-4.13008821807466	251	20	0.040983606557377	488	10287	2247,2668,3559,3569,1844,1847,1848,10125,1437,5698,26281,5699,2069,1839,6708,3561,1850,5721,2903,4233	FGF2,GDNF,IL2RA,IL6,DUSP2,DUSP5,DUSP6,RASGRP1,CSF2,PSMB9,FGF20,PSMB10,EREG,HBEGF,SPTA1,IL2RG,DUSP8,PSME2,GRIN2A,MET
R-HSA-196071	Metabolism of steroid hormones	0.0164116487575747	-4.10976390619259	32	5	0.0102459016393443	488	10287	441282,6716,1586,3290,231	AKR1B15,SRD5A2,CYP17A1,HSD11B1,AKR1B1
R-HSA-168138	Toll Like Receptor 9 (TLR9) Cascade	0.0164388039049504	-4.10811064717422	97	10	0.0204918032786885	488	10287	1326,3725,4790,3656,4791,4792,1848,8767,6288,64127	MAP3K8,JUN,NFKB1,IRAK2,NFKB2,NFKBIA,DUSP6,RIPK2,SAA1,NOD2
R-HSA-169893	Prolonged ERK activation events	0.0167253646952142	-4.0908288678116	252	20	0.040983606557377	488	10287	2247,4803,3559,2668,1847,1844,5698,1437,10125,1848,1839,5699,2069,26281,3561,1850,6708,2903,5721,4233	FGF2,NGF,IL2RA,GDNF,DUSP5,DUSP2,PSMB9,CSF2,RASGRP1,DUSP6,HBEGF,PSMB10,EREG,FGF20,IL2RG,DUSP8,SPTA1,GRIN2A,PSME2,MET
R-HSA-6788656	Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism	0.0168700755513361	-4.08221390399113	44	6	0.0122950819672131	488	10287	8564,8140,259307,3620,8942,6999	KMO,SLC7A5,IL4I1,IDO1,KYNU,TDO2
R-HSA-8853659	RET signaling	0.0177464348589815	-4.03157063624951	270	21	0.0430327868852459	488	10287	2247,3559,8503,2668,1847,1844,1437,5698,10125,1848,1839,2886,26281,2069,5699,3561,1850,6708,2903,5721,4233	FGF2,IL2RA,PIK3R3,GDNF,DUSP5,DUSP2,CSF2,PSMB9,RASGRP1,DUSP6,HBEGF,GRB7,FGF20,EREG,PSMB10,IL2RG,DUSP8,SPTA1,GRIN2A,PSME2,MET
R-HSA-196854	Metabolism of vitamins and cofactors	0.018333824259986	-3.99900760495888	174	15	0.0307377049180328	488	10287	1645,6513,4363,10135,375790,54625,6385,8876,5743,4023,8875,1591,952,441024,1594	AKR1C1,SLC2A1,ABCC1,NAMPT,AGRN,PARP14,SDC4,VNN1,PTGS2,LPL,VNN2,CYP24A1,CD38,MTHFD2L,CYP27B1
R-HSA-3000171	Non-integrin membrane-ECM interactions	0.0187109287403508	-3.97864750121346	45	6	0.0122950819672131	488	10287	3918,6385,3914,9378,375790,2247	LAMC2,SDC4,LAMB3,NRXN1,AGRN,FGF2
R-HSA-912526	Interleukin receptor SHC signaling	0.0187788485031354	-3.97502412214388	255	20	0.040983606557377	488	10287	2247,8503,3559,2668,1847,1844,1437,5698,1848,10125,1839,26281,2069,5699,3561,1850,6708,2903,5721,4233	FGF2,PIK3R3,IL2RA,GDNF,DUSP5,DUSP2,CSF2,PSMB9,DUSP6,RASGRP1,HBEGF,FGF20,EREG,PSMB10,IL2RG,DUSP8,SPTA1,GRIN2A,PSME2,MET
R-HSA-422475	Axon guidance	0.0191115430551489	-3.95746277803741	549	37	0.0758196721311475	488	10287	4318,137970,8828,2069,5699,26281,1437,10125,3559,8503,286,4233,1943,4067,5880,2903,5721,2048,1850,3561,6708,80031,1839,2886,375790,5698,4629,6092,1848,1847,1844,6461,9353,214,27289,2668,2247	MMP9,UNC5D,NRP2,EREG,PSMB10,FGF20,CSF2,RASGRP1,IL2RA,PIK3R3,ANK1,MET,EFNA2,LYN,RAC2,GRIN2A,PSME2,EPHB2,DUSP8,IL2RG,SPTA1,SEMA6D,HBEGF,GRB7,AGRN,PSMB9,MYH11,ROBO2,DUSP6,DUSP5,DUSP2,SHB,SLIT2,ALCAM,RND1,GDNF,FGF2
R-HSA-167044	Signalling to RAS	0.0195052650580073	-3.93707084688195	256	20	0.040983606557377	488	10287	2668,3559,2247,4803,10125,1848,5698,1437,1844,1847,6708,3561,1850,5699,2069,26281,1839,4233,5721,2903	GDNF,IL2RA,FGF2,NGF,RASGRP1,DUSP6,PSMB9,CSF2,DUSP2,DUSP5,SPTA1,IL2RG,DUSP8,PSMB10,EREG,FGF20,HBEGF,MET,PSME2,GRIN2A
R-HSA-2142850	Hyaluronan biosynthesis and export	0.0204116955082232	-3.89164723318429	5	2	0.00409836065573771	488	10287	3036,3038	HAS1,HAS3
R-HSA-192105	Synthesis of bile acids and bile salts	0.0209937528412179	-3.86353036926731	34	5	0.0102459016393443	488	10287	1646,9420,1645,9023,1581	AKR1C2,CYP7B1,AKR1C1,CH25H,CYP7A1
R-HSA-5218921	VEGFR2 mediated cell proliferation	0.0210233811423472	-3.86212007288433	258	20	0.040983606557377	488	10287	2247,3559,2668,1847,1844,1437,5698,10125,1848,1839,26281,2069,5699,1850,3561,6708,3710,2903,5721,4233	FGF2,IL2RA,GDNF,DUSP5,DUSP2,CSF2,PSMB9,RASGRP1,DUSP6,HBEGF,FGF20,EREG,PSMB10,DUSP8,IL2RG,SPTA1,ITPR3,GRIN2A,PSME2,MET
R-HSA-3134963	DEx/H-box helicases activate type I IFN and inflammatory cytokines production	0.0212594618603997	-3.85095321869351	13	3	0.00614754098360656	488	10287	4791,6288,4790	NFKB2,SAA1,NFKB1
R-HSA-2029481	FCGR activation	0.0212594618603997	-3.85095321869351	13	3	0.00614754098360656	488	10287	2268,3055,4067	FGR,HCK,LYN
R-HSA-180336	SHC1 events in EGFR signaling	0.0240084522366259	-3.72934933410771	245	19	0.0389344262295082	488	10287	4233,5721,2903,6708,3561,1850,26281,2069,5699,1839,1848,10125,1437,5698,1844,1847,2668,3559,2247	MET,PSME2,GRIN2A,SPTA1,IL2RG,DUSP8,FGF20,EREG,PSMB10,HBEGF,DUSP6,RASGRP1,CSF2,PSMB9,DUSP2,DUSP5,GDNF,IL2RA,FGF2
R-HSA-5673001	RAF/MAP kinase cascade	0.0240084522366259	-3.72934933410771	245	19	0.0389344262295082	488	10287	4233,2903,5721,1850,3561,6708,1839,26281,5699,2069,1437,5698,10125,1848,1847,1844,3559,2668,2247	MET,GRIN2A,PSME2,DUSP8,IL2RG,SPTA1,HBEGF,FGF20,PSMB10,EREG,CSF2,PSMB9,RASGRP1,DUSP6,DUSP5,DUSP2,IL2RA,GDNF,FGF2
R-HSA-179812	GRB2 events in EGFR signaling	0.0240084522366259	-3.72934933410771	245	19	0.0389344262295082	488	10287	1437,5698,1848,10125,1847,1844,3559,2668,2247,4233,2903,5721,3561,1850,6708,1839,26281,5699,2069	CSF2,PSMB9,DUSP6,RASGRP1,DUSP5,DUSP2,IL2RA,GDNF,FGF2,MET,GRIN2A,PSME2,IL2RG,DUSP8,SPTA1,HBEGF,FGF20,PSMB10,EREG
R-HSA-112412	SOS-mediated signalling	0.0240084522366259	-3.72934933410771	245	19	0.0389344262295082	488	10287	1848,10125,5698,1437,1844,1847,2668,3559,2247,4233,5721,2903,6708,3561,1850,5699,2069,26281,1839	DUSP6,RASGRP1,PSMB9,CSF2,DUSP2,DUSP5,GDNF,IL2RA,FGF2,MET,PSME2,GRIN2A,SPTA1,IL2RG,DUSP8,PSMB10,EREG,FGF20,HBEGF
R-HSA-451927	Interleukin-2 signaling	0.0243319248672116	-3.71596601034648	262	20	0.040983606557377	488	10287	2247,2668,3559,8503,1844,1847,10125,1848,5698,1437,5699,2069,26281,1839,6708,3561,1850,5721,2903,4233	FGF2,GDNF,IL2RA,PIK3R3,DUSP2,DUSP5,RASGRP1,DUSP6,PSMB9,CSF2,PSMB10,EREG,FGF20,HBEGF,SPTA1,IL2RG,DUSP8,PSME2,GRIN2A,MET
R-HSA-5602358	Diseases associated with the TLR signaling cascade	0.0249860994457002	-3.68943563092358	24	4	0.00819672131147541	488	10287	4792,4791,7097,4790	NFKBIA,NFKB2,TLR2,NFKB1
R-HSA-193368	Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol	0.0249860994457002	-3.68943563092358	24	4	0.00819672131147541	488	10287	9420,1646,1581,1645	CYP7B1,AKR1C2,CYP7A1,AKR1C1
R-HSA-5260271	Diseases of Immune System	0.0249860994457002	-3.68943563092358	24	4	0.00819672131147541	488	10287	7097,4790,4791,4792	TLR2,NFKB1,NFKB2,NFKBIA
R-HSA-187687	Signalling to ERKs	0.0252181116603594	-3.68019282593698	263	20	0.040983606557377	488	10287	3559,2668,4803,2247,1437,5698,1848,10125,1847,1844,3561,1850,6708,1839,26281,5699,2069,4233,2903,5721	IL2RA,GDNF,NGF,FGF2,CSF2,PSMB9,DUSP6,RASGRP1,DUSP5,DUSP2,IL2RG,DUSP8,SPTA1,HBEGF,FGF20,PSMB10,EREG,MET,GRIN2A,PSME2
R-HSA-209560	NF-kB is activated and signals survival	0.0261240003752616	-3.6449008325771	14	3	0.00614754098360656	488	10287	4792,4803,4790	NFKBIA,NGF,NFKB1
R-HSA-936440	Negative regulators of RIG-I/MDA5 signaling	0.0263376151661456	-3.63675712715534	36	5	0.0102459016393443	488	10287	23586,64135,9636,7128,1540	DDX58,IFIH1,ISG15,TNFAIP3,CYLD
R-HSA-425366	Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds	0.0286505853333823	-3.55258140554554	106	10	0.0204918032786885	488	10287	11182,6580,64116,80736,6534,6513,84102,6523,51458,64849	SLC2A6,SLC22A1,SLC39A8,SLC44A4,SLC6A7,SLC2A1,SLC41A2,SLC5A1,RHCG,SLC13A3
R-HSA-1606322	ZBP1(DAI) mediated induction of type I IFNs	0.0286631310544255	-3.5521436143139	25	4	0.00819672131147541	488	10287	4790,6288,4791,4792	NFKB1,SAA1,NFKB2,NFKBIA
R-HSA-977068	Termination of O-glycan biosynthesis	0.0286631310544255	-3.5521436143139	25	4	0.00819672131147541	488	10287	6482,6484,10071,4586	ST3GAL1,ST3GAL4,MUC12,MUC5AC
R-HSA-187015	Activation of TRKA receptors	0.0296646580850277	-3.51779890520926	6	2	0.00409836065573771	488	10287	135,4803	ADORA2A,NGF
R-HSA-5336415	Uptake and function of diphtheria toxin	0.0296646580850277	-3.51779890520926	6	2	0.00409836065573771	488	10287	7296,1839	TXNRD1,HBEGF
R-HSA-211916	Vitamins	0.0296646580850277	-3.51779890520926	6	2	0.00409836065573771	488	10287	1591,1594	CYP24A1,CYP27B1
R-HSA-2142770	Synthesis of 15-eicosatetraenoic acid derivatives	0.0296646580850277	-3.51779890520926	6	2	0.00409836065573771	488	10287	247,5743	ALOX15B,PTGS2
R-HSA-5660668	CLEC7A/inflammasome pathway	0.0296646580850277	-3.51779890520926	6	2	0.00409836065573771	488	10287	4790,3553	NFKB1,IL1B
R-HSA-1433557	Signaling by SCF-KIT	0.030506560322675	-3.48981352595114	337	24	0.0491803278688525	488	10287	10125,1848,5698,1437,1844,1847,2668,3559,8503,941,2247,4067,4233,4318,5721,2903,6708,1850,3561,2069,5699,26281,2886,1839	RASGRP1,DUSP6,PSMB9,CSF2,DUSP2,DUSP5,GDNF,IL2RA,PIK3R3,CD80,FGF2,LYN,MET,MMP9,PSME2,GRIN2A,SPTA1,DUSP8,IL2RG,EREG,PSMB10,FGF20,GRB7,HBEGF
R-HSA-450294	MAP kinase activation in TLR cascade	0.031196370234543	-3.46745352957101	64	7	0.014344262295082	488	10287	3656,64127,4790,3725,1326,8767,1848	IRAK2,NOD2,NFKB1,JUN,MAP3K8,RIPK2,DUSP6
R-HSA-194138	Signaling by VEGF	0.0314375533528085	-3.45975213401639	338	24	0.0491803278688525	488	10287	2069,5699,26281,1839,3710,6708,3561,1850,5721,2903,8828,4233,4688,2247,2668,3559,1844,6461,1847,857,10125,1848,5698,1437	EREG,PSMB10,FGF20,HBEGF,ITPR3,SPTA1,IL2RG,DUSP8,PSME2,GRIN2A,NRP2,MET,NCF2,FGF2,GDNF,IL2RA,DUSP2,SHB,DUSP5,CAV1,RASGRP1,DUSP6,PSMB9,CSF2
R-HSA-2586552	Signaling by Leptin	0.032030837841891	-3.44105615766725	253	19	0.0389344262295082	488	10287	2903,5721,4233,1839,2069,5699,26281,1850,3561,6708,1847,1844,5698,1437,1848,10125,2247,3559,2668	GRIN2A,PSME2,MET,HBEGF,EREG,PSMB10,FGF20,DUSP8,IL2RG,SPTA1,DUSP5,DUSP2,PSMB9,CSF2,DUSP6,RASGRP1,FGF2,IL2RA,GDNF
R-HSA-5357956	TNFR1-induced NFkappaB signaling pathway	0.0326445026491972	-3.4220788095891	26	4	0.00819672131147541	488	10287	7185,330,1540,7128	TRAF1,BIRC3,CYLD,TNFAIP3
R-HSA-2219530	Constitutive Signaling by Aberrant PI3K in Cancer	0.0335921393664082	-3.39346318681127	65	7	0.014344262295082	488	10287	4233,941,8503,2069,26281,2247,1839	MET,CD80,PIK3R3,EREG,FGF20,FGF2,HBEGF
R-HSA-5683057	MAPK family signaling cascades	0.0353440263784946	-3.3426258859688	290	21	0.0430327868852459	488	10287	4233,5721,2903,6708,1850,3561,2069,5699,26281,3725,1839,1848,10125,5698,1437,1844,1847,2668,3559,3569,2247	MET,PSME2,GRIN2A,SPTA1,DUSP8,IL2RG,EREG,PSMB10,FGF20,JUN,HBEGF,DUSP6,RASGRP1,PSMB9,CSF2,DUSP2,DUSP5,GDNF,IL2RA,IL6,FGF2
R-HSA-400685	Sema4D in semaphorin signaling	0.0369328914496883	-3.29865275776726	27	4	0.00819672131147541	488	10287	5880,27289,4233,4629	RAC2,RND1,MET,MYH11
R-HSA-380994	ATF4 activates genes	0.0369328914496883	-3.29865275776726	27	4	0.00819672131147541	488	10287	6347,3576,3484,467	CCL2,CXCL8,IGFBP1,ATF3
R-HSA-977606	Regulation of Complement cascade	0.0369328914496883	-3.29865275776726	27	4	0.00819672131147541	488	10287	629,1604,718,719	CFB,CD55,C3,C3AR1
R-HSA-114508	Effects of PIP2 hydrolysis	0.0369328914496883	-3.29865275776726	27	4	0.00819672131147541	488	10287	9162,10125,11343,3710	DGKI,RASGRP1,MGLL,ITPR3
R-HSA-2559584	Formation of Senescence-Associated Heterochromatin Foci (SAHF)	0.0374760260206053	-3.28405385656626	16	3	0.00614754098360656	488	10287	8091,3008,3159	HMGA2,HIST1H1E,HMGA1
R-HSA-5686938	Regulation of TLR by endogenous ligand	0.0374760260206053	-3.28405385656626	16	3	0.00614754098360656	488	10287	7097,6279,6280	TLR2,S100A8,S100A9
R-HSA-6806667	Metabolism of fat-soluble vitamins	0.038503376613399	-3.25700933729006	53	6	0.0122950819672131	488	10287	4023,6385,1591,1594,1645,375790	LPL,SDC4,CYP24A1,CYP27B1,AKR1C1,AGRN
R-HSA-375165	NCAM signaling for neurite out-growth	0.0390998309956019	-3.24163713436328	276	20	0.040983606557377	488	10287	5699,2069,375790,26281,1839,6708,1850,3561,5721,2903,4233,2247,2668,3559,1844,1847,10125,1848,5698,1437	PSMB10,EREG,AGRN,FGF20,HBEGF,SPTA1,DUSP8,IL2RG,PSME2,GRIN2A,MET,FGF2,GDNF,IL2RA,DUSP2,DUSP5,RASGRP1,DUSP6,PSMB9,CSF2
R-HSA-416476	G alpha (q) signalling events	0.0395539445173297	-3.23008985479023	192	15	0.0307377049180328	488	10287	9162,2151,147,623,2642,1910,8503,10887,3710,8111,10125,5021,11343,6288,2847	DGKI,F2RL2,ADRA1B,BDKRB1,GCGR,EDNRB,PIK3R3,PROKR1,ITPR3,GPR68,RASGRP1,OXTR,MGLL,SAA1,MCHR1
R-HSA-174577	Activation of C3 and C5	0.0402433296285949	-3.21281101236439	7	2	0.00409836065573771	488	10287	718,629	C3,CFB
R-HSA-4411364	Binding of TCF/LEF:CTNNB1 to target gene promoters	0.0402433296285949	-3.21281101236439	7	2	0.00409836065573771	488	10287	51176,8313	LEF1,AXIN2
R-HSA-196791	Vitamin D (calciferol) metabolism	0.0402433296285949	-3.21281101236439	7	2	0.00409836065573771	488	10287	1594,1591	CYP27B1,CYP24A1
R-HSA-447038	NrCAM interactions	0.0402433296285949	-3.21281101236439	7	2	0.00409836065573771	488	10287	8828,286	NRP2,ANK1
R-HSA-4420097	VEGFA-VEGFR2 Pathway	0.0414632670638158	-3.18294737469762	330	23	0.0471311475409836	488	10287	3710,6708,1850,3561,5699,2069,26281,1839,4233,4688,5721,2903,2668,3559,2247,10125,1848,5698,1437,1844,6461,1847,857	ITPR3,SPTA1,DUSP8,IL2RG,PSMB10,EREG,FGF20,HBEGF,MET,NCF2,PSME2,GRIN2A,GDNF,IL2RA,FGF2,RASGRP1,DUSP6,PSMB9,CSF2,DUSP2,SHB,DUSP5,CAV1
R-HSA-211897	Cytochrome P450 - arranged by substrate type	0.0415034400764967	-3.18197896177139	68	7	0.014344262295082	488	10287	9420,1594,1551,1586,1591,1581,1577	CYP7B1,CYP27B1,CYP3A7,CYP17A1,CYP24A1,CYP7A1,CYP3A5
R-HSA-75876	Synthesis of very long-chain fatty acyl-CoAs	0.0415297433039531	-3.18134540233731	28	4	0.00819672131147541	488	10287	79993,51703,2181,2182	ELOVL7,ACSL5,ACSL3,ACSL4
R-HSA-2142845	Hyaluronan metabolism	0.0439491216348273	-3.12472264060636	17	3	0.00614754098360656	488	10287	3038,3036,960	HAS3,HAS1,CD44
R-HSA-5173105	O-linked glycosylation	0.0439897835432024	-3.1237978642246	114	10	0.0204918032786885	488	10287	50614,9507,4586,10071,6484,6482,10164,79623,51301,56999	GALNT9,ADAMTS4,MUC5AC,MUC12,ST3GAL4,ST3GAL1,CHST4,GALNT14,GCNT4,ADAMTS9
R-HSA-196807	Nicotinate metabolism	0.0464353222200439	-3.06969485461503	29	4	0.00819672131147541	488	10287	54625,10135,5743,952	PARP14,NAMPT,PTGS2,CD38
R-HSA-5263617	Metabolism of ingested MeSeO2H into MeSeH	0.047438514629938	-3.04832083528163	1	1	0.00204918032786885	488	10287	7296	TXNRD1
R-HSA-2172127	DAP12 interactions	0.0483858657430436	-3.02854753801105	371	25	0.0512295081967213	488	10287	1839,5699,2069,26281,3937,1850,3561,3710,54210,6708,2903,5721,4233,2247,3559,8503,941,2668,1847,1844,5698,1437,342510,10125,1848	HBEGF,PSMB10,EREG,FGF20,LCP2,DUSP8,IL2RG,ITPR3,TREM1,SPTA1,GRIN2A,PSME2,MET,FGF2,IL2RA,PIK3R3,CD80,GDNF,DUSP5,DUSP2,PSMB9,CSF2,CD300E,RASGRP1,DUSP6
R-HSA-5688426	Deubiquitination	0.0493550701564443	-3.0087147796475	301	21	0.0430327868852459	488	10287	8767,79931,10318,5721,64127,8975,8313,219333,5699,1080,8900,723790,1540,5698,330,4792,23586,90865,84101,7128,64135	RIPK2,TNIP3,TNIP1,PSME2,NOD2,USP13,AXIN2,USP12,PSMB10,CFTR,CCNA1,HIST2H2AA4,CYLD,PSMB9,BIRC3,NFKBIA,DDX58,IL33,USP44,TNFAIP3,IFIH1
R-HSA-5607764	CLEC7A (Dectin-1) signaling	0.0500177090358428	-2.99537815554432	101	9	0.0184426229508197	488	10287	3710,3553,5971,4790,5699,4791,5698,4792,5721	ITPR3,IL1B,RELB,NFKB1,PSMB10,NFKB2,PSMB9,NFKBIA,PSME2
R-HSA-197264	Nicotinamide salvaging	0.0509388463316367	-2.97712945727981	18	3	0.00614754098360656	488	10287	5743,54625,10135	PTGS2,PARP14,NAMPT
R-HSA-912631	Regulation of signaling by CBL	0.0509388463316367	-2.97712945727981	18	3	0.00614754098360656	488	10287	4067,8503,3055	LYN,PIK3R3,HCK
R-HSA-381042	PERK regulates gene expression	0.0516487643418929	-2.96328900738334	30	4	0.00819672131147541	488	10287	3484,3576,6347,467	IGFBP1,CXCL8,CCL2,ATF3
R-HSA-416550	Sema4D mediated inhibition of cell attachment and migration	0.0520016396721219	-2.95648002874165	8	2	0.00409836065573771	488	10287	4233,27289	MET,RND1
R-HSA-917937	Iron uptake and transport	0.0559091215504287	-2.88402773591769	44	5	0.0102459016393443	488	10287	3162,245973,3934,2495,50617	HMOX1,ATP6V1C2,LCN2,FTH1,ATP6V0A4
R-HSA-114452	Activation of BH3-only proteins	0.0571681353798456	-2.86175860959855	31	4	0.00819672131147541	488	10287	8626,27113,5366,637	TP63,BBC3,PMAIP1,BID
R-HSA-450321	JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1	0.0584309000620443	-2.8399104184262	19	3	0.00614754098360656	488	10287	8767,64127,3656	RIPK2,NOD2,IRAK2
R-HSA-166658	Complement cascade	0.0605588956513926	-2.8041389056303	45	5	0.0102459016393443	488	10287	10584,1604,629,719,718	COLEC10,CD55,CFB,C3AR1,C3
R-HSA-390696	Adrenoceptors	0.0648043448040481	-2.73638262842643	9	2	0.00409836065573771	488	10287	147,150	ADRA1B,ADRA2A
R-HSA-2179392	EGFR Transactivation by Gastrin	0.0648043448040481	-2.73638262842643	9	2	0.00409836065573771	488	10287	4314,1839	MMP3,HBEGF
R-HSA-1296052	Ca2+ activated K+ channels	0.0648043448040481	-2.73638262842643	9	2	0.00409836065573771	488	10287	3779,3783	KCNMB1,KCNN4
R-HSA-194002	Glucocorticoid biosynthesis	0.0648043448040481	-2.73638262842643	9	2	0.00409836065573771	488	10287	1586,3290	CYP17A1,HSD11B1
R-HSA-5689880	Ub-specific processing proteases	0.0648737438057531	-2.73531230098601	223	16	0.0327868852459016	488	10287	90865,84101,330,5698,4792,23586,64135,5721,8975,5699,1080,8900,723790,1540,8313,219333	IL33,USP44,BIRC3,PSMB9,NFKBIA,DDX58,IFIH1,PSME2,USP13,PSMB10,CFTR,CCNA1,HIST2H2AA4,CYLD,AXIN2,USP12
R-HSA-450302	activated TAK1 mediates p38 MAPK activation	0.0664088582607615	-2.71192482385615	20	3	0.00614754098360656	488	10287	8767,64127,3656	RIPK2,NOD2,IRAK2
R-HSA-8874081	MET activates PTK2 signaling	0.0664088582607615	-2.71192482385615	20	3	0.00614754098360656	488	10287	3914,4233,3918	LAMB3,MET,LAMC2
R-HSA-389356	CD28 co-stimulation	0.0691119366880303	-2.67202781800379	33	4	0.00819672131147541	488	10287	1326,941,8503,4067	MAP3K8,CD80,PIK3R3,LYN
R-HSA-5357905	Regulation of TNFR1 signaling	0.0691119366880303	-2.67202781800379	33	4	0.00819672131147541	488	10287	7185,330,1540,7128	TRAF1,BIRC3,CYLD,TNFAIP3
R-HSA-1222556	ROS, RNS production in phagocytes	0.0691119366880303	-2.67202781800379	33	4	0.00819672131147541	488	10287	4688,4843,50617,245973	NCF2,NOS2,ATP6V0A4,ATP6V1C2
R-HSA-211945	Phase 1 - Functionalization of compounds	0.0737969813949573	-2.60643745071959	109	9	0.0184426229508197	488	10287	54498,1581,874,1586,1577,1591,1551,1594,9420	SMOX,CYP7A1,CBR3,CYP17A1,CYP3A5,CYP24A1,CYP3A7,CYP27B1,CYP7B1
R-HSA-186763	Downstream signal transduction	0.0741817376581261	-2.60123728230794	352	23	0.0471311475409836	488	10287	2668,8503,3559,941,2247,10125,1848,1437,5698,1844,1847,6708,3710,3561,1850,2886,26281,5699,2069,1839,4233,5721,2903	GDNF,PIK3R3,IL2RA,CD80,FGF2,RASGRP1,DUSP6,CSF2,PSMB9,DUSP2,DUSP5,SPTA1,ITPR3,IL2RG,DUSP8,GRB7,FGF20,PSMB10,EREG,HBEGF,MET,PSME2,GRIN2A
R-HSA-6804115	TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain	0.074854513388627	-2.59220887082117	21	3	0.00614754098360656	488	10287	7832,10769,1263	BTG2,PLK2,PLK3
R-HSA-3928663	EPHA-mediated growth cone collapse	0.0755276945318266	-2.58325587499625	34	4	0.00819672131147541	488	10287	6461,4629,1943,4067	SHB,MYH11,EFNA2,LYN
R-HSA-76002	Platelet activation, signaling and aggregation	0.0779534624704741	-2.55164326534395	282	19	0.0389344262295082	488	10287	11343,4067,5880,3561,5004,3937,3710,2151,1437,10125,7273,8503,3559,5341,5005,150,9162,2207,5552	MGLL,LYN,RAC2,IL2RG,ORM1,LCP2,ITPR3,F2RL2,CSF2,RASGRP1,TTN,PIK3R3,IL2RA,PLEK,ORM2,ADRA2A,DGKI,FCER1G,SRGN
R-HSA-983705	Signaling by the B Cell Receptor (BCR)	0.0780919893898664	-2.54986779602869	229	16	0.0327868852459016	488	10287	4794,5721,4233,4067,1839,5699,2069,26281,4790,3710,5698,4792,10125,2247,941,8503	NFKBIE,PSME2,MET,LYN,HBEGF,PSMB10,EREG,FGF20,NFKB1,ITPR3,PSMB9,NFKBIA,RASGRP1,FGF2,CD80,PIK3R3
R-HSA-425381	Bicarbonate transporters	0.0785263334903705	-2.54432125197133	10	2	0.00409836065573771	488	10287	8671,23382	SLC4A4,AHCYL2
R-HSA-139915	Activation of PUMA and translocation to mitochondria	0.0785263334903705	-2.54432125197133	10	2	0.00409836065573771	488	10287	8626,27113	TP63,BBC3
R-HSA-1250342	PI3K events in ERBB4 signaling	0.0785263334903705	-2.54432125197133	10	2	0.00409836065573771	488	10287	1839,2069	HBEGF,EREG
R-HSA-2871837	FCERI mediated NF-kB activation	0.0803022282858735	-2.52195790890169	79	7	0.014344262295082	488	10287	5699,4790,5721,4067,10125,4792,5698	PSMB10,NFKB1,PSME2,LYN,RASGRP1,NFKBIA,PSMB9
R-HSA-6791312	TP53 Regulates Transcription of Cell Cycle Genes	0.0812750103125388	-2.50991668590766	49	5	0.0102459016393443	488	10287	1263,10769,7832,8900,25946	PLK3,PLK2,BTG2,CCNA1,ZNF385A
R-HSA-2424491	DAP12 signaling	0.0816284272194444	-2.50557770489248	356	23	0.0471311475409836	488	10287	2903,5721,4233,1839,2069,5699,26281,3937,1850,3561,3710,6708,1847,1844,5698,1437,1848,10125,2247,8503,3559,941,2668	GRIN2A,PSME2,MET,HBEGF,EREG,PSMB10,FGF20,LCP2,DUSP8,IL2RG,ITPR3,SPTA1,DUSP5,DUSP2,PSMB9,CSF2,DUSP6,RASGRP1,FGF2,PIK3R3,IL2RA,CD80,GDNF
R-HSA-389357	CD28 dependent PI3K/Akt signaling	0.0837481839062728	-2.4799407932133	22	3	0.00614754098360656	488	10287	941,8503,1326	CD80,PIK3R3,MAP3K8
R-HSA-140875	Common Pathway of Fibrin Clot Formation	0.0837481839062728	-2.4799407932133	22	3	0.00614754098360656	488	10287	5270,5197,3053	SERPINE2,PF4V1,SERPIND1
R-HSA-166663	Initial triggering of complement	0.0837481839062728	-2.4799407932133	22	3	0.00614754098360656	488	10287	629,10584,718	CFB,COLEC10,C3
R-HSA-5621575	CD209 (DC-SIGN) signaling	0.0837481839062728	-2.4799407932133	22	3	0.00614754098360656	488	10287	4067,4790,5971	LYN,NFKB1,RELB
R-HSA-186797	Signaling by PDGF	0.0849359055614891	-2.46585835914997	376	24	0.0491803278688525	488	10287	2903,5721,4233,5327,1839,2886,26281,5699,2069,1850,3561,6708,3710,1847,1844,1437,5698,1848,10125,2247,941,8503,3559,2668	GRIN2A,PSME2,MET,PLAT,HBEGF,GRB7,FGF20,PSMB10,EREG,DUSP8,IL2RG,SPTA1,ITPR3,DUSP5,DUSP2,CSF2,PSMB9,DUSP6,RASGRP1,FGF2,CD80,PIK3R3,IL2RA,GDNF
R-HSA-1168372	Downstream signaling events of B Cell Receptor (BCR)	0.0853960199104244	-2.46045578453802	197	14	0.0286885245901639	488	10287	4794,5721,5698,4233,4792,10125,1839,2247,4790,26281,5699,2069,941,8503	NFKBIE,PSME2,PSMB9,MET,NFKBIA,RASGRP1,HBEGF,FGF2,NFKB1,FGF20,PSMB10,EREG,CD80,PIK3R3
R-HSA-74752	Signaling by Insulin receptor	0.086388168834006	-2.44890454734015	322	21	0.0430327868852459	488	10287	6708,1850,3561,2069,5699,245973,26281,1839,4233,50617,5721,2903,2668,3559,2247,10125,1848,5698,1437,1844,1847	SPTA1,DUSP8,IL2RG,EREG,PSMB10,ATP6V1C2,FGF20,HBEGF,MET,ATP6V0A4,PSME2,GRIN2A,GDNF,IL2RA,FGF2,RASGRP1,DUSP6,PSMB9,CSF2,DUSP2,DUSP5
R-HSA-6803157	Antimicrobial peptides	0.0891068361766762	-2.41791922268228	97	8	0.0163934426229508	488	10287	6280,5266,114770,5068,6279,7097,3934,6278	S100A9,PI3,PGLYRP2,REG3A,S100A8,TLR2,LCN2,S100A7
R-HSA-205017	NFG and proNGF binds to p75NTR	0.0926310097537533	-2.37913131483906	2	1	0.00204918032786885	488	10287	4803	NGF
R-HSA-141334	PAOs oxidise polyamines to amines	0.0926310097537533	-2.37913131483906	2	1	0.00204918032786885	488	10287	54498	SMOX
R-HSA-5652227	Fructose biosynthesis	0.0926310097537533	-2.37913131483906	2	1	0.00204918032786885	488	10287	231	AKR1B1
R-HSA-190872	Transport of connexons to the plasma membrane	0.0926310097537533	-2.37913131483906	2	1	0.00204918032786885	488	10287	2706	GJB2
R-HSA-187042	TRKA activation by NGF	0.0926310097537533	-2.37913131483906	2	1	0.00204918032786885	488	10287	4803	NGF
R-HSA-114294	Activation, translocation and oligomerization of BAX	0.0926310097537533	-2.37913131483906	2	1	0.00204918032786885	488	10287	637	BID
R-HSA-432030	Transport of glycerol from adipocytes to the liver by Aquaporins	0.0926310097537533	-2.37913131483906	2	1	0.00204918032786885	488	10287	366	AQP9
R-HSA-111452	Activation and oligomerization of BAK protein	0.0926310097537533	-2.37913131483906	2	1	0.00204918032786885	488	10287	637	BID
R-HSA-6804754	Regulation of TP53 Expression	0.0926310097537533	-2.37913131483906	2	1	0.00204918032786885	488	10287	639	PRDM1
R-HSA-1839122	Signaling by activated point mutants of FGFR1	0.0930519723186968	-2.37459709978647	11	2	0.00409836065573771	488	10287	2247,26281	FGF2,FGF20
R-HSA-193048	Androgen biosynthesis	0.0930519723186968	-2.37459709978647	11	2	0.00409836065573771	488	10287	6716,1586	SRD5A2,CYP17A1
R-HSA-446107	Type I hemidesmosome assembly	0.0930519723186968	-2.37459709978647	11	2	0.00409836065573771	488	10287	3918,3914	LAMC2,LAMB3
R-HSA-177929	Signaling by EGFR	0.0979888414696303	-2.32290166934919	364	23	0.0471311475409836	488	10287	5698,1437,10125,1848,1847,1844,8503,3559,941,10252,2668,2247,4233,2903,5721,1850,3561,3710,6708,1839,5699,2069,26281	PSMB9,CSF2,RASGRP1,DUSP6,DUSP5,DUSP2,PIK3R3,IL2RA,CD80,SPRY1,GDNF,FGF2,MET,GRIN2A,PSME2,DUSP8,IL2RG,ITPR3,SPTA1,HBEGF,PSMB10,EREG,FGF20
R-HSA-1169091	Activation of NF-kappaB in B cells	0.102651210073447	-2.27641834724331	68	6	0.0122950819672131	488	10287	4794,5721,4790,5699,4792,5698	NFKBIE,PSME2,NFKB1,PSMB10,NFKBIA,PSMB9
R-HSA-392154	Nitric oxide stimulates guanylate cyclase	0.102795120883183	-2.27501738931328	24	3	0.00614754098360656	488	10287	5152,3779,4843	PDE9A,KCNMB1,NOS2
R-HSA-416572	Sema4D induced cell migration and growth-cone collapse	0.102795120883183	-2.27501738931328	24	3	0.00614754098360656	488	10287	5880,27289,4629	RAC2,RND1,MYH11
R-HSA-3299685	Detoxification of Reactive Oxygen Species	0.104010810449548	-2.26326043861257	38	4	0.00819672131147541	488	10287	4688,6648,7295,7296	NCF2,SOD2,TXN,TXNRD1
R-HSA-112399	IRS-mediated signalling	0.105846400392136	-2.24576628866693	294	19	0.0389344262295082	488	10287	2903,5721,4233,1839,2069,5699,26281,3561,1850,6708,1847,1844,5698,1437,10125,1848,2247,3559,2668	GRIN2A,PSME2,MET,HBEGF,EREG,PSMB10,FGF20,IL2RG,DUSP8,SPTA1,DUSP5,DUSP2,PSMB9,CSF2,RASGRP1,DUSP6,FGF2,IL2RA,GDNF
R-HSA-2187338	Visual phototransduction	0.106291303044925	-2.24157181217484	101	8	0.0163934426229508	488	10287	375790,1645,6385,24,2986,5957,64220,4023	AGRN,AKR1C1,SDC4,ABCA4,GUCY2F,RCVRN,STRA6,LPL
R-HSA-1236975	Antigen processing-Cross presentation	0.106291303044925	-2.24157181217484	101	8	0.0163934426229508	488	10287	5699,7097,1520,5721,6890,4688,5698,6891	PSMB10,TLR2,CTSS,PSME2,TAP1,NCF2,PSMB9,TAP2
R-HSA-187037	NGF signalling via TRKA from the plasma membrane	0.107887912170933	-2.22666244106657	387	24	0.0491803278688525	488	10287	4233,2903,5721,1850,3561,3710,6708,135,1839,2069,5699,26281,5698,1437,1848,10125,1847,1844,8503,3559,941,2668,2247,4803	MET,GRIN2A,PSME2,DUSP8,IL2RG,ITPR3,SPTA1,ADORA2A,HBEGF,EREG,PSMB10,FGF20,PSMB9,CSF2,DUSP6,RASGRP1,DUSP5,DUSP2,PIK3R3,IL2RA,CD80,GDNF,FGF2,NGF
R-HSA-388841	Costimulation by the CD28 family	0.108200125364034	-2.22377275393795	69	6	0.0122950819672131	488	10287	29126,4067,23308,8503,941,1326	CD274,LYN,ICOSLG,PIK3R3,CD80,MAP3K8
R-HSA-1839130	Signaling by activated point mutants of FGFR3	0.108274491250967	-2.22308569056746	12	2	0.00409836065573771	488	10287	2247,26281	FGF2,FGF20
R-HSA-3656253	Defective EXT1 causes exostoses 1, TRPS2 and CHDS	0.108274491250967	-2.22308569056746	12	2	0.00409836065573771	488	10287	375790,6385	AGRN,SDC4
R-HSA-3656237	Defective EXT2 causes exostoses 2	0.108274491250967	-2.22308569056746	12	2	0.00409836065573771	488	10287	6385,375790	SDC4,AGRN
R-HSA-73621	Pyrimidine catabolism	0.108274491250967	-2.22308569056746	12	2	0.00409836065573771	488	10287	1890,51733	TYMP,UPB1
R-HSA-190373	FGFR1c ligand binding and activation	0.108274491250967	-2.22308569056746	12	2	0.00409836065573771	488	10287	2247,26281	FGF2,FGF20
R-HSA-879518	Transport of organic anions	0.108274491250967	-2.22308569056746	12	2	0.00409836065573771	488	10287	28232,28231	SLCO3A1,SLCO4A1
R-HSA-8851680	Butyrophilin (BTN) family interactions	0.108274491250967	-2.22308569056746	12	2	0.00409836065573771	488	10287	11119,7498	BTN3A1,XDH
R-HSA-2033514	FGFR3 mutant receptor activation	0.108274491250967	-2.22308569056746	12	2	0.00409836065573771	488	10287	2247,26281	FGF2,FGF20
R-HSA-140877	Formation of Fibrin Clot (Clotting Cascade)	0.111799868524839	-2.19104489424717	39	4	0.00819672131147541	488	10287	3053,2152,5197,5270	SERPIND1,F3,PF4V1,SERPINE2
R-HSA-1280218	Adaptive Immune System	0.113265535871431	-2.17802034193991	810	46	0.0942622950819672	488	10287	342510,6891,5698,2247,29126,7097,10517,57823,23308,23327,84676,55008,941,5721,718,4794,4067,4233,4688,255488,7087,117157,7498,1839,54210,127544,11119,1326,3383,92369,10125,4792,221687,8503,285852,55521,6890,3386,8767,5699,2069,4790,26281,3710,1520,3937	CD300E,TAP2,PSMB9,FGF2,CD274,TLR2,FBXW10,SLAMF7,ICOSLG,NEDD4L,TRIM63,HERC6,CD80,PSME2,C3,NFKBIE,LYN,MET,NCF2,RNF144B,ICAM5,SH2D1B,XDH,HBEGF,TREM1,RNF19B,BTN3A1,MAP3K8,ICAM1,SPSB4,RASGRP1,NFKBIA,RNF182,PIK3R3,TREML4,TRIM36,TAP1,ICAM4,RIPK2,PSMB10,EREG,NFKB1,FGF20,ITPR3,CTSS,LCP2
R-HSA-74751	Insulin receptor signalling cascade	0.113685042781556	-2.17432343673348	297	19	0.0389344262295082	488	10287	5698,1437,10125,1848,1847,1844,3559,2668,2247,4233,2903,5721,1850,3561,6708,1839,5699,2069,26281	PSMB9,CSF2,RASGRP1,DUSP6,DUSP5,DUSP2,IL2RA,GDNF,FGF2,MET,GRIN2A,PSME2,DUSP8,IL2RG,SPTA1,HBEGF,PSMB10,EREG,FGF20
R-HSA-2428928	IRS-related events triggered by IGF1R	0.116375065583998	-2.15093697982762	298	19	0.0389344262295082	488	10287	10125,1848,5698,1437,1844,1847,2668,3559,2247,4233,5721,2903,6708,1850,3561,2069,5699,26281,1839	RASGRP1,DUSP6,PSMB9,CSF2,DUSP2,DUSP5,GDNF,IL2RA,FGF2,MET,PSME2,GRIN2A,SPTA1,DUSP8,IL2RG,EREG,PSMB10,FGF20,HBEGF
R-HSA-2428924	IGF1R signaling cascade	0.116375065583998	-2.15093697982762	298	19	0.0389344262295082	488	10287	2247,2668,3559,1844,1847,1848,10125,5698,1437,2069,5699,26281,1839,6708,3561,1850,5721,2903,4233	FGF2,GDNF,IL2RA,DUSP2,DUSP5,DUSP6,RASGRP1,PSMB9,CSF2,EREG,PSMB10,FGF20,HBEGF,SPTA1,IL2RG,DUSP8,PSME2,GRIN2A,MET
R-HSA-351202	Metabolism of polyamines	0.118355140162616	-2.13406551208851	87	7	0.014344262295082	488	10287	6303,5698,6611,54498,5699,5721,6534	SAT1,PSMB9,SMS,SMOX,PSMB10,PSME2,SLC6A7
R-HSA-6811558	PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling	0.118355140162616	-2.13406551208851	87	7	0.014344262295082	488	10287	941,4233,8503,26281,2069,1839,2247	CD80,MET,PIK3R3,FGF20,EREG,HBEGF,FGF2
R-HSA-2404192	Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)	0.119103598072027	-2.12776159256481	299	19	0.0389344262295082	488	10287	2903,5721,4233,1839,5699,2069,26281,3561,1850,6708,1847,1844,5698,1437,10125,1848,2247,3559,2668	GRIN2A,PSME2,MET,HBEGF,PSMB10,EREG,FGF20,IL2RG,DUSP8,SPTA1,DUSP5,DUSP2,PSMB9,CSF2,RASGRP1,DUSP6,FGF2,IL2RA,GDNF
R-HSA-5675221	Negative regulation of MAPK pathway	0.119839491866962	-2.12160199931766	40	4	0.00819672131147541	488	10287	1848,1850,1844,1847	DUSP6,DUSP8,DUSP2,DUSP5
R-HSA-5357786	TNFR1-induced proapoptotic signaling	0.124095405684836	-2.08670460852991	13	2	0.00409836065573771	488	10287	1540,7128	CYLD,TNFAIP3
R-HSA-8866907	Activation of the TFAP2 (AP-2) family of transcription factors	0.124095405684836	-2.08670460852991	13	2	0.00409836065573771	488	10287	4435,163732	CITED1,CITED4
R-HSA-933543	NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10	0.124095405684836	-2.08670460852991	13	2	0.00409836065573771	488	10287	64135,23586	IFIH1,DDX58
R-HSA-5668599	RHO GTPases Activate NADPH Oxidases	0.124095405684836	-2.08670460852991	13	2	0.00409836065573771	488	10287	4688,5880	NCF2,RAC2
R-HSA-75892	Platelet Adhesion to exposed collagen	0.124095405684836	-2.08670460852991	13	2	0.00409836065573771	488	10287	4067,2207	LYN,FCER1G
R-HSA-190239	FGFR3 ligand binding and activation	0.124095405684836	-2.08670460852991	13	2	0.00409836065573771	488	10287	26281,2247	FGF20,FGF2
R-HSA-6804116	TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest	0.124095405684836	-2.08670460852991	13	2	0.00409836065573771	488	10287	8900,25946	CCNA1,ZNF385A
R-HSA-5654227	Phospholipase C-mediated cascade; FGFR3	0.124095405684836	-2.08670460852991	13	2	0.00409836065573771	488	10287	26281,2247	FGF20,FGF2
R-HSA-190372	FGFR3c ligand binding and activation	0.124095405684836	-2.08670460852991	13	2	0.00409836065573771	488	10287	26281,2247	FGF20,FGF2
R-HSA-8847993	ERBB2 Activates PTK6 Signaling	0.124095405684836	-2.08670460852991	13	2	0.00409836065573771	488	10287	1839,2069	HBEGF,EREG
R-HSA-190375	FGFR2c ligand binding and activation	0.124095405684836	-2.08670460852991	13	2	0.00409836065573771	488	10287	26281,2247	FGF20,FGF2
R-HSA-388396	GPCR downstream signaling	0.125031959358626	-2.07918589949008	974	54	0.110655737704918	488	10287	64108,11343,2920,5880,8111,26575,718,6004,3561,147,6352,2151,3576,5021,5999,1236,2918,5142,134864,150,2642,1910,623,6374,6363,2921,6372,2914,53831,26230,57007,719,6364,10887,3710,3627,7852,135,10125,2919,6288,2847,1437,4283,6752,643,283365,5996,8503,3559,9340,9628,9162,6373	RTP4,MGLL,CXCL2,RAC2,GPR68,RGS17,C3,RGS16,IL2RG,ADRA1B,CCL5,F2RL2,CXCL8,OXTR,RGS4,CCR7,GRM8,PDE4B,TAAR1,ADRA2A,GCGR,EDNRB,BDKRB1,CXCL5,CCL19,CXCL3,CXCL6,GRM4,GPR84,TIAM2,ACKR3,C3AR1,CCL20,PROKR1,ITPR3,CXCL10,CXCR4,ADORA2A,RASGRP1,CXCL1,SAA1,MCHR1,CSF2,CXCL9,SSTR2,CXCR5,OR6C6,RGS1,PIK3R3,IL2RA,GLP2R,RGS6,DGKI,CXCL11
R-HSA-196849	Metabolism of water-soluble vitamins and cofactors	0.125142664110012	-2.07830087960215	122	9	0.0184426229508197	488	10287	5743,952,441024,8875,4363,10135,54625,6513,8876	PTGS2,CD38,MTHFD2L,VNN2,ABCC1,NAMPT,PARP14,SLC2A1,VNN1
R-HSA-1630316	Glycosaminoglycan metabolism	0.134409996233735	-2.0068604769198	124	9	0.0184426229508197	488	10287	6482,3038,3036,6385,9435,50515,960,375790,6484	ST3GAL1,HAS3,HAS1,SDC4,CHST2,CHST11,CD44,AGRN,ST3GAL4
R-HSA-198933	Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	0.134409996233735	-2.0068604769198	124	9	0.0184426229508197	488	10287	54210,57823,7087,117157,3386,342510,3383,285852,718	TREM1,SLAMF7,ICAM5,SH2D1B,ICAM4,CD300E,ICAM1,TREML4,C3
R-HSA-2219528	PI3K/AKT Signaling in Cancer	0.134670301507062	-2.00492569866428	90	7	0.014344262295082	488	10287	941,8503,4233,2069,26281,2247,1839	CD80,PIK3R3,MET,EREG,FGF20,FGF2,HBEGF
R-HSA-382556	ABC-family proteins mediated transport	0.135231099409345	-2.00077011660797	107	8	0.0163934426229508	488	10287	5698,8714,26154,5721,24,5699,4363,1080	PSMB9,ABCC3,ABCA12,PSME2,ABCA4,PSMB10,ABCC1,CFTR
R-HSA-177539	Autointegration results in viral DNA circles	0.135683617168635	-1.99742944773733	3	1	0.00204918032786885	488	10287	3159	HMGA1
R-HSA-5250992	Toxicity of botulinum toxin type E (BoNT/E)	0.135683617168635	-1.99742944773733	3	1	0.00204918032786885	488	10287	6616	SNAP25
R-HSA-8875791	MET activates STAT3	0.135683617168635	-1.99742944773733	3	1	0.00204918032786885	488	10287	4233	MET
R-HSA-190704	Oligomerization of connexins into connexons	0.135683617168635	-1.99742944773733	3	1	0.00204918032786885	488	10287	2706	GJB2
R-HSA-193681	Ceramide signalling	0.135683617168635	-1.99742944773733	3	1	0.00204918032786885	488	10287	4803	NGF
R-HSA-198745	Signalling to STAT3	0.135683617168635	-1.99742944773733	3	1	0.00204918032786885	488	10287	4803	NGF
R-HSA-5653890	Lactose synthesis	0.135683617168635	-1.99742944773733	3	1	0.00204918032786885	488	10287	6513	SLC2A1
R-HSA-444411	Rhesus glycoproteins mediate ammonium transport.	0.135683617168635	-1.99742944773733	3	1	0.00204918032786885	488	10287	51458	RHCG
R-HSA-190827	Transport of connexins along the secretory pathway	0.135683617168635	-1.99742944773733	3	1	0.00204918032786885	488	10287	2706	GJB2
R-HSA-175567	Integration of viral DNA into host genomic DNA	0.135683617168635	-1.99742944773733	3	1	0.00204918032786885	488	10287	3159	HMGA1
R-HSA-170145	Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes	0.135683617168635	-1.99742944773733	3	1	0.00204918032786885	488	10287	8900	CCNA1
R-HSA-392023	Adrenaline signalling through Alpha-2 adrenergic receptor	0.135683617168635	-1.99742944773733	3	1	0.00204918032786885	488	10287	150	ADRA2A
R-HSA-5627083	RHO GTPases regulate CFTR trafficking	0.135683617168635	-1.99742944773733	3	1	0.00204918032786885	488	10287	1080	CFTR
R-HSA-5250971	Toxicity of botulinum toxin type C (BoNT/C)	0.135683617168635	-1.99742944773733	3	1	0.00204918032786885	488	10287	6616	SNAP25
R-HSA-964827	Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2	0.135683617168635	-1.99742944773733	3	1	0.00204918032786885	488	10287	4121	MAN1A1
R-HSA-2559583	Cellular Senescence	0.139576499012296	-1.96914244800963	196	13	0.0266393442622951	488	10287	3725,4790,7295,8900,723790,3159,3569,8091,3552,3576,3008,1030,23135	JUN,NFKB1,TXN,CCNA1,HIST2H2AA4,HMGA1,IL6,HMGA2,IL1A,CXCL8,HIST1H1E,CDKN2B,KDM6B
R-HSA-6794361	Interactions of neurexins and neuroligins at synapses	0.139580144169122	-1.96911633251559	58	5	0.0102459016393443	488	10287	9456,9228,9378,2903,9369	HOMER1,DLGAP2,NRXN1,GRIN2A,NRXN3
R-HSA-418346	Platelet homeostasis	0.14034349789675	-1.96366230502262	91	7	0.014344262295082	488	10287	4843,3779,5152,3710,490,2268,6547	NOS2,KCNMB1,PDE9A,ITPR3,ATP2B1,FGR,SLC8A3
R-HSA-1250347	SHC1 events in ERBB4 signaling	0.140423973236147	-1.96308905242126	14	2	0.00409836065573771	488	10287	2069,1839	EREG,HBEGF
R-HSA-162594	Early Phase of HIV Life Cycle	0.140423973236147	-1.96308905242126	14	2	0.00409836065573771	488	10287	3159,7852	HMGA1,CXCR4
R-HSA-428790	Facilitative Na+-independent glucose transporters	0.140423973236147	-1.96308905242126	14	2	0.00409836065573771	488	10287	6513,11182	SLC2A1,SLC2A6
R-HSA-190322	FGFR4 ligand binding and activation	0.140423973236147	-1.96308905242126	14	2	0.00409836065573771	488	10287	2247,26281	FGF2,FGF20
R-HSA-209543	p75NTR recruits signalling complexes	0.140423973236147	-1.96308905242126	14	2	0.00409836065573771	488	10287	4803,8767	NGF,RIPK2
R-HSA-6804759	Regulation of TP53 Activity through Association with Co-factors	0.140423973236147	-1.96308905242126	14	2	0.00409836065573771	488	10287	8626,25946	TP63,ZNF385A
R-HSA-193775	Synthesis of bile acids and bile salts via 24-hydroxycholesterol	0.140423973236147	-1.96308905242126	14	2	0.00409836065573771	488	10287	1646,1645	AKR1C2,AKR1C1
R-HSA-418359	Reduction of cytosolic Ca++ levels	0.140423973236147	-1.96308905242126	14	2	0.00409836065573771	488	10287	6547,490	SLC8A3,ATP2B1
R-HSA-166520	Signalling by NGF	0.141929863429293	-1.95242226291132	477	28	0.0573770491803279	488	10287	3710,6708,1850,3561,5699,2069,26281,4790,135,1839,8767,4233,26230,5721,2903,2668,8503,3559,941,4803,2247,1848,10125,4792,5698,1437,1844,1847	ITPR3,SPTA1,DUSP8,IL2RG,PSMB10,EREG,FGF20,NFKB1,ADORA2A,HBEGF,RIPK2,MET,TIAM2,PSME2,GRIN2A,GDNF,PIK3R3,IL2RA,CD80,NGF,FGF2,DUSP6,RASGRP1,NFKBIA,PSMB9,CSF2,DUSP2,DUSP5
R-HSA-2022854	Keratan sulfate biosynthesis	0.145295380632049	-1.92898650084486	28	3	0.00614754098360656	488	10287	6484,9435,6482	ST3GAL4,CHST2,ST3GAL1
R-HSA-1266695	Interleukin-7 signaling	0.145295380632049	-1.92898650084486	28	3	0.00614754098360656	488	10287	3575,3561,8503	IL7R,IL2RG,PIK3R3
R-HSA-211976	Endogenous sterols	0.145295380632049	-1.92898650084486	28	3	0.00614754098360656	488	10287	1581,9420,1586	CYP7A1,CYP7B1,CYP17A1
R-HSA-3769402	Deactivation of the beta-catenin transactivating complex	0.145367491420619	-1.92849031920639	43	4	0.00819672131147541	488	10287	51176,6658,83595,64321	LEF1,SOX3,SOX7,SOX17
R-HSA-75893	TNF signaling	0.145367491420619	-1.92849031920639	43	4	0.00819672131147541	488	10287	7185,330,7128,1540	TRAF1,BIRC3,TNFAIP3,CYLD
R-HSA-163125	Post-translational modification: synthesis of GPI-anchored proteins	0.146130628220935	-1.92325434344963	92	7	0.014344262295082	488	10287	5329,154064,8876,116372,27076,5277,8875	PLAUR,RAET1L,VNN1,LYPD1,LYPD3,PIGA,VNN2
R-HSA-2142753	Arachidonic acid metabolism	0.146966456056938	-1.91755090833157	59	5	0.0102459016393443	488	10287	9536,247,4363,242,5743	PTGES,ALOX15B,ABCC1,ALOX12B,PTGS2
R-HSA-2559582	Senescence-Associated Secretory Phenotype (SASP)	0.15105823509364	-1.89008985364423	110	8	0.0163934426229508	488	10287	3569,723790,8900,4790,3725,1030,3576,3552	IL6,HIST2H2AA4,CCNA1,NFKB1,JUN,CDKN2B,CXCL8,IL1A
R-HSA-975634	Retinoid metabolism and transport	0.1543133284076	-1.86877014351464	44	4	0.00819672131147541	488	10287	6385,4023,375790,1645	SDC4,LPL,AGRN,AKR1C1
R-HSA-109606	Intrinsic Pathway for Apoptosis	0.1543133284076	-1.86877014351464	44	4	0.00819672131147541	488	10287	8626,27113,637,5366	TP63,BBC3,BID,PMAIP1
R-HSA-5676590	NIK-->noncanonical NF-kB signaling	0.154515780462781	-1.86745904894248	60	5	0.0102459016393443	488	10287	4791,5698,5971,5721,5699	NFKB2,PSMB9,RELB,PSME2,PSMB10
R-HSA-5654228	Phospholipase C-mediated cascade; FGFR4	0.157176683245564	-1.85038473539823	15	2	0.00409836065573771	488	10287	2247,26281	FGF2,FGF20
R-HSA-6785631	ERBB2 Regulates Cell Motility	0.157176683245564	-1.85038473539823	15	2	0.00409836065573771	488	10287	1839,2069	HBEGF,EREG
R-HSA-2162123	Synthesis of Prostaglandins (PG) and Thromboxanes (TX)	0.157176683245564	-1.85038473539823	15	2	0.00409836065573771	488	10287	9536,5743	PTGES,PTGS2
R-HSA-3772470	Negative regulation of TCF-dependent signaling by WNT ligand antagonists	0.157176683245564	-1.85038473539823	15	2	0.00409836065573771	488	10287	27121,7474	DKK4,WNT5A
R-HSA-199418	Negative regulation of the PI3K/AKT network	0.158037509543109	-1.84492287195903	94	7	0.014344262295082	488	10287	2247,1839,2069,26281,941,8503,4233	FGF2,HBEGF,EREG,FGF20,CD80,PIK3R3,MET
R-HSA-187577	SCF(Skp2)-mediated degradation of p27/p21	0.162222336328189	-1.81878743822327	61	5	0.0102459016393443	488	10287	5698,595,5721,5699,8900	PSMB9,CCND1,PSME2,PSMB10,CCNA1
R-HSA-5607761	Dectin-1 mediated noncanonical NF-kB signaling	0.162222336328189	-1.81878743822327	61	5	0.0102459016393443	488	10287	4791,5698,5971,5721,5699	NFKB2,PSMB9,RELB,PSME2,PSMB10
R-HSA-5633008	TP53 Regulates Transcription of Cell Death Genes	0.163460102336451	-1.81118634083017	45	4	0.00819672131147541	488	10287	8626,27113,637,5366	TP63,BBC3,BID,PMAIP1
R-HSA-2871809	FCERI mediated Ca+2 mobilization	0.168374926678931	-1.78156207971462	30	3	0.00614754098360656	488	10287	3937,3710,4067	LCP2,ITPR3,LYN
R-HSA-1912408	Pre-NOTCH Transcription and Translation	0.168374926678931	-1.78156207971462	30	3	0.00614754098360656	488	10287	10046,3725,595	MAMLD1,JUN,CCND1
R-HSA-2122948	Activated NOTCH1 Transmits Signal to the Nucleus	0.168374926678931	-1.78156207971462	30	3	0.00614754098360656	488	10287	54567,92737,113878	DLL4,DNER,DTX2
R-HSA-1963642	PI3K events in ERBB2 signaling	0.174276777133238	-1.74711057036867	16	2	0.00409836065573771	488	10287	1839,2069	HBEGF,EREG
R-HSA-1963640	GRB2 events in ERBB2 signaling	0.174276777133238	-1.74711057036867	16	2	0.00409836065573771	488	10287	2069,1839	EREG,HBEGF
R-HSA-918233	TRAF3-dependent IRF activation pathway	0.174276777133238	-1.74711057036867	16	2	0.00409836065573771	488	10287	23586,64135	DDX58,IFIH1
R-HSA-5654219	Phospholipase C-mediated cascade: FGFR1	0.174276777133238	-1.74711057036867	16	2	0.00409836065573771	488	10287	26281,2247	FGF20,FGF2
R-HSA-190242	FGFR1 ligand binding and activation	0.174276777133238	-1.74711057036867	16	2	0.00409836065573771	488	10287	26281,2247	FGF20,FGF2
R-HSA-5684264	MAP3K8 (TPL2)-dependent MAPK1/3 activation	0.174276777133238	-1.74711057036867	16	2	0.00409836065573771	488	10287	4790,1326	NFKB1,MAP3K8
R-HSA-15869	Metabolism of nucleotides	0.176692046677291	-1.73334691098476	97	7	0.014344262295082	488	10287	272,51733,1890,7296,7498,7295,57089	AMPD3,UPB1,TYMP,TXNRD1,XDH,TXN,ENTPD7
R-HSA-417973	Adenosine P1 receptors	0.176697463417903	-1.73331625506285	4	1	0.00204918032786885	488	10287	135	ADORA2A
R-HSA-194306	Neurophilin interactions with VEGF and VEGFR	0.176697463417903	-1.73331625506285	4	1	0.00204918032786885	488	10287	8828	NRP2
R-HSA-427975	Proton/oligopeptide cotransporters	0.176697463417903	-1.73331625506285	4	1	0.00204918032786885	488	10287	51296	SLC15A3
R-HSA-210455	Astrocytic Glutamate-Glutamine Uptake And Metabolism	0.176697463417903	-1.73331625506285	4	1	0.00204918032786885	488	10287	6506	SLC1A2
R-HSA-209563	Axonal growth stimulation	0.176697463417903	-1.73331625506285	4	1	0.00204918032786885	488	10287	4803	NGF
R-HSA-173107	Binding and entry of HIV virion	0.176697463417903	-1.73331625506285	4	1	0.00204918032786885	488	10287	7852	CXCR4
R-HSA-112313	Neurotransmitter uptake and Metabolism In Glial Cells	0.176697463417903	-1.73331625506285	4	1	0.00204918032786885	488	10287	6506	SLC1A2
R-HSA-75108	Activation, myristolyation of BID and translocation to mitochondria	0.176697463417903	-1.73331625506285	4	1	0.00204918032786885	488	10287	637	BID
R-HSA-167060	NGF processing	0.176697463417903	-1.73331625506285	4	1	0.00204918032786885	488	10287	4803	NGF
R-HSA-69895	Transcriptional  activation of  cell cycle inhibitor p21	0.176697463417903	-1.73331625506285	4	1	0.00204918032786885	488	10287	25946	ZNF385A
R-HSA-2408550	Metabolism of ingested H2SeO4 and H2SeO3 into H2Se	0.176697463417903	-1.73331625506285	4	1	0.00204918032786885	488	10287	7296	TXNRD1
R-HSA-2473224	Antagonism of Activin by Follistatin	0.176697463417903	-1.73331625506285	4	1	0.00204918032786885	488	10287	3624	INHBA
R-HSA-140179	Amine Oxidase reactions	0.176697463417903	-1.73331625506285	4	1	0.00204918032786885	488	10287	54498	SMOX
R-HSA-209905	Catecholamine biosynthesis	0.176697463417903	-1.73331625506285	4	1	0.00204918032786885	488	10287	1644	DDC
R-HSA-5250968	Toxicity of botulinum toxin type A (BoNT/A)	0.176697463417903	-1.73331625506285	4	1	0.00204918032786885	488	10287	6616	SNAP25
R-HSA-69560	Transcriptional activation of p53 responsive genes	0.176697463417903	-1.73331625506285	4	1	0.00204918032786885	488	10287	25946	ZNF385A
R-HSA-5654687	Downstream signaling of activated FGFR1	0.180289940032747	-1.71318894604361	31	3	0.00614754098360656	488	10287	2247,26281,23767	FGF2,FGF20,FLRT3
R-HSA-2129379	Molecules associated with elastic fibres	0.180289940032747	-1.71318894604361	31	3	0.00614754098360656	488	10287	650,10516,27302	BMP2,FBLN5,BMP10
R-HSA-418360	Platelet calcium homeostasis	0.180289940032747	-1.71318894604361	31	3	0.00614754098360656	488	10287	6547,490,3710	SLC8A3,ATP2B1,ITPR3
R-HSA-8875878	MET promotes cell motility	0.180289940032747	-1.71318894604361	31	3	0.00614754098360656	488	10287	3914,3918,4233	LAMB3,LAMC2,MET
R-HSA-5339562	Uptake and actions of bacterial toxins	0.180289940032747	-1.71318894604361	31	3	0.00614754098360656	488	10287	1839,7296,6616	HBEGF,TXNRD1,SNAP25
R-HSA-1912422	Pre-NOTCH Expression and Processing	0.182313451768985	-1.70202781083174	47	4	0.00819672131147541	488	10287	595,3725,6484,10046	CCND1,JUN,ST3GAL4,MAMLD1
R-HSA-5083636	Defective GALNT12 causes colorectal cancer 1 (CRCS1)	0.19165379786805	-1.65206467066499	17	2	0.00409836065573771	488	10287	4586,10071	MUC5AC,MUC12
R-HSA-199220	Vitamin B5 (pantothenate) metabolism	0.19165379786805	-1.65206467066499	17	2	0.00409836065573771	488	10287	8876,8875	VNN1,VNN2
R-HSA-2033519	Activated point mutants of FGFR2	0.19165379786805	-1.65206467066499	17	2	0.00409836065573771	488	10287	26281,2247	FGF20,FGF2
R-HSA-5083625	Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)	0.19165379786805	-1.65206467066499	17	2	0.00409836065573771	488	10287	4586,10071	MUC5AC,MUC12
R-HSA-192456	Digestion of dietary lipid	0.19165379786805	-1.65206467066499	17	2	0.00409836065573771	488	10287	119548,9388	PNLIPRP3,LIPG
R-HSA-5083632	Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)	0.19165379786805	-1.65206467066499	17	2	0.00409836065573771	488	10287	10071,4586	MUC12,MUC5AC
R-HSA-392451	G beta:gamma signalling through PI3Kgamma	0.191998182317638	-1.65026937409481	48	4	0.00819672131147541	488	10287	1437,3561,8503,3559	CSF2,IL2RG,PIK3R3,IL2RA
R-HSA-3928665	EPH-ephrin mediated repulsion of cells	0.191998182317638	-1.65026937409481	48	4	0.00819672131147541	488	10287	4318,1943,4067,2048	MMP9,EFNA2,LYN,EPHB2
R-HSA-75109	Triglyceride Biosynthesis	0.193033830482251	-1.6448898179655	82	6	0.0122950819672131	488	10287	2710,79993,80168,51703,2181,2182	GK,ELOVL7,MOGAT2,ACSL5,ACSL3,ACSL4
R-HSA-69563	p53-Dependent G1 DNA Damage Response	0.194499249885087	-1.63732697256302	65	5	0.0102459016393443	488	10287	5698,5721,25946,5699,8900	PSMB9,PSME2,ZNF385A,PSMB10,CCNA1
R-HSA-69580	p53-Dependent G1/S DNA damage checkpoint	0.194499249885087	-1.63732697256302	65	5	0.0102459016393443	488	10287	8900,25946,5699,5721,5698	CCNA1,ZNF385A,PSMB10,PSME2,PSMB9
R-HSA-1638074	Keratan sulfate/keratin metabolism	0.204755608757564	-1.58593816342481	33	3	0.00614754098360656	488	10287	6482,9435,6484	ST3GAL1,CHST2,ST3GAL4
R-HSA-5357801	Programmed Cell Death	0.209083861923576	-1.56501985427502	175	11	0.0225409836065574	488	10287	637,660,27113,5699,330,5698,5366,3008,8626,5721,5317	BID,BMX,BBC3,PSMB10,BIRC3,PSMB9,PMAIP1,HIST1H1E,TP63,PSME2,PKP1
R-HSA-5654221	Phospholipase C-mediated cascade; FGFR2	0.209243166811837	-1.56425822576422	18	2	0.00409836065573771	488	10287	26281,2247	FGF20,FGF2
R-HSA-418457	cGMP effects	0.209243166811837	-1.56425822576422	18	2	0.00409836065573771	488	10287	3779,5152	KCNMB1,PDE9A
R-HSA-181430	Norepinephrine Neurotransmitter Release Cycle	0.209243166811837	-1.56425822576422	18	2	0.00409836065573771	488	10287	6616,6580	SNAP25,SLC22A1
R-HSA-5654710	PI-3K cascade:FGFR3	0.209243166811837	-1.56425822576422	18	2	0.00409836065573771	488	10287	2247,26281	FGF2,FGF20
R-HSA-210993	Tie2 Signaling	0.209243166811837	-1.56425822576422	18	2	0.00409836065573771	488	10287	2888,2886	GRB14,GRB7
R-HSA-5654704	SHC-mediated cascade:FGFR3	0.209243166811837	-1.56425822576422	18	2	0.00409836065573771	488	10287	26281,2247	FGF20,FGF2
R-HSA-69615	G1/S DNA Damage Checkpoints	0.211419174347164	-1.55391250792233	67	5	0.0102459016393443	488	10287	8900,5699,25946,5721,5698	CCNA1,PSMB10,ZNF385A,PSME2,PSMB9
R-HSA-73887	Death Receptor Signalling	0.211828548787379	-1.55197806364539	50	4	0.00819672131147541	488	10287	330,7185,7128,1540	BIRC3,TRAF1,TNFAIP3,CYLD
R-HSA-1236974	ER-Phagosome pathway	0.215478642089082	-1.53489348298527	85	6	0.0122950819672131	488	10287	5721,5699,6890,7097,5698,6891	PSME2,PSMB10,TAP1,TLR2,PSMB9,TAP2
R-HSA-3781865	Diseases of glycosylation	0.215478642089082	-1.53489348298527	85	6	0.0122950819672131	488	10287	375790,56999,10071,4586,6385,9507	AGRN,ADAMTS9,MUC12,MUC5AC,SDC4,ADAMTS4
R-HSA-203641	NOSTRIN mediated eNOS trafficking	0.215768905395017	-1.5335473264612	5	1	0.00204918032786885	488	10287	857	CAV1
R-HSA-187024	NGF-independant TRKA activation	0.215768905395017	-1.5335473264612	5	1	0.00204918032786885	488	10287	135	ADORA2A
R-HSA-426048	Arachidonate production from DAG	0.215768905395017	-1.5335473264612	5	1	0.00204918032786885	488	10287	11343	MGLL
R-HSA-3000471	Scavenging by Class B Receptors	0.215768905395017	-1.5335473264612	5	1	0.00204918032786885	488	10287	6288	SAA1
R-HSA-964739	N-glycan trimming and elongation in the cis-Golgi	0.215768905395017	-1.5335473264612	5	1	0.00204918032786885	488	10287	4121	MAN1A1
R-HSA-433137	Sodium-coupled sulphate, di- and tri-carboxylate transporters	0.215768905395017	-1.5335473264612	5	1	0.00204918032786885	488	10287	64849	SLC13A3
R-HSA-8875513	MET interacts with TNS proteins	0.215768905395017	-1.5335473264612	5	1	0.00204918032786885	488	10287	4233	MET
R-HSA-111448	Activation of NOXA and translocation to mitochondria	0.215768905395017	-1.5335473264612	5	1	0.00204918032786885	488	10287	5366	PMAIP1
R-HSA-112303	Electric Transmission Across Gap Junctions	0.215768905395017	-1.5335473264612	5	1	0.00204918032786885	488	10287	56666	PANX2
R-HSA-2161517	Abacavir transmembrane transport	0.215768905395017	-1.5335473264612	5	1	0.00204918032786885	488	10287	6580	SLC22A1
R-HSA-180689	APOBEC3G mediated resistance to HIV-1 infection	0.215768905395017	-1.5335473264612	5	1	0.00204918032786885	488	10287	3159	HMGA1
R-HSA-140834	Extrinsic Pathway of Fibrin Clot Formation	0.215768905395017	-1.5335473264612	5	1	0.00204918032786885	488	10287	2152	F3
R-HSA-1614517	Sulfide oxidation to sulfate	0.215768905395017	-1.5335473264612	5	1	0.00204918032786885	488	10287	58472	SQOR
R-HSA-112307	Transmission across Electrical Synapses	0.215768905395017	-1.5335473264612	5	1	0.00204918032786885	488	10287	56666	PANX2
R-HSA-1306955	GRB7 events in ERBB2 signaling	0.215768905395017	-1.5335473264612	5	1	0.00204918032786885	488	10287	2886	GRB7
R-HSA-8865999	MET activates PTPN11	0.215768905395017	-1.5335473264612	5	1	0.00204918032786885	488	10287	4233	MET
R-HSA-209931	Serotonin and melatonin biosynthesis	0.215768905395017	-1.5335473264612	5	1	0.00204918032786885	488	10287	1644	DDC
R-HSA-1169092	Activation of RAS in B cells	0.215768905395017	-1.5335473264612	5	1	0.00204918032786885	488	10287	10125	RASGRP1
R-HSA-68911	G2 Phase	0.215768905395017	-1.5335473264612	5	1	0.00204918032786885	488	10287	8900	CCNA1
R-HSA-373755	Semaphorin interactions	0.220051552470563	-1.51389343066897	68	5	0.0102459016393443	488	10287	5880,80031,4629,4233,27289	RAC2,SEMA6D,MYH11,MET,RND1
R-HSA-397795	G-protein beta:gamma signalling	0.221952022007649	-1.50529403754918	51	4	0.00819672131147541	488	10287	1437,3561,3559,8503	CSF2,IL2RG,IL2RA,PIK3R3
R-HSA-3560783	Defective B4GALT7 causes EDS, progeroid type	0.22698578642623	-1.48286787832355	19	2	0.00409836065573771	488	10287	375790,6385	AGRN,SDC4
R-HSA-442660	Na+/Cl- dependent neurotransmitter transporters	0.22698578642623	-1.48286787832355	19	2	0.00409836065573771	488	10287	6580,6534	SLC22A1,SLC6A7
R-HSA-3560801	Defective B3GAT3 causes JDSSDHD	0.22698578642623	-1.48286787832355	19	2	0.00409836065573771	488	10287	6385,375790	SDC4,AGRN
R-HSA-4420332	Defective B3GALT6 causes EDSP2 and SEMDJL1	0.22698578642623	-1.48286787832355	19	2	0.00409836065573771	488	10287	6385,375790	SDC4,AGRN
R-HSA-933541	TRAF6 mediated IRF7 activation	0.229920539668315	-1.47002150945378	35	3	0.00614754098360656	488	10287	64135,3659,23586	IFIH1,IRF1,DDX58
R-HSA-69229	Ubiquitin-dependent degradation of Cyclin D1	0.232199615571483	-1.46015786531195	52	4	0.00819672131147541	488	10287	5699,5721,595,5698	PSMB10,PSME2,CCND1,PSMB9
R-HSA-75815	Ubiquitin-dependent degradation of Cyclin D	0.232199615571483	-1.46015786531195	52	4	0.00819672131147541	488	10287	5699,5721,595,5698	PSMB10,PSME2,CCND1,PSMB9
R-HSA-201681	TCF dependent signaling in response to WNT	0.240137298511631	-1.42654444208209	238	14	0.0286885245901639	488	10287	27121,83595,8313,51176,6658,5699,7474,723790,284654,5698,5721,64321,84870,857	DKK4,SOX7,AXIN2,LEF1,SOX3,PSMB10,WNT5A,HIST2H2AA4,RSPO1,PSMB9,PSME2,SOX17,RSPO3,CAV1
R-HSA-6806003	Regulation of TP53 Expression and Degradation	0.242711590432733	-1.41588141117754	36	3	0.00614754098360656	488	10287	639,6446,8900	PRDM1,SGK1,CCNA1
R-HSA-5654720	PI-3K cascade:FGFR4	0.244827667335926	-1.40720071456717	20	2	0.00409836065573771	488	10287	26281,2247	FGF20,FGF2
R-HSA-163560	Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis	0.244827667335926	-1.40720071456717	20	2	0.00409836065573771	488	10287	857,11343	CAV1,MGLL
R-HSA-5654719	SHC-mediated cascade:FGFR4	0.244827667335926	-1.40720071456717	20	2	0.00409836065573771	488	10287	26281,2247	FGF20,FGF2
R-HSA-5654706	FRS-mediated FGFR3 signaling	0.244827667335926	-1.40720071456717	20	2	0.00409836065573771	488	10287	26281,2247	FGF20,FGF2
R-HSA-3000170	Syndecan interactions	0.244827667335926	-1.40720071456717	20	2	0.00409836065573771	488	10287	6385,2247	SDC4,FGF2
R-HSA-190241	FGFR2 ligand binding and activation	0.244827667335926	-1.40720071456717	20	2	0.00409836065573771	488	10287	26281,2247	FGF20,FGF2
R-HSA-69656	Cyclin A:Cdk2-associated events at S phase entry	0.246557769853884	-1.40015895249551	71	5	0.0102459016393443	488	10287	595,5721,5699,8900,5698	CCND1,PSME2,PSMB10,CCNA1,PSMB9
R-HSA-205025	NADE modulates death signalling	0.252989754859387	-1.37440628570148	6	1	0.00204918032786885	488	10287	4803	NGF
R-HSA-189483	Heme degradation	0.252989754859387	-1.37440628570148	6	1	0.00204918032786885	488	10287	3162	HMOX1
R-HSA-5690714	CD22 mediated BCR regulation	0.252989754859387	-1.37440628570148	6	1	0.00204918032786885	488	10287	4067	LYN
R-HSA-8849470	PTK6 Regulates Cell Cycle	0.252989754859387	-1.37440628570148	6	1	0.00204918032786885	488	10287	595	CCND1
R-HSA-8857538	PTK6 promotes HIF1A stabilization	0.252989754859387	-1.37440628570148	6	1	0.00204918032786885	488	10287	1839	HBEGF
R-HSA-193670	p75NTR negatively regulates cell cycle via SC1	0.252989754859387	-1.37440628570148	6	1	0.00204918032786885	488	10287	4803	NGF
R-HSA-8851907	MET activates PI3K/AKT signaling	0.252989754859387	-1.37440628570148	6	1	0.00204918032786885	488	10287	4233	MET
R-HSA-190370	FGFR1b ligand binding and activation	0.252989754859387	-1.37440628570148	6	1	0.00204918032786885	488	10287	2247	FGF2
R-HSA-428808	Na+-dependent glucose transporters	0.252989754859387	-1.37440628570148	6	1	0.00204918032786885	488	10287	6523	SLC5A1
R-HSA-2142712	Synthesis of 12-eicosatetraenoic acid derivatives	0.252989754859387	-1.37440628570148	6	1	0.00204918032786885	488	10287	242	ALOX12B
R-HSA-3000484	Scavenging by Class F Receptors	0.252989754859387	-1.37440628570148	6	1	0.00204918032786885	488	10287	8578	SCARF1
R-HSA-6806942	MET Receptor Activation	0.252989754859387	-1.37440628570148	6	1	0.00204918032786885	488	10287	4233	MET
R-HSA-388479	Vasopressin-like receptors	0.252989754859387	-1.37440628570148	6	1	0.00204918032786885	488	10287	5021	OXTR
R-HSA-193144	Estrogen biosynthesis	0.252989754859387	-1.37440628570148	6	1	0.00204918032786885	488	10287	441282	AKR1B15
R-HSA-5676934	Protein repair	0.252989754859387	-1.37440628570148	6	1	0.00204918032786885	488	10287	7295	TXN
R-HSA-5339717	Misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling	0.252989754859387	-1.37440628570148	6	1	0.00204918032786885	488	10287	27121	DKK4
R-HSA-6794362	Protein-protein interactions at synapses	0.255573663698472	-1.36424459896088	72	5	0.0102459016393443	488	10287	9369,9456,9228,9378,2903	NRXN3,HOMER1,DLGAP2,NRXN1,GRIN2A
R-HSA-69202	Cyclin E associated events during G1/S transition	0.255573663698472	-1.36424459896088	72	5	0.0102459016393443	488	10287	5699,595,5721,8900,5698	PSMB10,CCND1,PSME2,CCNA1,PSMB9
R-HSA-198203	PI3K/AKT activation	0.261933163781568	-1.33966590783495	128	8	0.0163934426229508	488	10287	2247,4803,1839,2069,26281,8503,941,4233	FGF2,NGF,HBEGF,EREG,FGF20,PIK3R3,CD80,MET
R-HSA-5654689	PI-3K cascade:FGFR1	0.262719578278297	-1.33666805793291	21	2	0.00409836065573771	488	10287	26281,2247	FGF20,FGF2
R-HSA-5654688	SHC-mediated cascade:FGFR1	0.262719578278297	-1.33666805793291	21	2	0.00409836065573771	488	10287	26281,2247	FGF20,FGF2
R-HSA-2024096	HS-GAG degradation	0.262719578278297	-1.33666805793291	21	2	0.00409836065573771	488	10287	375790,6385	AGRN,SDC4
R-HSA-75105	Fatty Acyl-CoA Biosynthesis	0.263577796271248	-1.33340671255994	55	4	0.00819672131147541	488	10287	79993,2182,2181,51703	ELOVL7,ACSL4,ACSL3,ACSL5
R-HSA-373080	Class B/2 (Secretin family receptors)	0.270898767877733	-1.30601007815639	92	6	0.0122950819672131	488	10287	2642,1604,11211,90226,9340,7474	GCGR,CD55,FZD10,UCN2,GLP2R,WNT5A
R-HSA-4641257	Degradation of AXIN	0.274213115950104	-1.29384967948185	56	4	0.00819672131147541	488	10287	5721,5699,5698,8313	PSME2,PSMB10,PSMB9,AXIN2
R-HSA-1250196	SHC1 events in ERBB2 signaling	0.280616717709147	-1.27076553465248	22	2	0.00409836065573771	488	10287	1839,2069	HBEGF,EREG
R-HSA-4641263	Regulation of FZD by ubiquitination	0.280616717709147	-1.27076553465248	22	2	0.00409836065573771	488	10287	84870,284654	RSPO3,RSPO1
R-HSA-140837	Intrinsic Pathway of Fibrin Clot Formation	0.280616717709147	-1.27076553465248	22	2	0.00409836065573771	488	10287	5270,3053	SERPINE2,SERPIND1
R-HSA-203765	eNOS activation and regulation	0.280616717709147	-1.27076553465248	22	2	0.00409836065573771	488	10287	2643,857	GCH1,CAV1
R-HSA-5655332	Signaling by FGFR3 in disease	0.280616717709147	-1.27076553465248	22	2	0.00409836065573771	488	10287	26281,2247	FGF20,FGF2
R-HSA-5654712	FRS-mediated FGFR4 signaling	0.280616717709147	-1.27076553465248	22	2	0.00409836065573771	488	10287	26281,2247	FGF20,FGF2
R-HSA-8853338	Signaling by FGFR3 point mutants in cancer	0.280616717709147	-1.27076553465248	22	2	0.00409836065573771	488	10287	2247,26281	FGF2,FGF20
R-HSA-202131	Metabolism of nitric oxide	0.280616717709147	-1.27076553465248	22	2	0.00409836065573771	488	10287	857,2643	CAV1,GCH1
R-HSA-389513	CTLA4 inhibitory signaling	0.280616717709147	-1.27076553465248	22	2	0.00409836065573771	488	10287	941,4067	CD80,LYN
R-HSA-157118	Signaling by NOTCH	0.281615857173022	-1.26721134529991	112	7	0.014344262295082	488	10287	6484,595,3725,113878,10046,54567,92737	ST3GAL4,CCND1,JUN,DTX2,MAMLD1,DLL4,DNER
R-HSA-2730905	Role of LAT2/NTAL/LAB on calcium mobilization	0.282482441108737	-1.26413888569467	131	8	0.0163934426229508	488	10287	8503,941,2069,26281,2247,1839,4067,4233	PIK3R3,CD80,EREG,FGF20,FGF2,HBEGF,LYN,MET
R-HSA-2660826	Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	0.288447492397108	-1.24324221168812	7	1	0.00204918032786885	488	10287	54567	DLL4
R-HSA-5652084	Fructose metabolism	0.288447492397108	-1.24324221168812	7	1	0.00204918032786885	488	10287	231	AKR1B1
R-HSA-429593	Inositol transporters	0.288447492397108	-1.24324221168812	7	1	0.00204918032786885	488	10287	6523	SLC5A1
R-HSA-162791	Attachment of GPI anchor to uPAR	0.288447492397108	-1.24324221168812	7	1	0.00204918032786885	488	10287	5329	PLAUR
R-HSA-164843	2-LTR circle formation	0.288447492397108	-1.24324221168812	7	1	0.00204918032786885	488	10287	3159	HMGA1
R-HSA-83936	Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane	0.288447492397108	-1.24324221168812	7	1	0.00204918032786885	488	10287	64078	SLC28A3
R-HSA-2660825	Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	0.288447492397108	-1.24324221168812	7	1	0.00204918032786885	488	10287	54567	DLL4
R-HSA-190371	FGFR3b ligand binding and activation	0.288447492397108	-1.24324221168812	7	1	0.00204918032786885	488	10287	26281	FGF20
R-HSA-447043	Neurofascin interactions	0.288447492397108	-1.24324221168812	7	1	0.00204918032786885	488	10287	286	ANK1
R-HSA-420597	Nectin/Necl  trans heterodimerization	0.288447492397108	-1.24324221168812	7	1	0.00204918032786885	488	10287	5818	NECTIN1
R-HSA-425397	Transport of vitamins, nucleosides, and related molecules	0.294798182685791	-1.22146428325247	40	3	0.00614754098360656	488	10287	28231,28232,64078	SLCO4A1,SLCO3A1,SLC28A3
R-HSA-2682334	EPH-Ephrin signaling	0.295656189346514	-1.21855802222611	95	6	0.0122950819672131	488	10287	4067,4318,1943,4629,2048,6461	LYN,MMP9,EFNA2,MYH11,EPHB2,SHB
R-HSA-5654693	FRS-mediated FGFR1 signaling	0.298478405763787	-1.2090576912662	23	2	0.00409836065573771	488	10287	26281,2247	FGF20,FGF2
R-HSA-2453902	The canonical retinoid cycle in rods (twilight vision)	0.298478405763787	-1.2090576912662	23	2	0.00409836065573771	488	10287	24,64220	ABCA4,STRA6
R-HSA-5654695	PI-3K cascade:FGFR2	0.298478405763787	-1.2090576912662	23	2	0.00409836065573771	488	10287	26281,2247	FGF20,FGF2
R-HSA-8862803	Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models	0.298478405763787	-1.2090576912662	23	2	0.00409836065573771	488	10287	3725,6648	JUN,SOD2
R-HSA-8863678	Neurodegenerative Diseases	0.298478405763787	-1.2090576912662	23	2	0.00409836065573771	488	10287	6648,3725	SOD2,JUN
R-HSA-5654699	SHC-mediated cascade:FGFR2	0.298478405763787	-1.2090576912662	23	2	0.00409836065573771	488	10287	2247,26281	FGF2,FGF20
R-HSA-109581	Apoptosis	0.299733531103069	-1.20486142869208	172	10	0.0204918032786885	488	10287	8626,5721,5317,5698,3008,5366,660,27113,5699,637	TP63,PSME2,PKP1,PSMB9,HIST1H1E,PMAIP1,BMX,BBC3,PSMB10,BID
R-HSA-556833	Metabolism of lipids and lipoproteins	0.301417862011236	-1.19925773107118	813	42	0.0860655737704918	488	10287	5743,2710,79993,9536,9023,242,441282,247,3290,25816,11343,6716,85441,9108,1581,2182,9388,857,3638,84879,1645,660,8503,51703,80168,1586,231,130367,8714,119548,26230,2181,4023,27242,29923,80736,9420,7296,4363,50486,1646,51365	PTGS2,GK,ELOVL7,PTGES,CH25H,ALOX12B,AKR1B15,ALOX15B,HSD11B1,TNFAIP8,MGLL,SRD5A2,HELZ2,MTMR7,CYP7A1,ACSL4,LIPG,CAV1,INSIG1,MFSD2A,AKR1C1,BMX,PIK3R3,ACSL5,MOGAT2,CYP17A1,AKR1B1,SGPP2,ABCC3,PNLIPRP3,TIAM2,ACSL3,LPL,TNFRSF21,HILPDA,SLC44A4,CYP7B1,TXNRD1,ABCC1,G0S2,AKR1C2,PLA1A
R-HSA-4086400	PCP/CE pathway	0.304008504331518	-1.19069960319247	96	6	0.0122950819672131	488	10287	5698,5880,23002,5699,7474,5721	PSMB9,RAC2,DAAM1,PSMB10,WNT5A,PSME2
R-HSA-3906995	Diseases associated with O-glycosylation of proteins	0.30650052638373	-1.18253580620529	59	4	0.00819672131147541	488	10287	4586,56999,10071,9507	MUC5AC,ADAMTS9,MUC12,ADAMTS4
R-HSA-201451	Signaling by BMP	0.316267795298706	-1.15116597080426	24	2	0.00409836065573771	488	10287	650,658	BMP2,BMPR1B
R-HSA-210500	Glutamate Neurotransmitter Release Cycle	0.316267795298706	-1.15116597080426	24	2	0.00409836065573771	488	10287	6506,6616	SLC1A2,SNAP25
R-HSA-2559586	DNA Damage/Telomere Stress Induced Senescence	0.320521762269464	-1.13780510392981	79	5	0.0102459016393443	488	10287	723790,3159,8900,8091,3008	HIST2H2AA4,HMGA1,CCNA1,HMGA2,HIST1H1E
R-HSA-202424	Downstream TCR signaling	0.320835060070403	-1.13682811946517	98	6	0.0122950819672131	488	10287	8767,4792,5698,5721,4790,5699	RIPK2,NFKBIA,PSMB9,PSME2,NFKB1,PSMB10
R-HSA-1566948	Elastic fibre formation	0.321135708339608	-1.13589147777998	42	3	0.00614754098360656	488	10287	10516,650,27302	FBLN5,BMP2,BMP10
R-HSA-444473	Formyl peptide receptors bind formyl peptides and many other ligands	0.322225471349073	-1.1325037568975	8	1	0.00204918032786885	488	10287	6288	SAA1
R-HSA-1482883	Acyl chain remodeling of DAG and TAG	0.322225471349073	-1.1325037568975	8	1	0.00204918032786885	488	10287	11343	MGLL
R-HSA-448424	Interleukin-17 signaling	0.322225471349073	-1.1325037568975	8	1	0.00204918032786885	488	10287	27189	IL17C
R-HSA-1236973	Cross-presentation of particulate exogenous antigens (phagosomes)	0.322225471349073	-1.1325037568975	8	1	0.00204918032786885	488	10287	4688	NCF2
R-HSA-446210	Synthesis of UDP-N-acetyl-glucosamine	0.322225471349073	-1.1325037568975	8	1	0.00204918032786885	488	10287	9945	GFPT2
R-HSA-8850843	Phosphate bond hydrolysis by NTPDase proteins	0.322225471349073	-1.1325037568975	8	1	0.00204918032786885	488	10287	57089	ENTPD7
R-HSA-174430	Telomere C-strand synthesis initiation	0.322225471349073	-1.1325037568975	8	1	0.00204918032786885	488	10287	23649	POLA2
R-HSA-164944	Nef and signal transduction	0.322225471349073	-1.1325037568975	8	1	0.00204918032786885	488	10287	3055	HCK
R-HSA-68952	DNA replication initiation	0.322225471349073	-1.1325037568975	8	1	0.00204918032786885	488	10287	23649	POLA2
R-HSA-196836	Vitamin C (ascorbate) metabolism	0.322225471349073	-1.1325037568975	8	1	0.00204918032786885	488	10287	6513	SLC2A1
R-HSA-5576890	Phase 3 - rapid repolarisation	0.322225471349073	-1.1325037568975	8	1	0.00204918032786885	488	10287	23630	KCNE5
R-HSA-422356	Regulation of insulin secretion	0.329983504935169	-1.10871261081585	80	5	0.0102459016393443	488	10287	4082,6616,3710,150,6513	MARCKS,SNAP25,ITPR3,ADRA2A,SLC2A1
R-HSA-425410	Metal ion SLC transporters	0.333951601098754	-1.09675920339541	25	2	0.00409836065573771	488	10287	64116,84102	SLC39A8,SLC41A2
R-HSA-3000157	Laminin interactions	0.333951601098754	-1.09675920339541	25	2	0.00409836065573771	488	10287	3914,3918	LAMB3,LAMC2
R-HSA-5654700	FRS-mediated FGFR2 signaling	0.333951601098754	-1.09675920339541	25	2	0.00409836065573771	488	10287	26281,2247	FGF20,FGF2
R-HSA-5654708	Downstream signaling of activated FGFR3	0.333951601098754	-1.09675920339541	25	2	0.00409836065573771	488	10287	2247,26281	FGF2,FGF20
R-HSA-499943	Synthesis and interconversion of nucleotide di- and triphosphates	0.333951601098754	-1.09675920339541	25	2	0.00409836065573771	488	10287	7295,7296	TXN,TXNRD1
R-HSA-211981	Xenobiotics	0.333951601098754	-1.09675920339541	25	2	0.00409836065573771	488	10287	1577,1551	CYP3A5,CYP3A7
R-HSA-1614635	Sulfur amino acid metabolism	0.333951601098754	-1.09675920339541	25	2	0.00409836065573771	488	10287	2730,58472	GCLM,SQOR
R-HSA-1251985	Nuclear signaling by ERBB4	0.333951601098754	-1.09675920339541	25	2	0.00409836065573771	488	10287	1839,2069	HBEGF,EREG
R-HSA-983170	Antigen Presentation: Folding, assembly and peptide loading of class I MHC	0.333951601098754	-1.09675920339541	25	2	0.00409836065573771	488	10287	6890,6891	TAP1,TAP2
R-HSA-2173782	Binding and Uptake of Ligands by Scavenger Receptors	0.334318324605152	-1.09566167220598	43	3	0.00614754098360656	488	10287	6288,8578,2495	SAA1,SCARF1,FTH1
R-HSA-375280	Amine ligand-binding receptors	0.334318324605152	-1.09566167220598	43	3	0.00614754098360656	488	10287	147,150,134864	ADRA1B,ADRA2A,TAAR1
R-HSA-202403	TCR signaling	0.335107296073293	-1.09330451165198	119	7	0.014344262295082	488	10287	4790,5721,5699,8767,5698,3937,4792	NFKB1,PSME2,PSMB10,RIPK2,PSMB9,LCP2,NFKBIA
R-HSA-5678895	Defective CFTR causes cystic fibrosis	0.339150988697956	-1.08130987637108	62	4	0.00819672131147541	488	10287	5698,5721,1080,5699	PSMB9,PSME2,CFTR,PSMB10
R-HSA-69239	Synthesis of DNA	0.346311229844722	-1.06041740001776	101	6	0.0122950819672131	488	10287	5698,64785,23649,8900,5721,5699	PSMB9,GINS3,POLA2,CCNA1,PSME2,PSMB10
R-HSA-1266738	Developmental Biology	0.346430533272733	-1.06007296162659	1075	54	0.110655737704918	488	10287	1850,5266,3561,55203,80031,6708,1839,2312,375790,3725,2886,4233,1943,4067,5880,85441,2903,2048,5721,27289,214,4211,2668,2247,1000,4629,5698,6092,3854,1848,1847,6461,1844,9353,688,3849,723790,5699,2069,4790,3855,26281,4023,4318,137970,8828,3559,8503,286,3868,1437,10125,9119,5317	DUSP8,PI3,IL2RG,LGI2,SEMA6D,SPTA1,HBEGF,FLG,AGRN,JUN,GRB7,MET,EFNA2,LYN,RAC2,HELZ2,GRIN2A,EPHB2,PSME2,RND1,ALCAM,MEIS1,GDNF,FGF2,CDH2,MYH11,PSMB9,ROBO2,KRT6B,DUSP6,DUSP5,SHB,DUSP2,SLIT2,KLF5,KRT2,HIST2H2AA4,PSMB10,EREG,NFKB1,KRT7,FGF20,LPL,MMP9,UNC5D,NRP2,IL2RA,PIK3R3,ANK1,KRT16,CSF2,RASGRP1,KRT75,PKP1
R-HSA-73848	Pyrimidine metabolism	0.351499845988956	-1.04554600588527	26	2	0.00409836065573771	488	10287	51733,1890	UPB1,TYMP
R-HSA-3560782	Diseases associated with glycosaminoglycan metabolism	0.351499845988956	-1.04554600588527	26	2	0.00409836065573771	488	10287	6385,375790	SDC4,AGRN
R-HSA-1971475	A tetrasaccharide linker sequence is required for GAG synthesis	0.351499845988956	-1.04554600588527	26	2	0.00409836065573771	488	10287	6385,375790	SDC4,AGRN
R-HSA-2474795	Diseases associated with visual transduction	0.354403112180835	-1.03732027874114	9	1	0.00204918032786885	488	10287	64220	STRA6
R-HSA-112411	MAPK1 (ERK2) activation	0.354403112180835	-1.03732027874114	9	1	0.00204918032786885	488	10287	3569	IL6
R-HSA-447041	CHL1 interactions	0.354403112180835	-1.03732027874114	9	1	0.00204918032786885	488	10287	286	ANK1
R-HSA-428890	Role of Abl in Robo-Slit signaling	0.354403112180835	-1.03732027874114	9	1	0.00204918032786885	488	10287	9353	SLIT2
R-HSA-428543	Inactivation of Cdc42 and Rac	0.354403112180835	-1.03732027874114	9	1	0.00204918032786885	488	10287	9353	SLIT2
R-HSA-1614558	Degradation of cysteine and homocysteine	0.354403112180835	-1.03732027874114	9	1	0.00204918032786885	488	10287	58472	SQOR
R-HSA-162592	Integration of provirus	0.354403112180835	-1.03732027874114	9	1	0.00204918032786885	488	10287	3159	HMGA1
R-HSA-193697	p75NTR regulates axonogenesis	0.354403112180835	-1.03732027874114	9	1	0.00204918032786885	488	10287	4803	NGF
R-HSA-2453864	Retinoid cycle disease events	0.354403112180835	-1.03732027874114	9	1	0.00204918032786885	488	10287	64220	STRA6
R-HSA-1362409	Mitochondrial iron-sulfur cluster biogenesis	0.354403112180835	-1.03732027874114	9	1	0.00204918032786885	488	10287	81894	SLC25A28
R-HSA-77387	Insulin receptor recycling	0.368885622970705	-0.99726864783968	27	2	0.00409836065573771	488	10287	245973,50617	ATP6V1C2,ATP6V0A4
R-HSA-5654716	Downstream signaling of activated FGFR4	0.368885622970705	-0.99726864783968	27	2	0.00409836065573771	488	10287	26281,2247	FGF20,FGF2
R-HSA-1257604	PIP3 activates AKT signaling	0.381995662332237	-0.962346025591245	125	7	0.014344262295082	488	10287	2247,1839,2069,26281,8503,4233,941	FGF2,HBEGF,EREG,FGF20,PIK3R3,MET,CD80
R-HSA-168799	Neurotoxicity of clostridium toxins	0.385056087586503	-0.954366273262085	10	1	0.00204918032786885	488	10287	6616	SNAP25
R-HSA-1660517	Synthesis of PIPs at the late endosome membrane	0.385056087586503	-0.954366273262085	10	1	0.00204918032786885	488	10287	9108	MTMR7
R-HSA-2161522	Abacavir transport and metabolism	0.385056087586503	-0.954366273262085	10	1	0.00204918032786885	488	10287	6580	SLC22A1
R-HSA-8875656	MET receptor recycling	0.385056087586503	-0.954366273262085	10	1	0.00204918032786885	488	10287	4233	MET
R-HSA-450341	Activation of the AP-1 family of transcription factors	0.385056087586503	-0.954366273262085	10	1	0.00204918032786885	488	10287	3725	JUN
R-HSA-399997	Acetylcholine regulates insulin secretion	0.385056087586503	-0.954366273262085	10	1	0.00204918032786885	488	10287	4082	MARCKS
R-HSA-112311	Neurotransmitter Clearance In The Synaptic Cleft	0.385056087586503	-0.954366273262085	10	1	0.00204918032786885	488	10287	6580	SLC22A1
R-HSA-1300644	Interaction With The Zona Pellucida	0.385056087586503	-0.954366273262085	10	1	0.00204918032786885	488	10287	7784	ZP3
R-HSA-418886	Netrin mediated repulsion signals	0.385056087586503	-0.954366273262085	10	1	0.00204918032786885	488	10287	137970	UNC5D
R-HSA-193692	Regulated proteolysis of p75NTR	0.385056087586503	-0.954366273262085	10	1	0.00204918032786885	488	10287	4790	NFKB1
R-HSA-74259	Purine catabolism	0.385056087586503	-0.954366273262085	10	1	0.00204918032786885	488	10287	7498	XDH
R-HSA-937042	IRAK2 mediated activation of TAK1 complex	0.385056087586503	-0.954366273262085	10	1	0.00204918032786885	488	10287	3656	IRAK2
R-HSA-110056	MAPK3 (ERK1) activation	0.385056087586503	-0.954366273262085	10	1	0.00204918032786885	488	10287	3569	IL6
R-HSA-1855167	Synthesis of pyrophosphates in the cytosol	0.385056087586503	-0.954366273262085	10	1	0.00204918032786885	488	10287	117283	IP6K3
R-HSA-190377	FGFR2b ligand binding and activation	0.385056087586503	-0.954366273262085	10	1	0.00204918032786885	488	10287	2247	FGF2
R-HSA-427601	Multifunctional anion exchangers	0.385056087586503	-0.954366273262085	10	1	0.00204918032786885	488	10287	115019	SLC26A9
R-HSA-196108	Pregnenolone biosynthesis	0.385056087586503	-0.954366273262085	10	1	0.00204918032786885	488	10287	231	AKR1B1
R-HSA-442380	Zinc influx into cells by the SLC39 gene family	0.385056087586503	-0.954366273262085	10	1	0.00204918032786885	488	10287	64116	SLC39A8
R-HSA-1483191	Synthesis of PC	0.386084872375926	-0.951698057065057	28	2	0.00409836065573771	488	10287	80736,84879	SLC44A4,MFSD2A
R-HSA-8948216	Collagen chain trimerization	0.386791061726788	-0.949870623925457	47	3	0.00614754098360656	488	10287	1305,1294,169044	COL13A1,COL7A1,COL22A1
R-HSA-2029480	Fcgamma receptor (FCGR) dependent phagocytosis	0.387103306223195	-0.949063680429597	86	5	0.0102459016393443	488	10287	4067,3710,644150,2268,3055	LYN,ITPR3,WIPF3,FGR,HCK
R-HSA-4608870	Asymmetric localization of PCP proteins	0.393697902359371	-0.932171409064494	67	4	0.00819672131147541	488	10287	5721,5699,7474,5698	PSME2,PSMB10,WNT5A,PSMB9
R-HSA-418597	G alpha (z) signalling events	0.399777253688437	-0.916847752760395	48	3	0.00614754098360656	488	10287	26575,150,5999	RGS17,ADRA2A,RGS4
R-HSA-1368108	BMAL1:CLOCK,NPAS2 activates circadian gene expression	0.399777253688437	-0.916847752760395	48	3	0.00614754098360656	488	10287	10135,85441,56938	NAMPT,HELZ2,ARNTL2
R-HSA-5654732	Negative regulation of FGFR3 signaling	0.403076173252864	-0.908629719380844	29	2	0.00409836065573771	488	10287	2247,26281	FGF2,FGF20
R-HSA-1834949	Cytosolic sensors of pathogen-associated DNA	0.404550799238688	-0.904977965106242	68	4	0.00819672131147541	488	10287	6288,4791,4792,4790	SAA1,NFKB2,NFKBIA,NFKB1
R-HSA-180292	GAB1 signalosome	0.405558498182361	-0.902490153976019	128	7	0.014344262295082	488	10287	8503,941,4233,2247,1839,2069,26281	PIK3R3,CD80,MET,FGF2,HBEGF,EREG,FGF20
R-HSA-3858494	Beta-catenin independent WNT signaling	0.411709969833558	-0.887436134241148	149	8	0.0163934426229508	488	10287	23002,5721,5880,5698,5699,7474,3710,51176	DAAM1,PSME2,RAC2,PSMB9,PSMB10,WNT5A,ITPR3,LEF1
R-HSA-8875555	MET activates RAP1 and RAC1	0.414256499109444	-0.881269933940491	11	1	0.00204918032786885	488	10287	4233	MET
R-HSA-1980150	Signaling by NOTCH4	0.414256499109444	-0.881269933940491	11	1	0.00204918032786885	488	10287	54567	DLL4
R-HSA-5661231	Metallothioneins bind metals	0.414256499109444	-0.881269933940491	11	1	0.00204918032786885	488	10287	4504	MT3
R-HSA-1059683	Interleukin-6 signaling	0.414256499109444	-0.881269933940491	11	1	0.00204918032786885	488	10287	3569	IL6
R-HSA-5603041	IRAK4 deficiency (TLR2/4)	0.414256499109444	-0.881269933940491	11	1	0.00204918032786885	488	10287	7097	TLR2
R-HSA-549127	Organic cation transport	0.414256499109444	-0.881269933940491	11	1	0.00204918032786885	488	10287	6580	SLC22A1
R-HSA-5660526	Response to metal ions	0.414256499109444	-0.881269933940491	11	1	0.00204918032786885	488	10287	4504	MT3
R-HSA-71182	Phenylalanine and tyrosine catabolism	0.414256499109444	-0.881269933940491	11	1	0.00204918032786885	488	10287	259307	IL4I1
R-HSA-5602498	MyD88 deficiency (TLR2/4)	0.414256499109444	-0.881269933940491	11	1	0.00204918032786885	488	10287	7097	TLR2
R-HSA-73614	Pyrimidine salvage reactions	0.414256499109444	-0.881269933940491	11	1	0.00204918032786885	488	10287	1890	TYMP
R-HSA-8851805	MET activates RAS signaling	0.414256499109444	-0.881269933940491	11	1	0.00204918032786885	488	10287	4233	MET
R-HSA-71288	Creatine metabolism	0.414256499109444	-0.881269933940491	11	1	0.00204918032786885	488	10287	6534	SLC6A7
R-HSA-351906	Apoptotic cleavage of cell adhesion  proteins	0.414256499109444	-0.881269933940491	11	1	0.00204918032786885	488	10287	5317	PKP1
R-HSA-1980148	Signaling by NOTCH3	0.414256499109444	-0.881269933940491	11	1	0.00204918032786885	488	10287	54567	DLL4
R-HSA-69306	DNA Replication	0.414798557955945	-0.879962279113171	109	6	0.0122950819672131	488	10287	8900,23649,5721,5699,5698,64785	CCNA1,POLA2,PSME2,PSMB10,PSMB9,GINS3
R-HSA-5619084	ABC transporter disorders	0.415366851781362	-0.878593169035778	69	4	0.00819672131147541	488	10287	5699,5721,1080,5698	PSMB10,PSME2,CFTR,PSMB9
R-HSA-5683826	Surfactant metabolism	0.419840548007952	-0.867880287389232	30	2	0.00409836065573771	488	10287	135,150	ADORA2A,ADRA2A
R-HSA-420092	Glucagon-type ligand receptors	0.419840548007952	-0.867880287389232	30	2	0.00409836065573771	488	10287	9340,2642	GLP2R,GCGR
R-HSA-445095	Interaction between L1 and Ankyrins	0.419840548007952	-0.867880287389232	30	2	0.00409836065573771	488	10287	286,6708	ANK1,SPTA1
R-HSA-5654696	Downstream signaling of activated FGFR2	0.419840548007952	-0.867880287389232	30	2	0.00409836065573771	488	10287	26281,2247	FGF20,FGF2
R-HSA-8863795	Downregulation of ERBB2 signaling	0.419840548007952	-0.867880287389232	30	2	0.00409836065573771	488	10287	2069,1839	EREG,HBEGF
R-HSA-917977	Transferrin endocytosis and recycling	0.419840548007952	-0.867880287389232	30	2	0.00409836065573771	488	10287	50617,245973	ATP6V0A4,ATP6V1C2
R-HSA-69242	S Phase	0.421252818892392	-0.864522105605274	130	7	0.014344262295082	488	10287	5698,64785,8900,23649,5721,595,5699	PSMB9,GINS3,CCNA1,POLA2,PSME2,CCND1,PSMB10
R-HSA-5654736	Signaling by FGFR1	0.42550688967909	-0.854474139139537	50	3	0.00614754098360656	488	10287	26281,2247,23767	FGF20,FGF2,FLRT3
R-HSA-195721	Signaling by Wnt	0.427659309928035	-0.849428405221456	336	17	0.0348360655737705	488	10287	5698,857,64321,83595,27121,7474,5880,284654,23002,84870,5721,6658,51176,8313,3710,723790,5699	PSMB9,CAV1,SOX17,SOX7,DKK4,WNT5A,RAC2,RSPO1,DAAM1,RSPO3,PSME2,SOX3,LEF1,AXIN2,ITPR3,HIST2H2AA4,PSMB10
R-HSA-163685	Integration of energy metabolism	0.43186659018482	-0.83963855744906	111	6	0.0122950819672131	488	10287	6513,6616,4082,2642,150,3710	SLC2A1,SNAP25,MARCKS,GCGR,ADRA2A,ITPR3
R-HSA-71387	Metabolism of carbohydrates	0.434065783942737	-0.834559180463275	296	15	0.0307377049180328	488	10287	231,6484,3099,669,1118,3036,6385,6482,3038,6523,9435,960,50515,6513,375790	AKR1B1,ST3GAL4,HK2,BPGM,CHIT1,HAS1,SDC4,ST3GAL1,HAS3,SLC5A1,CHST2,CD44,CHST11,SLC2A1,AGRN
R-HSA-2022928	HS-GAG biosynthesis	0.436361279600386	-0.829284755814891	31	2	0.00409836065573771	488	10287	6385,375790	SDC4,AGRN
R-HSA-418990	Adherens junctions interactions	0.436361279600386	-0.829284755814891	31	2	0.00409836065573771	488	10287	5818,1000	NECTIN1,CDH2
R-HSA-450282	MAPK targets/ Nuclear events mediated by MAP kinases	0.436361279600386	-0.829284755814891	31	2	0.00409836065573771	488	10287	3725,1848	JUN,DUSP6
R-HSA-1839124	FGFR1 mutant receptor activation	0.436361279600386	-0.829284755814891	31	2	0.00409836065573771	488	10287	26281,2247	FGF20,FGF2
R-HSA-5654733	Negative regulation of FGFR4 signaling	0.436361279600386	-0.829284755814891	31	2	0.00409836065573771	488	10287	26281,2247	FGF20,FGF2
R-HSA-112310	Neurotransmitter Release Cycle	0.43822906891142	-0.825013516934214	51	3	0.00614754098360656	488	10287	6506,6616,6580	SLC1A2,SNAP25,SLC22A1
R-HSA-211733	Regulation of activated PAK-2p34 by proteasome mediated degradation	0.43822906891142	-0.825013516934214	51	3	0.00614754098360656	488	10287	5699,5721,5698	PSMB10,PSME2,PSMB9
R-HSA-1236978	Cross-presentation of soluble exogenous antigens (endosomes)	0.43822906891142	-0.825013516934214	51	3	0.00614754098360656	488	10287	5698,5721,5699	PSMB9,PSME2,PSMB10
R-HSA-1227986	Signaling by ERBB2	0.43822906891142	-0.825013516934214	51	3	0.00614754098360656	488	10287	1839,2886,2069	HBEGF,GRB7,EREG
R-HSA-1793185	Chondroitin sulfate/dermatan sulfate metabolism	0.43822906891142	-0.825013516934214	51	3	0.00614754098360656	488	10287	375790,50515,6385	AGRN,CHST11,SDC4
R-HSA-209822	Glycoprotein hormones	0.442073045284242	-0.816280149734427	12	1	0.00204918032786885	488	10287	3624	INHBA
R-HSA-210990	PECAM1 interactions	0.442073045284242	-0.816280149734427	12	1	0.00204918032786885	488	10287	4067	LYN
R-HSA-6803207	TP53 Regulates Transcription of Caspase Activators and Caspases	0.442073045284242	-0.816280149734427	12	1	0.00204918032786885	488	10287	8626	TP63
R-HSA-1474151	Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation	0.442073045284242	-0.816280149734427	12	1	0.00204918032786885	488	10287	2643	GCH1
R-HSA-1236977	Endosomal/Vacuolar pathway	0.442073045284242	-0.816280149734427	12	1	0.00204918032786885	488	10287	1520	CTSS
R-HSA-1475029	Reversible hydration of carbon dioxide	0.442073045284242	-0.816280149734427	12	1	0.00204918032786885	488	10287	771	CA12
R-HSA-6803211	TP53 Regulates Transcription of Death Receptors and Ligands	0.442073045284242	-0.816280149734427	12	1	0.00204918032786885	488	10287	8626	TP63
R-HSA-389359	CD28 dependent Vav1 pathway	0.442073045284242	-0.816280149734427	12	1	0.00204918032786885	488	10287	941	CD80
R-HSA-844456	The NLRP3 inflammasome	0.442073045284242	-0.816280149734427	12	1	0.00204918032786885	488	10287	7295	TXN
R-HSA-4641265	Repression of WNT target genes	0.442073045284242	-0.816280149734427	12	1	0.00204918032786885	488	10287	51176	LEF1
R-HSA-176974	Unwinding of DNA	0.442073045284242	-0.816280149734427	12	1	0.00204918032786885	488	10287	64785	GINS3
R-HSA-2160916	Hyaluronan uptake and degradation	0.442073045284242	-0.816280149734427	12	1	0.00204918032786885	488	10287	960	CD44
R-HSA-203615	eNOS activation	0.442073045284242	-0.816280149734427	12	1	0.00204918032786885	488	10287	857	CAV1
R-HSA-69052	Switching of origins to a post-replicative state	0.447524103719245	-0.804024879658024	72	4	0.00819672131147541	488	10287	5721,5699,8900,5698	PSME2,PSMB10,CCNA1,PSMB9
R-HSA-68949	Orc1 removal from chromatin	0.447524103719245	-0.804024879658024	72	4	0.00819672131147541	488	10287	5721,5699,8900,5698	PSME2,PSMB10,CCNA1,PSMB9
R-HSA-350562	Regulation of ornithine decarboxylase (ODC)	0.450843117073417	-0.796635855708337	52	3	0.00614754098360656	488	10287	5698,5721,5699	PSMB9,PSME2,PSMB10
R-HSA-69017	CDK-mediated phosphorylation and removal of Cdc6	0.450843117073417	-0.796635855708337	52	3	0.00614754098360656	488	10287	5698,5699,5721	PSMB9,PSMB10,PSME2
R-HSA-376176	Signaling by Robo receptor	0.45262374052095	-0.792694093510643	32	2	0.00409836065573771	488	10287	6092,9353	ROBO2,SLIT2
R-HSA-69190	DNA strand elongation	0.45262374052095	-0.792694093510643	32	2	0.00409836065573771	488	10287	23649,64785	POLA2,GINS3
R-HSA-1980143	Signaling by NOTCH1	0.45812442709905	-0.780614456876136	73	4	0.00819672131147541	488	10287	92737,10046,54567,113878	DNER,MAMLD1,DLL4,DTX2
R-HSA-174184	Cdc20:Phospho-APC/C mediated degradation of Cyclin A	0.45812442709905	-0.780614456876136	73	4	0.00819672131147541	488	10287	5698,5699,5721,8900	PSMB9,PSMB10,PSME2,CCNA1
R-HSA-349425	Autodegradation of the E3 ubiquitin ligase COP1	0.463340083213383	-0.769293973545186	53	3	0.00614754098360656	488	10287	5699,5721,5698	PSMB10,PSME2,PSMB9
R-HSA-180534	Vpu mediated degradation of CD4	0.463340083213383	-0.769293973545186	53	3	0.00614754098360656	488	10287	5699,5721,5698	PSMB10,PSME2,PSMB9
R-HSA-75153	Apoptotic execution  phase	0.463340083213383	-0.769293973545186	53	3	0.00614754098360656	488	10287	660,5317,3008	BMX,PKP1,HIST1H1E
R-HSA-73923	Lipid digestion, mobilization, and transport	0.465726132468835	-0.764157516183716	115	6	0.0122950819672131	488	10287	9388,11343,29923,4023,119548,857	LIPG,MGLL,HILPDA,LPL,PNLIPRP3,CAV1
R-HSA-350054	Notch-HLH transcription pathway	0.468571181908843	-0.758067253073454	13	1	0.00204918032786885	488	10287	10046	MAMLD1
R-HSA-140342	Apoptosis induced DNA fragmentation	0.468571181908843	-0.758067253073454	13	1	0.00204918032786885	488	10287	3008	HIST1H1E
R-HSA-74217	Purine salvage	0.468571181908843	-0.758067253073454	13	1	0.00204918032786885	488	10287	272	AMPD3
R-HSA-1237044	Erythrocytes take up carbon dioxide and release oxygen	0.468571181908843	-0.758067253073454	13	1	0.00204918032786885	488	10287	51700	CYB5R2
R-HSA-1502540	Signaling by Activin	0.468571181908843	-0.758067253073454	13	1	0.00204918032786885	488	10287	3624	INHBA
R-HSA-5140745	WNT5A-dependent internalization of FZD2, FZD5 and ROR2	0.468571181908843	-0.758067253073454	13	1	0.00204918032786885	488	10287	7474	WNT5A
R-HSA-2892247	POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation	0.468571181908843	-0.758067253073454	13	1	0.00204918032786885	488	10287	2247	FGF2
R-HSA-425561	Sodium/Calcium exchangers	0.468571181908843	-0.758067253073454	13	1	0.00204918032786885	488	10287	6547	SLC8A3
R-HSA-202670	ERKs are inactivated	0.468571181908843	-0.758067253073454	13	1	0.00204918032786885	488	10287	1848	DUSP6
R-HSA-432047	Passive transport by Aquaporins	0.468571181908843	-0.758067253073454	13	1	0.00204918032786885	488	10287	366	AQP9
R-HSA-211227	Activation of DNA fragmentation factor	0.468571181908843	-0.758067253073454	13	1	0.00204918032786885	488	10287	3008	HIST1H1E
R-HSA-113501	Inhibition of replication initiation of damaged DNA by RB1/E2F1	0.468571181908843	-0.758067253073454	13	1	0.00204918032786885	488	10287	23649	POLA2
R-HSA-879415	Advanced glycosylation endproduct receptor signaling	0.468571181908843	-0.758067253073454	13	1	0.00204918032786885	488	10287	6288	SAA1
R-HSA-5607763	CLEC7A (Dectin-1) induces NFAT activation	0.468571181908843	-0.758067253073454	13	1	0.00204918032786885	488	10287	3710	ITPR3
R-HSA-5658623	FGFRL1 modulation of FGFR1 signaling	0.468571181908843	-0.758067253073454	13	1	0.00204918032786885	488	10287	2247	FGF2
R-HSA-1480926	O2/CO2 exchange in erythrocytes	0.468571181908843	-0.758067253073454	13	1	0.00204918032786885	488	10287	51700	CYB5R2
R-HSA-2197563	NOTCH2 intracellular domain regulates transcription	0.468571181908843	-0.758067253073454	13	1	0.00204918032786885	488	10287	10046	MAMLD1
R-HSA-5654726	Negative regulation of FGFR1 signaling	0.468615232902575	-0.757973246175642	33	2	0.00409836065573771	488	10287	2247,26281	FGF2,FGF20
R-HSA-1839126	FGFR2 mutant receptor activation	0.468615232902575	-0.757973246175642	33	2	0.00409836065573771	488	10287	26281,2247	FGF20,FGF2
R-HSA-4085001	Sialic acid metabolism	0.468615232902575	-0.757973246175642	33	2	0.00409836065573771	488	10287	6484,6482	ST3GAL4,ST3GAL1
R-HSA-1980145	Signaling by NOTCH2	0.468615232902575	-0.757973246175642	33	2	0.00409836065573771	488	10287	10046,54567	MAMLD1,DLL4
R-HSA-69300	Removal of licensing factors from origins	0.468655216343697	-0.757887927277177	74	4	0.00819672131147541	488	10287	5721,5699,8900,5698	PSME2,PSMB10,CCNA1,PSMB9
R-HSA-179419	APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint	0.468655216343697	-0.757887927277177	74	4	0.00819672131147541	488	10287	5698,5699,5721,8900	PSMB9,PSMB10,PSME2,CCNA1
R-HSA-69613	p53-Independent G1/S DNA damage checkpoint	0.475711656841556	-0.742943371237122	54	3	0.00614754098360656	488	10287	5721,5699,5698	PSME2,PSMB10,PSMB9
R-HSA-189200	Hexose transport	0.475711656841556	-0.742943371237122	54	3	0.00614754098360656	488	10287	6523,3099,6513	SLC5A1,HK2,SLC2A1
R-HSA-69610	p53-Independent DNA Damage Response	0.475711656841556	-0.742943371237122	54	3	0.00614754098360656	488	10287	5698,5699,5721	PSMB9,PSMB10,PSME2
R-HSA-69601	Ubiquitin Mediated Degradation of Phosphorylated Cdc25A	0.475711656841556	-0.742943371237122	54	3	0.00614754098360656	488	10287	5721,5699,5698	PSME2,PSMB10,PSMB9
R-HSA-169911	Regulation of Apoptosis	0.475711656841556	-0.742943371237122	54	3	0.00614754098360656	488	10287	5698,5721,5699	PSMB9,PSME2,PSMB10
R-HSA-73847	Purine metabolism	0.484324838945686	-0.724999442542738	34	2	0.00409836065573771	488	10287	272,7498	AMPD3,XDH
R-HSA-5654727	Negative regulation of FGFR2 signaling	0.484324838945686	-0.724999442542738	34	2	0.00409836065573771	488	10287	26281,2247	FGF20,FGF2
R-HSA-5694530	Cargo concentration in the ER	0.484324838945686	-0.724999442542738	34	2	0.00409836065573771	488	10287	374,1294	AREG,COL7A1
R-HSA-113510	E2F mediated regulation of DNA replication	0.484324838945686	-0.724999442542738	34	2	0.00409836065573771	488	10287	23649,8900	POLA2,CCNA1
R-HSA-211859	Biological oxidations	0.485390208028815	-0.722802158886902	222	11	0.0225409836065574	488	10287	1577,1594,9420,27233,1551,1591,1581,54498,1586,874,2730	CYP3A5,CYP27B1,CYP7B1,SULT1C4,CYP3A7,CYP24A1,CYP7A1,SMOX,CYP17A1,CBR3,GCLM
R-HSA-180585	Vif-mediated degradation of APOBEC3G	0.487950148800019	-0.717542032445396	55	3	0.00614754098360656	488	10287	5721,5699,5698	PSME2,PSMB10,PSMB9
R-HSA-176409	APC/C:Cdc20 mediated degradation of mitotic proteins	0.489485882902532	-0.714399657258843	76	4	0.00819672131147541	488	10287	8900,5699,5721,5698	CCNA1,PSMB10,PSME2,PSMB9
R-HSA-5619115	Disorders of transmembrane transporters	0.489485882902532	-0.714399657258843	76	4	0.00819672131147541	488	10287	5721,1080,5699,5698	PSME2,CFTR,PSMB10,PSMB9
R-HSA-1430728	Metabolism	0.490215399583114	-0.712910393483328	2158	103	0.211065573770492	488	10287	1644,3038,1118,6385,3162,960,2182,9388,2643,6611,5721,952,6716,11343,1551,85441,1594,9023,1890,242,441282,247,9435,79993,2710,5698,1591,441024,27233,5699,4363,8564,771,2730,6482,3620,8714,130367,119548,2181,27242,8875,80736,6303,58472,1645,10135,54625,8503,80168,3638,1577,84879,8942,6999,9108,6534,7498,1581,375790,51733,6616,50515,25816,6484,3099,7295,2642,150,6523,8876,3290,5743,9536,51700,6513,7296,272,3036,4082,50486,669,3710,1646,874,51365,81894,231,26230,4023,29923,9420,259307,660,54498,117283,57089,51703,1586,8140,4504,857,6580	DDC,HAS3,CHIT1,SDC4,HMOX1,CD44,ACSL4,LIPG,GCH1,SMS,PSME2,CD38,SRD5A2,MGLL,CYP3A7,HELZ2,CYP27B1,CH25H,TYMP,ALOX12B,AKR1B15,ALOX15B,CHST2,ELOVL7,GK,PSMB9,CYP24A1,MTHFD2L,SULT1C4,PSMB10,ABCC1,KMO,CA12,GCLM,ST3GAL1,IDO1,ABCC3,SGPP2,PNLIPRP3,ACSL3,TNFRSF21,VNN2,SLC44A4,SAT1,SQOR,AKR1C1,NAMPT,PARP14,PIK3R3,MOGAT2,INSIG1,CYP3A5,MFSD2A,KYNU,TDO2,MTMR7,SLC6A7,XDH,CYP7A1,AGRN,UPB1,SNAP25,CHST11,TNFAIP8,ST3GAL4,HK2,TXN,GCGR,ADRA2A,SLC5A1,VNN1,HSD11B1,PTGS2,PTGES,CYB5R2,SLC2A1,TXNRD1,AMPD3,HAS1,MARCKS,G0S2,BPGM,ITPR3,AKR1C2,CBR3,PLA1A,SLC25A28,AKR1B1,TIAM2,LPL,HILPDA,CYP7B1,IL4I1,BMX,SMOX,IP6K3,ENTPD7,ACSL5,CYP17A1,SLC7A5,MT3,CAV1,SLC22A1
R-HSA-193704	p75 NTR receptor-mediated signalling	0.490296851903556	-0.712744251101109	97	5	0.0102459016393443	488	10287	4792,8767,4803,4790,26230	NFKBIA,RIPK2,NGF,NFKB1,TIAM2
R-HSA-1679131	Trafficking and processing of endosomal TLR	0.493813274886532	-0.705597819308604	14	1	0.00204918032786885	488	10287	1520	CTSS
R-HSA-6803205	TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain	0.493813274886532	-0.705597819308604	14	1	0.00204918032786885	488	10287	8626	TP63
R-HSA-877312	Regulation of IFNG signaling	0.493813274886532	-0.705597819308604	14	1	0.00204918032786885	488	10287	3460	IFNGR2
R-HSA-174411	Polymerase switching on the C-strand of the telomere	0.493813274886532	-0.705597819308604	14	1	0.00204918032786885	488	10287	23649	POLA2
R-HSA-209952	Peptide hormone biosynthesis	0.493813274886532	-0.705597819308604	14	1	0.00204918032786885	488	10287	3624	INHBA
R-HSA-177504	Retrograde neurotrophin signalling	0.493813274886532	-0.705597819308604	14	1	0.00204918032786885	488	10287	4803	NGF
R-HSA-5675482	Regulation of necroptotic cell death	0.493813274886532	-0.705597819308604	14	1	0.00204918032786885	488	10287	330	BIRC3
R-HSA-174403	Glutathione synthesis and recycling	0.493813274886532	-0.705597819308604	14	1	0.00204918032786885	488	10287	2730	GCLM
R-HSA-428540	Activation of Rac	0.493813274886532	-0.705597819308604	14	1	0.00204918032786885	488	10287	9353	SLIT2
R-HSA-69166	Removal of the Flap Intermediate	0.493813274886532	-0.705597819308604	14	1	0.00204918032786885	488	10287	23649	POLA2
R-HSA-69109	Leading Strand Synthesis	0.493813274886532	-0.705597819308604	14	1	0.00204918032786885	488	10287	23649	POLA2
R-HSA-69091	Polymerase switching	0.493813274886532	-0.705597819308604	14	1	0.00204918032786885	488	10287	23649	POLA2
R-HSA-69206	G1/S Transition	0.499037327935779	-0.695074380545887	119	6	0.0122950819672131	488	10287	5698,5699,5721,595,23649,8900	PSMB9,PSMB10,PSME2,CCND1,POLA2,CCNA1
R-HSA-2514859	Inactivation, recovery and regulation of the phototransduction cascade	0.499743281329023	-0.693660749755987	35	2	0.00409836065573771	488	10287	2986,5957	GUCY2F,RCVRN
R-HSA-6804757	Regulation of TP53 Degradation	0.499743281329023	-0.693660749755987	35	2	0.00409836065573771	488	10287	6446,8900	SGK1,CCNA1
R-HSA-176814	Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins	0.499775330456744	-0.693596620629516	77	4	0.00819672131147541	488	10287	5698,5721,5699,8900	PSMB9,PSME2,PSMB10,CCNA1
R-HSA-69304	Regulation of DNA replication	0.499775330456744	-0.693596620629516	77	4	0.00819672131147541	488	10287	5698,8900,5699,5721	PSMB9,CCNA1,PSMB10,PSME2
R-HSA-69541	Stabilization of p53	0.500048471408873	-0.69305024244085	56	3	0.00614754098360656	488	10287	5698,5699,5721	PSMB9,PSMB10,PSME2
R-HSA-5578775	Ion homeostasis	0.500048471408873	-0.69305024244085	56	3	0.00614754098360656	488	10287	6547,3710,490	SLC8A3,ITPR3,ATP2B1
R-HSA-174113	SCF-beta-TrCP mediated degradation of Emi1	0.500048471408873	-0.69305024244085	56	3	0.00614754098360656	488	10287	5699,5721,5698	PSMB10,PSME2,PSMB9
R-HSA-8854050	FBXL7 down-regulates AURKA during mitotic entry and in early mitosis	0.500048471408873	-0.69305024244085	56	3	0.00614754098360656	488	10287	5698,5721,5699	PSMB9,PSME2,PSMB10
R-HSA-3000178	ECM proteoglycans	0.512000118227656	-0.669430423029265	57	3	0.00614754098360656	488	10287	3687,375790,63923	ITGAX,AGRN,TNN
R-HSA-450408	AUF1 (hnRNP D0) binds and destabilizes mRNA	0.512000118227656	-0.669430423029265	57	3	0.00614754098360656	488	10287	5699,5721,5698	PSMB10,PSME2,PSMB9
R-HSA-2514856	The phototransduction cascade	0.514862792563501	-0.663854836021896	36	2	0.00409836065573771	488	10287	2986,5957	GUCY2F,RCVRN
R-HSA-167021	PLC-gamma1 signalling	0.514862792563501	-0.663854836021896	36	2	0.00409836065573771	488	10287	4803,3710	NGF,ITPR3
R-HSA-111447	Activation of BAD and translocation to mitochondria	0.517858745724938	-0.658052765560482	15	1	0.00204918032786885	488	10287	637	BID
R-HSA-205043	NRIF signals cell death from the nucleus	0.517858745724938	-0.658052765560482	15	1	0.00204918032786885	488	10287	4803	NGF
R-HSA-2691230	Signaling by NOTCH1 HD Domain Mutants in Cancer	0.517858745724938	-0.658052765560482	15	1	0.00204918032786885	488	10287	54567	DLL4
R-HSA-2691232	Constitutive Signaling by NOTCH1 HD Domain Mutants	0.517858745724938	-0.658052765560482	15	1	0.00204918032786885	488	10287	54567	DLL4
R-HSA-8875360	InlB-mediated entry of Listeria monocytogenes into host cell	0.517858745724938	-0.658052765560482	15	1	0.00204918032786885	488	10287	4233	MET
R-HSA-69183	Processive synthesis on the lagging strand	0.517858745724938	-0.658052765560482	15	1	0.00204918032786885	488	10287	23649	POLA2
R-HSA-975577	N-Glycan antennae elongation	0.517858745724938	-0.658052765560482	15	1	0.00204918032786885	488	10287	6484	ST3GAL4
R-HSA-399955	SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion	0.517858745724938	-0.658052765560482	15	1	0.00204918032786885	488	10287	27289	RND1
R-HSA-5099900	WNT5A-dependent internalization of FZD4	0.517858745724938	-0.658052765560482	15	1	0.00204918032786885	488	10287	7474	WNT5A
R-HSA-5682910	LGI-ADAM interactions	0.517858745724938	-0.658052765560482	15	1	0.00204918032786885	488	10287	55203	LGI2
R-HSA-1483255	PI Metabolism	0.520078516785176	-0.653775484987437	79	4	0.00819672131147541	488	10287	8503,9108,660,25816	PIK3R3,MTMR7,BMX,TNFAIP8
R-HSA-453279	Mitotic G1-G1/S phases	0.521322255707113	-0.651386895414392	143	7	0.014344262295082	488	10287	8900,23649,5699,5721,595,5698,1030	CCNA1,POLA2,PSMB10,PSME2,CCND1,PSMB9,CDKN2B
R-HSA-5362768	Hh mutants that don't undergo autocatalytic processing are degraded by ERAD	0.523799143376694	-0.646646982311363	58	3	0.00614754098360656	488	10287	5721,5699,5698	PSME2,PSMB10,PSMB9
R-HSA-373760	L1CAM interactions	0.526351065428704	-0.641786864103886	101	5	0.0102459016393443	488	10287	214,8828,6708,286,2048	ALCAM,NRP2,SPTA1,ANK1,EPHB2
R-HSA-5083635	Defective B3GALTL causes Peters-plus syndrome (PpS)	0.529676993204909	-0.635487905007341	37	2	0.00409836065573771	488	10287	9507,56999	ADAMTS4,ADAMTS9
R-HSA-419037	NCAM1 interactions	0.529676993204909	-0.635487905007341	37	2	0.00409836065573771	488	10287	375790,2668	AGRN,GDNF
R-HSA-4641258	Degradation of DVL	0.535440140707514	-0.624666177401211	59	3	0.00614754098360656	488	10287	5721,5699,5698	PSME2,PSMB10,PSMB9
R-HSA-1989781	PPARA activates gene expression	0.539613326216317	-0.616902458481441	124	6	0.0122950819672131	488	10287	26230,1581,7296,85441,50486,27242	TIAM2,CYP7A1,TXNRD1,HELZ2,G0S2,TNFRSF21
R-HSA-176408	Regulation of APC/C activators between G1/S and early anaphase	0.539985417773734	-0.616213143911149	81	4	0.00819672131147541	488	10287	5698,8900,5699,5721	PSMB9,CCNA1,PSMB10,PSME2
R-HSA-159418	Recycling of bile acids and salts	0.540764210283224	-0.614771935653338	16	1	0.00204918032786885	488	10287	8714	ABCC3
R-HSA-162710	Synthesis of glycosylphosphatidylinositol (GPI)	0.540764210283224	-0.614771935653338	16	1	0.00204918032786885	488	10287	5277	PIGA
R-HSA-975163	IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation	0.540764210283224	-0.614771935653338	16	1	0.00204918032786885	488	10287	3656	IRAK2
R-HSA-1433559	Regulation of KIT signaling	0.540764210283224	-0.614771935653338	16	1	0.00204918032786885	488	10287	4067	LYN
R-HSA-5218859	Regulated Necrosis	0.540764210283224	-0.614771935653338	16	1	0.00204918032786885	488	10287	330	BIRC3
R-HSA-5213460	RIPK1-mediated regulated necrosis	0.540764210283224	-0.614771935653338	16	1	0.00204918032786885	488	10287	330	BIRC3
R-HSA-549132	Organic cation/anion/zwitterion transport	0.540764210283224	-0.614771935653338	16	1	0.00204918032786885	488	10287	6580	SLC22A1
R-HSA-392517	Rap1 signalling	0.540764210283224	-0.614771935653338	16	1	0.00204918032786885	488	10287	10125	RASGRP1
R-HSA-418038	Nucleotide-like (purinergic) receptors	0.540764210283224	-0.614771935653338	16	1	0.00204918032786885	488	10287	135	ADORA2A
R-HSA-535734	Fatty acid, triacylglycerol, and ketone body metabolism	0.542813867427099	-0.610988803398063	253	12	0.0245901639344262	488	10287	79993,2710,26230,85441,2181,27242,1581,7296,2182,80168,50486,51703	ELOVL7,GK,TIAM2,HELZ2,ACSL3,TNFRSF21,CYP7A1,TXNRD1,ACSL4,MOGAT2,G0S2,ACSL5
R-HSA-76009	Platelet Aggregation (Plug Formation)	0.544180778148651	-0.6084737745566	38	2	0.00409836065573771	488	10287	150,10125	ADRA2A,RASGRP1
R-HSA-5655302	Signaling by FGFR1 in disease	0.544180778148651	-0.6084737745566	38	2	0.00409836065573771	488	10287	26281,2247	FGF20,FGF2
R-HSA-68827	CDT1 association with the CDC6:ORC:origin complex	0.546918222862451	-0.603455988902106	60	3	0.00614754098360656	488	10287	5698,5699,5721	PSMB9,PSMB10,PSME2
R-HSA-5387390	Hh mutants abrogate ligand secretion	0.546918222862451	-0.603455988902106	60	3	0.00614754098360656	488	10287	5698,5721,5699	PSMB9,PSME2,PSMB10
R-HSA-71291	Metabolism of amino acids and derivatives	0.548794903938691	-0.600030488439576	361	17	0.0348360655737705	488	10287	6303,6611,5721,2730,3620,6534,1644,7296,5699,8564,5698,8942,6999,8140,259307,58472,54498	SAT1,SMS,PSME2,GCLM,IDO1,SLC6A7,DDC,TXNRD1,PSMB10,KMO,PSMB9,KYNU,TDO2,SLC7A5,IL4I1,SQOR,SMOX
R-HSA-5628897	TP53 Regulates Metabolic Genes	0.549780521093541	-0.598236132955479	82	4	0.00819672131147541	488	10287	54541,7295,8626,7296	DDIT4,TXN,TP63,TXNRD1
R-HSA-2672351	Stimuli-sensing channels	0.552642720179347	-0.593043561881646	104	5	0.0102459016393443	488	10287	6338,8989,6446,23327,266675	SCNN1B,TRPA1,SGK1,NEDD4L,BEST4
R-HSA-4086398	Ca2+ pathway	0.558229000262355	-0.582986006054309	61	3	0.00614754098360656	488	10287	7474,3710,51176	WNT5A,ITPR3,LEF1
R-HSA-5610780	Degradation of GLI1 by the proteasome	0.558229000262355	-0.582986006054309	61	3	0.00614754098360656	488	10287	5698,5699,5721	PSMB9,PSMB10,PSME2
R-HSA-5610783	Degradation of GLI2 by the proteasome	0.558229000262355	-0.582986006054309	61	3	0.00614754098360656	488	10287	5699,5721,5698	PSMB10,PSME2,PSMB9
R-HSA-5610785	GLI3 is processed to GLI3R by the proteasome	0.558229000262355	-0.582986006054309	61	3	0.00614754098360656	488	10287	5699,5721,5698	PSMB10,PSME2,PSMB9
R-HSA-8852276	The role of GTSE1 in G2/M progression after G2 checkpoint	0.558229000262355	-0.582986006054309	61	3	0.00614754098360656	488	10287	5699,5721,5698	PSMB10,PSME2,PSMB9
R-HSA-111465	Apoptotic cleavage of cellular proteins	0.55837021042401	-0.582733077051573	39	2	0.00409836065573771	488	10287	5317,660	PKP1,BMX
R-HSA-420499	Class C/3 (Metabotropic glutamate/pheromone receptors)	0.55837021042401	-0.582733077051573	39	2	0.00409836065573771	488	10287	2914,2918	GRM4,GRM8
R-HSA-69231	Cyclin D associated events in G1	0.55837021042401	-0.582733077051573	39	2	0.00409836065573771	488	10287	1030,595	CDKN2B,CCND1
R-HSA-5173214	O-glycosylation of TSR domain-containing proteins	0.55837021042401	-0.582733077051573	39	2	0.00409836065573771	488	10287	9507,56999	ADAMTS4,ADAMTS9
R-HSA-69236	G1 Phase	0.55837021042401	-0.582733077051573	39	2	0.00409836065573771	488	10287	1030,595	CDKN2B,CCND1
R-HSA-983695	Antigen activates B Cell Receptor (BCR) leading to generation of second messengers	0.55837021042401	-0.582733077051573	39	2	0.00409836065573771	488	10287	4067,3710	LYN,ITPR3
R-HSA-195253	Degradation of beta-catenin by the destruction complex	0.559465389349793	-0.580773613108188	83	4	0.00819672131147541	488	10287	5698,51176,5699,5721	PSMB9,LEF1,PSMB10,PSME2
R-HSA-139853	Elevation of cytosolic Ca2+ levels	0.562583611082098	-0.575215514025948	17	1	0.00204918032786885	488	10287	3710	ITPR3
R-HSA-189445	Metabolism of porphyrins	0.562583611082098	-0.575215514025948	17	1	0.00204918032786885	488	10287	3162	HMOX1
R-HSA-432142	Platelet sensitization by LDL	0.562583611082098	-0.575215514025948	17	1	0.00204918032786885	488	10287	2268	FGR
R-HSA-416993	Trafficking of GluR2-containing AMPA receptors	0.562583611082098	-0.575215514025948	17	1	0.00204918032786885	488	10287	80852	GRIP2
R-HSA-5627117	RHO GTPases Activate ROCKs	0.562583611082098	-0.575215514025948	17	1	0.00204918032786885	488	10287	4629	MYH11
R-HSA-622312	Inflammasomes	0.562583611082098	-0.575215514025948	17	1	0.00204918032786885	488	10287	7295	TXN
R-HSA-438066	Unblocking of NMDA receptor, glutamate binding and activation	0.562583611082098	-0.575215514025948	17	1	0.00204918032786885	488	10287	2903	GRIN2A
R-HSA-435354	Zinc transporters	0.562583611082098	-0.575215514025948	17	1	0.00204918032786885	488	10287	64116	SLC39A8
R-HSA-5625900	RHO GTPases activate CIT	0.562583611082098	-0.575215514025948	17	1	0.00204918032786885	488	10287	4629	MYH11
R-HSA-937072	TRAF6 mediated induction of TAK1 complex	0.562583611082098	-0.575215514025948	17	1	0.00204918032786885	488	10287	3656	IRAK2
R-HSA-264642	Acetylcholine Neurotransmitter Release Cycle	0.562583611082098	-0.575215514025948	17	1	0.00204918032786885	488	10287	6616	SNAP25
R-HSA-442729	CREB phosphorylation through the activation of CaMKII	0.562583611082098	-0.575215514025948	17	1	0.00204918032786885	488	10287	2903	GRIN2A
R-HSA-400206	Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)	0.56326794293278	-0.573999844104775	127	6	0.0122950819672131	488	10287	85441,50486,27242,1581,26230,7296	HELZ2,G0S2,TNFRSF21,CYP7A1,TIAM2,TXNRD1
R-HSA-8864260	Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors	0.572242422411773	-0.558192561981523	40	2	0.00409836065573771	488	10287	163732,4435	CITED4,CITED1
R-HSA-5654741	Signaling by FGFR3	0.572242422411773	-0.558192561981523	40	2	0.00409836065573771	488	10287	26281,2247	FGF20,FGF2
R-HSA-446219	Synthesis of substrates in N-glycan biosythesis	0.580333445974566	-0.544152433784605	63	3	0.00614754098360656	488	10287	6484,9945,6482	ST3GAL4,GFPT2,ST3GAL1
R-HSA-181429	Serotonin Neurotransmitter Release Cycle	0.583368343092074	-0.538936485804349	18	1	0.00204918032786885	488	10287	6616	SNAP25
R-HSA-5676594	TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway	0.583368343092074	-0.538936485804349	18	1	0.00204918032786885	488	10287	330	BIRC3
R-HSA-209776	Amine-derived hormones	0.583368343092074	-0.538936485804349	18	1	0.00204918032786885	488	10287	1644	DDC
R-HSA-1912420	Pre-NOTCH Processing in Golgi	0.583368343092074	-0.538936485804349	18	1	0.00204918032786885	488	10287	6484	ST3GAL4
R-HSA-196757	Metabolism of folate and pterines	0.583368343092074	-0.538936485804349	18	1	0.00204918032786885	488	10287	441024	MTHFD2L
R-HSA-69205	G1/S-Specific Transcription	0.583368343092074	-0.538936485804349	18	1	0.00204918032786885	488	10287	8900	CCNA1
R-HSA-1369062	ABC transporters in lipid homeostasis	0.583368343092074	-0.538936485804349	18	1	0.00204918032786885	488	10287	26154	ABCA12
R-HSA-5654743	Signaling by FGFR4	0.585795523489581	-0.53478448632207	41	2	0.00409836065573771	488	10287	2247,26281	FGF2,FGF20
R-HSA-68874	M/G1 Transition	0.587827955951333	-0.531320965816379	86	4	0.00819672131147541	488	10287	5698,5699,5721,23649	PSMB9,PSMB10,PSME2,POLA2
R-HSA-69002	DNA Replication Pre-Initiation	0.587827955951333	-0.531320965816379	86	4	0.00819672131147541	488	10287	5698,23649,5721,5699	PSMB9,POLA2,PSME2,PSMB10
R-HSA-174084	Autodegradation of Cdh1 by Cdh1:APC/C	0.591120636571752	-0.525735159611419	64	3	0.00614754098360656	488	10287	5698,5721,5699	PSMB9,PSME2,PSMB10
R-HSA-453276	Regulation of mitotic cell cycle	0.597042462078297	-0.515767042359561	87	4	0.00819672131147541	488	10287	5698,8900,5699,5721	PSMB9,CCNA1,PSMB10,PSME2
R-HSA-174143	APC/C-mediated degradation of cell cycle proteins	0.597042462078297	-0.515767042359561	87	4	0.00819672131147541	488	10287	5721,5699,8900,5698	PSME2,PSMB10,CCNA1,PSMB9
R-HSA-373752	Netrin-1 signaling	0.599028514251468	-0.512446078908747	42	2	0.00409836065573771	488	10287	9353,137970	SLIT2,UNC5D
R-HSA-3928662	EPHB-mediated forward signaling	0.599028514251468	-0.512446078908747	42	2	0.00409836065573771	488	10287	4067,2048	LYN,EPHB2
R-HSA-442982	Ras activation uopn Ca2+ infux through NMDA receptor	0.603167374005849	-0.5055605519378	19	1	0.00204918032786885	488	10287	2903	GRIN2A
R-HSA-190861	Gap junction assembly	0.603167374005849	-0.5055605519378	19	1	0.00204918032786885	488	10287	2706	GJB2
R-HSA-416700	Other semaphorin interactions	0.603167374005849	-0.5055605519378	19	1	0.00204918032786885	488	10287	80031	SEMA6D
R-HSA-8851708	Signaling by FGFR2 IIIa TM	0.603167374005849	-0.5055605519378	19	1	0.00204918032786885	488	10287	2247	FGF2
R-HSA-6804114	TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest	0.603167374005849	-0.5055605519378	19	1	0.00204918032786885	488	10287	25946	ZNF385A
R-HSA-3928664	Ephrin signaling	0.603167374005849	-0.5055605519378	19	1	0.00204918032786885	488	10287	2048	EPHB2
R-HSA-156584	Cytosolic sulfonation of small molecules	0.603167374005849	-0.5055605519378	19	1	0.00204918032786885	488	10287	27233	SULT1C4
R-HSA-888590	GABA synthesis, release, reuptake and degradation	0.603167374005849	-0.5055605519378	19	1	0.00204918032786885	488	10287	6616	SNAP25
R-HSA-983169	Class I MHC mediated antigen processing & presentation	0.604136938374288	-0.503954387581499	373	17	0.0348360655737705	488	10287	6890,5721,55521,255488,4688,5699,1520,127544,5698,6891,92369,10517,7097,84676,55008,221687,23327	TAP1,PSME2,TRIM36,RNF144B,NCF2,PSMB10,CTSS,RNF19B,PSMB9,TAP2,SPSB4,FBXW10,TLR2,TRIM63,HERC6,RNF182,NEDD4L
R-HSA-416482	G alpha (12/13) signalling events	0.60613320472833	-0.500655507284731	88	4	0.00819672131147541	488	10287	147,26230,8503,5880	ADRA1B,TIAM2,PIK3R3,RAC2
R-HSA-381340	Transcriptional regulation of white adipocyte differentiation	0.60613320472833	-0.500655507284731	88	4	0.00819672131147541	488	10287	4023,85441,688,4790	LPL,HELZ2,KLF5,NFKB1
R-HSA-446728	Cell junction organization	0.60613320472833	-0.500655507284731	88	4	0.00819672131147541	488	10287	3918,5818,1000,3914	LAMC2,NECTIN1,CDH2,LAMB3
R-HSA-1236394	Signaling by ERBB4	0.611941206429547	-0.491119069010206	43	2	0.00409836065573771	488	10287	2069,1839	EREG,HBEGF
R-HSA-5655253	Signaling by FGFR2 in disease	0.611941206429547	-0.491119069010206	43	2	0.00409836065573771	488	10287	2247,26281	FGF2,FGF20
R-HSA-69186	Lagging Strand Synthesis	0.622027358584527	-0.474771202347679	20	1	0.00204918032786885	488	10287	23649	POLA2
R-HSA-8876384	Listeria monocytogenes entry into host cells	0.622027358584527	-0.474771202347679	20	1	0.00204918032786885	488	10287	4233	MET
R-HSA-8848021	Signaling by PTK6	0.622391935339458	-0.474185263561385	67	3	0.00614754098360656	488	10287	1839,2069,595	HBEGF,EREG,CCND1
R-HSA-1234176	Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha	0.622391935339458	-0.474185263561385	67	3	0.00614754098360656	488	10287	5699,5721,5698	PSMB10,PSME2,PSMB9
R-HSA-5358346	Hedgehog ligand biogenesis	0.622391935339458	-0.474185263561385	67	3	0.00614754098360656	488	10287	5721,5699,5698	PSME2,PSMB10,PSMB9
R-HSA-5687128	MAPK6/MAPK4 signaling	0.623935532673746	-0.47170822897271	90	4	0.00819672131147541	488	10287	5721,3725,5699,5698	PSME2,JUN,PSMB10,PSMB9
R-HSA-174154	APC/C:Cdc20 mediated degradation of Securin	0.632446141634617	-0.458160213571886	68	3	0.00614754098360656	488	10287	5698,5699,5721	PSMB9,PSMB10,PSME2
R-HSA-196741	Cobalamin (Cbl, vitamin B12) transport and metabolism	0.639992747590915	-0.446298434581821	21	1	0.00204918032786885	488	10287	4363	ABCC1
R-HSA-5423646	Aflatoxin activation and detoxification	0.639992747590915	-0.446298434581821	21	1	0.00204918032786885	488	10287	1577	CYP3A5
R-HSA-3000480	Scavenging by Class A Receptors	0.639992747590915	-0.446298434581821	21	1	0.00204918032786885	488	10287	2495	FTH1
R-HSA-2028269	Signaling by Hippo	0.639992747590915	-0.446298434581821	21	1	0.00204918032786885	488	10287	23286	WWC1
R-HSA-8849932	SALM protein interactions at the synapses	0.639992747590915	-0.446298434581821	21	1	0.00204918032786885	488	10287	2903	GRIN2A
R-HSA-2979096	NOTCH2 Activation and Transmission of Signal to the Nucleus	0.639992747590915	-0.446298434581821	21	1	0.00204918032786885	488	10287	54567	DLL4
R-HSA-6807004	Negative regulation of MET activity	0.639992747590915	-0.446298434581821	21	1	0.00204918032786885	488	10287	4233	MET
R-HSA-2022870	Chondroitin sulfate biosynthesis	0.639992747590915	-0.446298434581821	21	1	0.00204918032786885	488	10287	50515	CHST11
R-HSA-381119	Unfolded Protein Response (UPR)	0.641221288381362	-0.44438065795358	92	4	0.00819672131147541	488	10287	467,6347,3484,3576	ATF3,CCL2,IGFBP1,CXCL8
R-HSA-6806834	Signaling by MET	0.642313382066713	-0.44267896033055	69	3	0.00614754098360656	488	10287	3914,4233,3918	LAMB3,MET,LAMC2
R-HSA-68867	Assembly of the pre-replicative complex	0.642313382066713	-0.44267896033055	69	3	0.00614754098360656	488	10287	5699,5721,5698	PSMB10,PSME2,PSMB9
R-HSA-2173793	Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	0.648766250210398	-0.432682796321877	46	2	0.00409836065573771	488	10287	23327,1030	NEDD4L,CDKN2B
R-HSA-70153	Glucose transport	0.648766250210398	-0.432682796321877	46	2	0.00409836065573771	488	10287	6513,3099	SLC2A1,HK2
R-HSA-1650814	Collagen biosynthesis and modifying enzymes	0.651992835268404	-0.427721705968003	70	3	0.00614754098360656	488	10287	1305,1294,169044	COL13A1,COL7A1,COL22A1
R-HSA-5658442	Regulation of RAS by GAPs	0.651992835268404	-0.427721705968003	70	3	0.00614754098360656	488	10287	5698,5721,5699	PSMB9,PSME2,PSMB10
R-HSA-198753	ERK/MAPK targets	0.657105891865451	-0.419910098651536	22	1	0.00204918032786885	488	10287	1848	DUSP6
R-HSA-2142691	Synthesis of Leukotrienes (LT) and Eoxins (EX)	0.657105891865451	-0.419910098651536	22	1	0.00204918032786885	488	10287	4363	ABCC1
R-HSA-1482801	Acyl chain remodelling of PS	0.657105891865451	-0.419910098651536	22	1	0.00204918032786885	488	10287	51365	PLA1A
R-HSA-69273	Cyclin A/B1 associated events during G2/M transition	0.657105891865451	-0.419910098651536	22	1	0.00204918032786885	488	10287	8900	CCNA1
R-HSA-6809371	Formation of the cornified envelope	0.661483981368533	-0.413269511338572	71	3	0.00614754098360656	488	10287	2312,5317,5266	FLG,PKP1,PI3
R-HSA-400253	Circadian Clock	0.661483981368533	-0.413269511338572	71	3	0.00614754098360656	488	10287	10135,85441,56938	NAMPT,HELZ2,ARNTL2
R-HSA-948021	Transport to the Golgi and subsequent modification	0.666427429201275	-0.405824028710546	164	7	0.014344262295082	488	10287	374,1604,6708,6484,1294,4121,286	AREG,CD55,SPTA1,ST3GAL4,COL7A1,MAN1A1,ANK1
R-HSA-5620922	BBSome-mediated cargo-targeting to cilium	0.673407141248015	-0.395405167547486	23	1	0.00204918032786885	488	10287	2847	MCHR1
R-HSA-2173795	Downregulation of SMAD2/3:SMAD4 transcriptional activity	0.673407141248015	-0.395405167547486	23	1	0.00204918032786885	488	10287	23327	NEDD4L
R-HSA-5627123	RHO GTPases activate PAKs	0.673407141248015	-0.395405167547486	23	1	0.00204918032786885	488	10287	4629	MYH11
R-HSA-389948	PD-1 signaling	0.673407141248015	-0.395405167547486	23	1	0.00204918032786885	488	10287	29126	CD274
R-HSA-5365859	RA biosynthesis pathway	0.673407141248015	-0.395405167547486	23	1	0.00204918032786885	488	10287	195814	SDR16C5
R-HSA-212676	Dopamine Neurotransmitter Release Cycle	0.673407141248015	-0.395405167547486	23	1	0.00204918032786885	488	10287	6616	SNAP25
R-HSA-174178	APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1	0.679900677216831	-0.385808554396637	73	3	0.00614754098360656	488	10287	5721,5699,5698	PSME2,PSMB10,PSMB9
R-HSA-174417	Telomere C-strand (Lagging Strand) Synthesis	0.688934938892363	-0.372608440740083	24	1	0.00204918032786885	488	10287	23649	POLA2
R-HSA-937041	IKK complex recruitment mediated by RIP1	0.688934938892363	-0.372608440740083	24	1	0.00204918032786885	488	10287	330	BIRC3
R-HSA-1660499	Synthesis of PIPs at the plasma membrane	0.693484150526375	-0.366026893812315	50	2	0.00409836065573771	488	10287	660,8503	BMX,PIK3R3
R-HSA-418555	G alpha (s) signalling events	0.697639632113023	-0.36005259591249	146	6	0.0122950819672131	488	10287	9340,5142,135,53831,134864,2642	GLP2R,PDE4B,ADORA2A,GPR84,TAAR1,GCGR
R-HSA-597592	Post-translational protein modification	0.703541959378101	-0.351627760456345	1034	46	0.0942622950819672	488	10287	154064,10071,50614,5698,330,9507,64135,56999,8876,5277,5721,8975,6484,4586,79931,10318,10164,79623,8900,51301,6708,116372,8313,1604,90865,84101,1294,4121,374,23586,4792,286,7128,124872,64127,8767,8875,1080,5699,723790,1540,5329,9945,219333,27076,6482	RAET1L,MUC12,GALNT9,PSMB9,BIRC3,ADAMTS4,IFIH1,ADAMTS9,VNN1,PIGA,PSME2,USP13,ST3GAL4,MUC5AC,TNIP3,TNIP1,CHST4,GALNT14,CCNA1,GCNT4,SPTA1,LYPD1,AXIN2,CD55,IL33,USP44,COL7A1,MAN1A1,AREG,DDX58,NFKBIA,ANK1,TNFAIP3,B4GALNT2,NOD2,RIPK2,VNN2,CFTR,PSMB10,HIST2H2AA4,CYLD,PLAUR,GFPT2,USP12,LYPD3,ST3GAL1
R-HSA-1538133	G0 and Early G1	0.703725911301193	-0.351366329170984	25	1	0.00204918032786885	488	10287	8900	CCNA1
R-HSA-982772	Growth hormone receptor signaling	0.703725911301193	-0.351366329170984	25	1	0.00204918032786885	488	10287	4067	LYN
R-HSA-162588	Budding and maturation of HIV virion	0.703725911301193	-0.351366329170984	25	1	0.00204918032786885	488	10287	23327	NEDD4L
R-HSA-182971	EGFR downregulation	0.703725911301193	-0.351366329170984	25	1	0.00204918032786885	488	10287	10252	SPRY1
R-HSA-3295583	TRP channels	0.703725911301193	-0.351366329170984	25	1	0.00204918032786885	488	10287	8989	TRPA1
R-HSA-198725	Nuclear Events (kinase and transcription factor activation)	0.703725911301193	-0.351366329170984	25	1	0.00204918032786885	488	10287	1848	DUSP6
R-HSA-383280	Nuclear Receptor transcription pathway	0.703902725295675	-0.351115106666958	51	2	0.00409836065573771	488	10287	8013,4929	NR4A3,NR4A2
R-HSA-445717	Aquaporin-mediated transport	0.714025109622763	-0.336837149722032	52	2	0.00409836065573771	488	10287	366,4645	AQP9,MYO5B
R-HSA-1234174	Regulation of Hypoxia-inducible Factor (HIF) by oxygen	0.71448103836564	-0.336198820290968	77	3	0.00614754098360656	488	10287	5698,5699,5721	PSMB9,PSMB10,PSME2
R-HSA-2262749	Cellular response to hypoxia	0.71448103836564	-0.336198820290968	77	3	0.00614754098360656	488	10287	5698,5721,5699	PSMB9,PSME2,PSMB10
R-HSA-975576	N-glycan antennae elongation in the medial/trans-Golgi	0.717814953916644	-0.331543467500618	26	1	0.00204918032786885	488	10287	6484	ST3GAL4
R-HSA-1474165	Reproduction	0.717814953916644	-0.331543467500618	26	1	0.00204918032786885	488	10287	7784	ZP3
R-HSA-1187000	Fertilization	0.717814953916644	-0.331543467500618	26	1	0.00204918032786885	488	10287	7784	ZP3
R-HSA-3238698	WNT ligand biogenesis and trafficking	0.717814953916644	-0.331543467500618	26	1	0.00204918032786885	488	10287	7474	WNT5A
R-HSA-2029485	Role of phospholipids in phagocytosis	0.717814953916644	-0.331543467500618	26	1	0.00204918032786885	488	10287	3710	ITPR3
R-HSA-912694	Regulation of IFNA signaling	0.717814953916644	-0.331543467500618	26	1	0.00204918032786885	488	10287	3455	IFNAR2
R-HSA-2559580	Oxidative Stress Induced Senescence	0.719997825924077	-0.328507086526488	126	5	0.0102459016393443	488	10287	723790,7295,3725,23135,1030	HIST2H2AA4,TXN,JUN,KDM6B,CDKN2B
R-HSA-446193	Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein	0.722661304799834	-0.32481462467566	78	3	0.00614754098360656	488	10287	6484,9945,6482	ST3GAL4,GFPT2,ST3GAL1
R-HSA-6807878	COPI-mediated anterograde transport	0.730657993819898	-0.313809789424825	79	3	0.00614754098360656	488	10287	286,6708,1604	ANK1,SPTA1,CD55
R-HSA-180024	DARPP-32 events	0.731235312800806	-0.313019965696505	27	1	0.00204918032786885	488	10287	5142	PDE4B
R-HSA-2173788	Downregulation of TGF-beta receptor signaling	0.731235312800806	-0.313019965696505	27	1	0.00204918032786885	488	10287	23327	NEDD4L
R-HSA-1638091	Heparan sulfate/heparin (HS-GAG) metabolism	0.733399904137787	-0.310064154054236	54	2	0.00409836065573771	488	10287	6385,375790	SDC4,AGRN
R-HSA-2262752	Cellular responses to stress	0.738169936432574	-0.30358121472005	451	19	0.0389344262295082	488	10287	3552,5721,4688,1030,723790,7296,8900,3725,4790,5699,6648,23135,5698,3576,3008,3159,7295,8091,3569	IL1A,PSME2,NCF2,CDKN2B,HIST2H2AA4,TXNRD1,CCNA1,JUN,NFKB1,PSMB10,SOD2,KDM6B,PSMB9,CXCL8,HIST1H1E,HMGA1,TXN,HMGA2,IL6
R-HSA-5689603	UCH proteinases	0.740524330118996	-0.300396789475087	105	4	0.00819672131147541	488	10287	5698,5721,5699,723790	PSMB9,PSME2,PSMB10,HIST2H2AA4
R-HSA-1655829	Regulation of cholesterol biosynthesis by SREBP (SREBF)	0.742662159058766	-0.297514036111483	55	2	0.00409836065573771	488	10287	3638,85441	INSIG1,HELZ2
R-HSA-174800	Chylomicron-mediated lipid transport	0.744018662439819	-0.295689160539153	28	1	0.00204918032786885	488	10287	4023	LPL
R-HSA-400042	Adrenaline,noradrenaline inhibits insulin secretion	0.744018662439819	-0.295689160539153	28	1	0.00204918032786885	488	10287	150	ADRA2A
R-HSA-5576893	Phase 2 - plateau phase	0.744018662439819	-0.295689160539153	28	1	0.00204918032786885	488	10287	23630	KCNE5
R-HSA-190828	Gap junction trafficking	0.744018662439819	-0.295689160539153	28	1	0.00204918032786885	488	10287	2706	GJB2
R-HSA-354192	Integrin alphaIIb beta3 signaling	0.744018662439819	-0.295689160539153	28	1	0.00204918032786885	488	10287	10125	RASGRP1
R-HSA-1368082	RORA activates gene expression	0.744018662439819	-0.295689160539153	28	1	0.00204918032786885	488	10287	85441	HELZ2
R-HSA-983231	Factors involved in megakaryocyte development and platelet production	0.756133138761692	-0.27953780883492	156	6	0.0122950819672131	488	10287	9732,10938,3659,4602,23764,55619	DOCK4,EHD1,IRF1,MYB,MAFF,DOCK10
R-HSA-2032785	YAP1- and WWTR1 (TAZ)-stimulated gene expression	0.756195179897355	-0.279455761656496	29	1	0.00204918032786885	488	10287	85441	HELZ2
R-HSA-164952	The role of Nef in HIV-1 replication and disease pathogenesis	0.756195179897355	-0.279455761656496	29	1	0.00204918032786885	488	10287	3055	HCK
R-HSA-5601884	PIWI-interacting RNA (piRNA) biogenesis	0.756195179897355	-0.279455761656496	29	1	0.00204918032786885	488	10287	54514	DDX4
R-HSA-525793	Myogenesis	0.756195179897355	-0.279455761656496	29	1	0.00204918032786885	488	10287	1000	CDH2
R-HSA-442742	CREB phosphorylation through the activation of Ras	0.756195179897355	-0.279455761656496	29	1	0.00204918032786885	488	10287	2903	GRIN2A
R-HSA-5218920	VEGFR2 mediated vascular permeability	0.756195179897355	-0.279455761656496	29	1	0.00204918032786885	488	10287	857	CAV1
R-HSA-389957	Prefoldin mediated transfer of substrate  to CCT/TriC	0.756195179897355	-0.279455761656496	29	1	0.00204918032786885	488	10287	10471	PFDN6
R-HSA-375170	CDO in myogenesis	0.756195179897355	-0.279455761656496	29	1	0.00204918032786885	488	10287	1000	CDH2
R-HSA-114608	Platelet degranulation	0.756946122469155	-0.278463200509329	132	5	0.0102459016393443	488	10287	5341,5005,5004,7273,5552	PLEK,ORM2,ORM1,TTN,SRGN
R-HSA-3700989	Transcriptional Regulation by TP53	0.761478663933029	-0.272493125512158	367	15	0.0307377049180328	488	10287	639,1263,637,54541,7832,7295,8900,27113,7296,3725,10769,5366,6446,8626,25946	PRDM1,PLK3,BID,DDIT4,BTG2,TXN,CCNA1,BBC3,TXNRD1,JUN,PLK2,PMAIP1,SGK1,TP63,ZNF385A
R-HSA-199977	ER to Golgi Anterograde Transport	0.762734849885727	-0.270844818072654	133	5	0.0102459016393443	488	10287	286,1294,6708,374,1604	ANK1,COL7A1,SPTA1,AREG,CD55
R-HSA-157858	Gap junction trafficking and regulation	0.767793615489284	-0.264234311780458	30	1	0.00204918032786885	488	10287	2706	GJB2
R-HSA-162909	Host Interactions of HIV factors	0.76841917956225	-0.263419888011097	134	5	0.0102459016393443	488	10287	3159,3055,5721,5699,5698	HMGA1,HCK,PSME2,PSMB10,PSMB9
R-HSA-2644602	Signaling by NOTCH1 PEST Domain Mutants in Cancer	0.768810998884663	-0.262910114866656	58	2	0.00409836065573771	488	10287	10046,54567	MAMLD1,DLL4
R-HSA-2644603	Signaling by NOTCH1 in Cancer	0.768810998884663	-0.262910114866656	58	2	0.00409836065573771	488	10287	10046,54567	MAMLD1,DLL4
R-HSA-2644606	Constitutive Signaling by NOTCH1 PEST Domain Mutants	0.768810998884663	-0.262910114866656	58	2	0.00409836065573771	488	10287	10046,54567	MAMLD1,DLL4
R-HSA-2894858	Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer	0.768810998884663	-0.262910114866656	58	2	0.00409836065573771	488	10287	54567,10046	DLL4,MAMLD1
R-HSA-2894862	Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants	0.768810998884663	-0.262910114866656	58	2	0.00409836065573771	488	10287	10046,54567	MAMLD1,DLL4
R-HSA-1483257	Phospholipid metabolism	0.772310936088738	-0.258368043091874	207	8	0.0163934426229508	488	10287	9108,660,51365,8503,25816,80736,11343,84879	MTMR7,BMX,PLA1A,PIK3R3,TNFAIP8,SLC44A4,MGLL,MFSD2A
R-HSA-180786	Extension of Telomeres	0.778841360022374	-0.249947899520878	31	1	0.00204918032786885	488	10287	23649	POLA2
R-HSA-983712	Ion channel transport	0.781271518581306	-0.246832534526777	209	8	0.0163934426229508	488	10287	490,23327,6338,8989,245973,266675,6446,50617	ATP2B1,NEDD4L,SCNN1B,TRPA1,ATP6V1C2,BEST4,SGK1,ATP6V0A4
R-HSA-5632684	Hedgehog 'on' state	0.781636568187162	-0.246365393028714	86	3	0.00614754098360656	488	10287	5698,5699,5721	PSMB9,PSMB10,PSME2
R-HSA-76005	Response to elevated platelet cytosolic Ca2+	0.784851705585549	-0.24226048912759	137	5	0.0102459016393443	488	10287	5004,5005,5341,7273,5552	ORM1,ORM2,PLEK,TTN,SRGN
R-HSA-193648	NRAGE signals death through JNK	0.784933285445957	-0.24215655150435	60	2	0.00409836065573771	488	10287	26230,4803	TIAM2,NGF
R-HSA-5633007	Regulation of TP53 Activity	0.787030530763386	-0.23948823746283	162	6	0.0122950819672131	488	10287	6446,8900,8626,25946,639,1263	SGK1,CCNA1,TP63,ZNF385A,PRDM1,PLK3
R-HSA-68962	Activation of the pre-replicative complex	0.78936450904924	-0.236527076164601	32	1	0.00204918032786885	488	10287	23649	POLA2
R-HSA-399719	Trafficking of AMPA receptors	0.78936450904924	-0.236527076164601	32	1	0.00204918032786885	488	10287	80852	GRIP2
R-HSA-456926	Thrombin signalling through proteinase activated receptors (PARs)	0.78936450904924	-0.236527076164601	32	1	0.00204918032786885	488	10287	2151	F2RL2
R-HSA-4641262	Disassembly of the destruction complex and recruitment of AXIN to the membrane	0.78936450904924	-0.236527076164601	32	1	0.00204918032786885	488	10287	857	CAV1
R-HSA-399721	Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity	0.78936450904924	-0.236527076164601	32	1	0.00204918032786885	488	10287	80852	GRIP2
R-HSA-2559585	Oncogene Induced Senescence	0.78936450904924	-0.236527076164601	32	1	0.00204918032786885	488	10287	1030	CDKN2B
R-HSA-70171	Glycolysis	0.78936450904924	-0.236527076164601	32	1	0.00204918032786885	488	10287	3099	HK2
R-HSA-421270	Cell-cell junction organization	0.792618176481172	-0.232413665759543	61	2	0.00409836065573771	488	10287	5818,1000	NECTIN1,CDH2
R-HSA-202433	Generation of second messenger molecules	0.799387923936479	-0.223908939228225	33	1	0.00204918032786885	488	10287	3937	LCP2
R-HSA-163359	Glucagon signaling in metabolic regulation	0.799387923936479	-0.223908939228225	33	1	0.00204918032786885	488	10287	2642	GCGR
R-HSA-180910	Vpr-mediated nuclear import of PICs	0.799387923936479	-0.223908939228225	33	1	0.00204918032786885	488	10287	3159	HMGA1
R-HSA-190236	Signaling by FGFR	0.800919782917696	-0.221994483098908	89	3	0.00614754098360656	488	10287	2247,26281,23767	FGF2,FGF20,FLRT3
R-HSA-6805567	Keratinization	0.80253885519619	-0.219975007460109	214	8	0.0163934426229508	488	10287	2312,3855,3849,5266,9119,5317,3854,3868	FLG,KRT7,KRT2,PI3,KRT75,PKP1,KRT6B,KRT16
R-HSA-1226099	Signaling by FGFR in disease	0.807263974107584	-0.214104558737826	63	2	0.00409836065573771	488	10287	26281,2247	FGF20,FGF2
R-HSA-983168	Antigen processing: Ubiquitination & Proteasome degradation	0.808835070698796	-0.212160250817838	311	12	0.0245901639344262	488	10287	92369,5698,255488,55521,5721,221687,23327,127544,84676,55008,5699,10517	SPSB4,PSMB9,RNF144B,TRIM36,PSME2,RNF182,NEDD4L,RNF19B,TRIM63,HERC6,PSMB10,FBXW10
R-HSA-1489509	DAG and IP3 signaling	0.808935290122943	-0.212036352609906	34	1	0.00204918032786885	488	10287	3710	ITPR3
R-HSA-390522	Striated Muscle Contraction	0.808935290122943	-0.212036352609906	34	1	0.00204918032786885	488	10287	7273	TTN
R-HSA-389958	Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding	0.808935290122943	-0.212036352609906	34	1	0.00204918032786885	488	10287	10471	PFDN6
R-HSA-2173796	SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription	0.808935290122943	-0.212036352609906	34	1	0.00204918032786885	488	10287	1030	CDKN2B
R-HSA-5656169	Termination of translesion DNA synthesis	0.808935290122943	-0.212036352609906	34	1	0.00204918032786885	488	10287	9636	ISG15
R-HSA-2173789	TGF-beta receptor signaling activates SMADs	0.808935290122943	-0.212036352609906	34	1	0.00204918032786885	488	10287	23327	NEDD4L
R-HSA-450531	Regulation of mRNA stability by proteins that bind AU-rich elements	0.812967426045354	-0.207064236601883	91	3	0.00614754098360656	488	10287	5698,5721,5699	PSMB9,PSME2,PSMB10
R-HSA-201722	Formation of the beta-catenin:TCF transactivating complex	0.812967426045354	-0.207064236601883	91	3	0.00614754098360656	488	10287	723790,8313,51176	HIST2H2AA4,AXIN2,LEF1
R-HSA-194840	Rho GTPase cycle	0.8149908922465	-0.204578340961385	143	5	0.0102459016393443	488	10287	116984,9938,26230,83478,5880	ARAP2,ARHGAP25,TIAM2,ARHGAP24,RAC2
R-HSA-4791275	Signaling by WNT in cancer	0.818029172748691	-0.200857279508361	35	1	0.00204918032786885	488	10287	27121	DKK4
R-HSA-212718	EGFR interacts with phospholipase C-gamma	0.826691069330403	-0.190324209575612	36	1	0.00204918032786885	488	10287	3710	ITPR3
R-HSA-452723	Transcriptional regulation of pluripotent stem cells	0.826691069330403	-0.190324209575612	36	1	0.00204918032786885	488	10287	2247	FGF2
R-HSA-5663213	RHO GTPases Activate WASPs and WAVEs	0.826691069330403	-0.190324209575612	36	1	0.00204918032786885	488	10287	644150	WIPF3
R-HSA-176033	Interactions of Vpr with host cellular proteins	0.826691069330403	-0.190324209575612	36	1	0.00204918032786885	488	10287	3159	HMGA1
R-HSA-445355	Smooth Muscle Contraction	0.826691069330403	-0.190324209575612	36	1	0.00204918032786885	488	10287	4629	MYH11
R-HSA-438064	Post NMDA receptor activation events	0.834941460336737	-0.180393663970072	37	1	0.00204918032786885	488	10287	2903	GRIN2A
R-HSA-156590	Glutathione conjugation	0.842799857175206	-0.171025766516753	38	1	0.00204918032786885	488	10287	2730	GCLM
R-HSA-5689901	Metalloprotease DUBs	0.842799857175206	-0.171025766516753	38	1	0.00204918032786885	488	10287	723790	HIST2H2AA4
R-HSA-5663202	Diseases of signal transduction	0.844206070661884	-0.169358654636277	370	14	0.0286885245901639	488	10287	5721,64220,5698,4233,26281,2069,5699,1839,2247,27121,10046,8503,941,54567	PSME2,STRA6,PSMB9,MET,FGF20,EREG,PSMB10,HBEGF,FGF2,DKK4,MAMLD1,PIK3R3,CD80,DLL4
R-HSA-204005	COPII (Coat Protein 2) Mediated Vesicle Transport	0.845820898118924	-0.167447646139597	69	2	0.00409836065573771	488	10287	374,1294	AREG,COL7A1
R-HSA-112316	Neuronal System	0.851846775235489	-0.160348609599103	349	13	0.0266393442622951	488	10287	6506,3783,9378,9369,6616,131096,56666,2903,9456,9228,6580,80852,3779	SLC1A2,KCNN4,NRXN1,NRXN3,SNAP25,KCNH8,PANX2,GRIN2A,HOMER1,DLGAP2,SLC22A1,GRIP2,KCNMB1
R-HSA-390466	Chaperonin-mediated protein folding	0.855153225445318	-0.156474615054602	99	3	0.00614754098360656	488	10287	10517,9628,10471	FBXW10,RGS6,PFDN6
R-HSA-390471	Association of TriC/CCT with target proteins during biosynthesis	0.857414140821453	-0.153834232277037	40	1	0.00204918032786885	488	10287	10517	FBXW10
R-HSA-168276	NS1 Mediated Effects on Host Pathways	0.857414140821453	-0.153834232277037	40	1	0.00204918032786885	488	10287	9636	ISG15
R-HSA-1296071	Potassium Channels	0.859796153853619	-0.151059948233498	100	3	0.00614754098360656	488	10287	3779,131096,3783	KCNMB1,KCNH8,KCNN4
R-HSA-110313	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template	0.864204606239907	-0.145945725436131	41	1	0.00204918032786885	488	10287	9636	ISG15
R-HSA-442755	Activation of NMDA receptor upon glutamate binding and postsynaptic events	0.864204606239907	-0.145945725436131	41	1	0.00204918032786885	488	10287	2903	GRIN2A
R-HSA-5610787	Hedgehog 'off' state	0.864308276303994	-0.145825772538749	101	3	0.00614754098360656	488	10287	5721,5699,5698	PSME2,PSMB10,PSMB9
R-HSA-1483206	Glycerophospholipid biosynthesis	0.86707154899581	-0.142633780813257	129	4	0.00819672131147541	488	10287	80736,11343,51365,84879	SLC44A4,MGLL,PLA1A,MFSD2A
R-HSA-3214841	PKMTs methylate histone lysines	0.867490760451152	-0.142150417994613	73	2	0.00409836065573771	488	10287	4790,4791	NFKB1,NFKB2
R-HSA-2426168	Activation of gene expression by SREBF (SREBP)	0.870672315813614	-0.138489588974498	42	1	0.00204918032786885	488	10287	85441	HELZ2
R-HSA-168253	Host Interactions with Influenza Factors	0.870672315813614	-0.138489588974498	42	1	0.00204918032786885	488	10287	9636	ISG15
R-HSA-381676	Glucagon-like Peptide-1 (GLP1) regulates insulin secretion	0.870672315813614	-0.138489588974498	42	1	0.00204918032786885	488	10287	3710	ITPR3
R-HSA-1461957	Beta defensins	0.870672315813614	-0.138489588974498	42	1	0.00204918032786885	488	10287	7097	TLR2
R-HSA-446203	Asparagine N-linked glycosylation	0.872786463544478	-0.136064353813061	284	10	0.0204918032786885	488	10287	1294,6484,4121,374,286,6482,1604,6708,124872,9945	COL7A1,ST3GAL4,MAN1A1,AREG,ANK1,ST3GAL1,CD55,SPTA1,B4GALNT2,GFPT2
R-HSA-5362517	Signaling by Retinoic Acid	0.876832580320377	-0.131439205266627	43	1	0.00204918032786885	488	10287	195814	SDR16C5
R-HSA-432040	Vasopressin regulates renal water homeostasis via Aquaporins	0.876832580320377	-0.131439205266627	43	1	0.00204918032786885	488	10287	4645	MYO5B
R-HSA-6814122	Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding	0.876832580320377	-0.131439205266627	43	1	0.00204918032786885	488	10287	9628	RGS6
R-HSA-5654738	Signaling by FGFR2	0.877245133740722	-0.130968811709208	75	2	0.00409836065573771	488	10287	2247,26281	FGF2,FGF20
R-HSA-391251	Protein folding	0.881104099928341	-0.126579498927292	105	3	0.00614754098360656	488	10287	10517,9628,10471	FBXW10,RGS6,PFDN6
R-HSA-1169410	Antiviral mechanism by IFN-stimulated genes	0.881870248688004	-0.125710344128193	76	2	0.00409836065573771	488	10287	9636,23586	ISG15,DDX58
R-HSA-1169408	ISG15 antiviral mechanism	0.881870248688004	-0.125710344128193	76	2	0.00409836065573771	488	10287	23586,9636	DDX58,ISG15
R-HSA-204998	Cell death signalling via NRAGE, NRIF and NADE	0.881870248688004	-0.125710344128193	76	2	0.00409836065573771	488	10287	26230,4803	TIAM2,NGF
R-HSA-1500931	Cell-Cell communication	0.881988327896798	-0.125576456740011	133	4	0.00819672131147541	488	10287	5818,3918,3914,1000	NECTIN1,LAMC2,LAMB3,CDH2
R-HSA-1296072	Voltage gated Potassium channels	0.882699985715096	-0.124769903139142	44	1	0.00204918032786885	488	10287	131096	KCNH8
R-HSA-1660661	Sphingolipid de novo biosynthesis	0.882699985715096	-0.124769903139142	44	1	0.00204918032786885	488	10287	130367	SGPP2
R-HSA-170834	Signaling by TGF-beta Receptor Complex	0.886333960950612	-0.120661468302237	77	2	0.00409836065573771	488	10287	1030,23327	CDKN2B,NEDD4L
R-HSA-2151201	Transcriptional activation of mitochondrial biogenesis	0.888288427277991	-0.118458783234618	45	1	0.00204918032786885	488	10287	85441	HELZ2
R-HSA-6811438	Intra-Golgi traffic	0.888288427277991	-0.118458783234618	45	1	0.00204918032786885	488	10287	4121	MAN1A1
R-HSA-1643685	Disease	0.890131348722169	-0.116386244311329	859	34	0.069672131147541	488	10287	3055,64220,4791,4790,26281,1080,2069,7852,5699,7296,6648,4792,27121,8503,5721,4586,4233,3725,375790,1839,6385,6616,10071,5698,9507,9636,3159,56999,7097,2247,23327,10046,941,54567	HCK,STRA6,NFKB2,NFKB1,FGF20,CFTR,EREG,CXCR4,PSMB10,TXNRD1,SOD2,NFKBIA,DKK4,PIK3R3,PSME2,MUC5AC,MET,JUN,AGRN,HBEGF,SDC4,SNAP25,MUC12,PSMB9,ADAMTS4,ISG15,HMGA1,ADAMTS9,TLR2,FGF2,NEDD4L,MAMLD1,CD80,DLL4
R-HSA-3214858	RMTs methylate histone arginines	0.89479654241784	-0.111158913457401	79	2	0.00409836065573771	488	10287	595,723790	CCND1,HIST2H2AA4
R-HSA-109704	PI3K Cascade	0.89479654241784	-0.111158913457401	79	2	0.00409836065573771	488	10287	2247,26281	FGF2,FGF20
R-HSA-1483249	Inositol phosphate metabolism	0.898680741240389	-0.106827434123047	47	1	0.00204918032786885	488	10287	117283	IP6K3
R-HSA-112043	PLC beta mediated events	0.898680741240389	-0.106827434123047	47	1	0.00204918032786885	488	10287	3710	ITPR3
R-HSA-70326	Glucose metabolism	0.902670624808084	-0.102397548685209	81	2	0.00409836065573771	488	10287	3099,669	HK2,BPGM
R-HSA-2122947	NOTCH1 Intracellular Domain Regulates Transcription	0.903509237167354	-0.101468945241901	48	1	0.00204918032786885	488	10287	10046	MAMLD1
R-HSA-112040	G-protein mediated events	0.903509237167354	-0.101468945241901	48	1	0.00204918032786885	488	10287	3710	ITPR3
R-HSA-157579	Telomere Maintenance	0.90639833715869	-0.0982764038257497	82	2	0.00409836065573771	488	10287	723790,23649	HIST2H2AA4,POLA2
R-HSA-5576891	Cardiac conduction	0.910331492439939	-0.0939464683976211	142	4	0.00819672131147541	488	10287	3710,490,6547,23630	ITPR3,ATP2B1,SLC8A3,KCNE5
R-HSA-73893	DNA Damage Bypass	0.912488154256471	-0.0915801752464967	50	1	0.00204918032786885	488	10287	9636	ISG15
R-HSA-171306	Packaging Of Telomere Ends	0.916659862849145	-0.087018799363563	51	1	0.00204918032786885	488	10287	723790	HIST2H2AA4
R-HSA-1461973	Defensins	0.916659862849145	-0.087018799363563	51	1	0.00204918032786885	488	10287	7097	TLR2
R-HSA-111885	Opioid Signalling	0.916796234903883	-0.0868700398103272	85	2	0.00409836065573771	488	10287	5142,3710	PDE4B,ITPR3
R-HSA-3214842	HDMs demethylate histones	0.92063309329898	-0.082693700711984	52	1	0.00204918032786885	488	10287	23135	KDM6B
R-HSA-5620920	Cargo trafficking to the periciliary membrane	0.924417270198221	-0.0785917181534206	53	1	0.00204918032786885	488	10287	2847	MCHR1
R-HSA-397014	Muscle contraction	0.926631798808953	-0.0761989888580676	204	6	0.0122950819672131	488	10287	6547,7273,23630,3710,490,4629	SLC8A3,TTN,KCNE5,ITPR3,ATP2B1,MYH11
R-HSA-1592230	Mitochondrial biogenesis	0.928021371445426	-0.0747005168863002	54	1	0.00204918032786885	488	10287	85441	HELZ2
R-HSA-162906	HIV Infection	0.935888021807563	-0.0662594444823403	236	7	0.014344262295082	488	10287	3159,3055,5721,5699,7852,5698,23327	HMGA1,HCK,PSME2,PSMB10,CXCR4,PSMB9,NEDD4L
R-HSA-432722	Golgi Associated Vesicle Biogenesis	0.937836737616294	-0.0641793988389898	57	1	0.00204918032786885	488	10287	2495	FTH1
R-HSA-5625740	RHO GTPases activate PKNs	0.939466443210406	-0.0624431784776267	93	2	0.00409836065573771	488	10287	4629,723790	MYH11,HIST2H2AA4
R-HSA-6804756	Regulation of TP53 Activity through Phosphorylation	0.939466443210406	-0.0624431784776267	93	2	0.00409836065573771	488	10287	1263,8900	PLK3,CCNA1
R-HSA-936837	Ion transport by P-type ATPases	0.940802101458325	-0.0610224681473221	58	1	0.00204918032786885	488	10287	490	ATP2B1
R-HSA-5617472	Activation of anterior HOX genes in hindbrain development during early embryogenesis	0.942348263593637	-0.0593803661554241	126	3	0.00614754098360656	488	10287	723790,3725,4211	HIST2H2AA4,JUN,MEIS1
R-HSA-5619507	Activation of HOX genes during differentiation	0.942348263593637	-0.0593803661554241	126	3	0.00614754098360656	488	10287	4211,3725,723790	MEIS1,JUN,HIST2H2AA4
R-HSA-2029482	Regulation of actin dynamics for phagocytic cup formation	0.948877627290076	-0.0524754378016383	61	1	0.00204918032786885	488	10287	644150	WIPF3
R-HSA-8856825	Cargo recognition for clathrin-mediated endocytosis	0.952482761745278	-0.0486832700502702	99	2	0.00409836065573771	488	10287	1080,7474	CFTR,WNT5A
R-HSA-73728	RNA Polymerase I Promoter Opening	0.953640703451928	-0.0474682995929688	63	1	0.00204918032786885	488	10287	723790	HIST2H2AA4
R-HSA-977225	Amyloid fiber formation	0.95619384132477	-0.0447946235923338	101	2	0.00409836065573771	488	10287	6288,723790	SAA1,HIST2H2AA4
R-HSA-5334118	DNA methylation	0.957960827700937	-0.0429483915122738	65	1	0.00204918032786885	488	10287	723790	HIST2H2AA4
R-HSA-5663205	Infectious disease	0.960753575009818	-0.0400373284826253	388	12	0.0245901639344262	488	10287	5721,3055,4233,5698,9636,7852,5699,3159,7296,1839,23327,6616	PSME2,HCK,MET,PSMB9,ISG15,CXCR4,PSMB10,HMGA1,TXNRD1,HBEGF,NEDD4L,SNAP25
R-HSA-2467813	Separation of Sister Chromatids	0.961294334842026	-0.0394746371535444	168	4	0.00819672131147541	488	10287	9700,5721,5699,5698	ESPL1,PSME2,PSMB10,PSMB9
R-HSA-5625886	Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3	0.961879116519019	-0.0388664947162599	67	1	0.00204918032786885	488	10287	723790	HIST2H2AA4
R-HSA-5358351	Signaling by Hedgehog	0.962608930662968	-0.038108044509201	138	3	0.00614754098360656	488	10287	5698,5699,5721	PSMB9,PSMB10,PSME2
R-HSA-156580	Phase II conjugation	0.964297564839949	-0.0363553547827393	106	2	0.00409836065573771	488	10287	2730,27233	GCLM,SULT1C4
R-HSA-69620	Cell Cycle Checkpoints	0.965147320033575	-0.0354745260477712	201	5	0.0102459016393443	488	10287	5698,8900,5721,25946,5699	PSMB9,CCNA1,PSME2,ZNF385A,PSMB10
R-HSA-6796648	TP53 Regulates Transcription of DNA Repair Genes	0.965432876991774	-0.0351787010302745	69	1	0.00204918032786885	488	10287	3725	JUN
R-HSA-427359	SIRT1 negatively regulates rRNA Expression	0.965432876991774	-0.0351787010302745	69	1	0.00204918032786885	488	10287	723790	HIST2H2AA4
R-HSA-73886	Chromosome Maintenance	0.968447160975322	-0.0320613552121291	109	2	0.00409836065573771	488	10287	23649,723790	POLA2,HIST2H2AA4
R-HSA-774815	Nucleosome assembly	0.970153207620665	-0.030301273956179	72	1	0.00204918032786885	488	10287	723790	HIST2H2AA4
R-HSA-606279	Deposition of new CENPA-containing nucleosomes at the centromere	0.970153207620665	-0.030301273956179	72	1	0.00204918032786885	488	10287	723790	HIST2H2AA4
R-HSA-6807505	RNA polymerase II transcribes snRNA genes	0.971579074942923	-0.0288326187853764	73	1	0.00204918032786885	488	10287	5452	POU2F2
R-HSA-199992	trans-Golgi Network Vesicle Budding	0.971579074942923	-0.0288326187853764	73	1	0.00204918032786885	488	10287	2495	FTH1
R-HSA-421837	Clathrin derived vesicle budding	0.971579074942923	-0.0288326187853764	73	1	0.00204918032786885	488	10287	2495	FTH1
R-HSA-195258	RHO GTPase Effectors	0.972029304246964	-0.0283693265739253	294	8	0.0163934426229508	488	10287	1080,723790,644150,23002,5880,91010,4629,4688	CFTR,HIST2H2AA4,WIPF3,DAAM1,RAC2,FMNL3,MYH11,NCF2
R-HSA-2299718	Condensation of Prophase Chromosomes	0.97293695740623	-0.0274359908723759	74	1	0.00204918032786885	488	10287	723790	HIST2H2AA4
R-HSA-212300	PRC2 methylates histones and DNA	0.97293695740623	-0.0274359908723759	74	1	0.00204918032786885	488	10287	723790	HIST2H2AA4
R-HSA-174824	Lipoprotein metabolism	0.97293695740623	-0.0274359908723759	74	1	0.00204918032786885	488	10287	4023	LPL
R-HSA-68882	Mitotic Anaphase	0.973355500742697	-0.0270058979116126	179	4	0.00819672131147541	488	10287	5699,5721,9700,5698	PSMB10,PSME2,ESPL1,PSMB9
R-HSA-2555396	Mitotic Metaphase and Anaphase	0.974256892348016	-0.0260802602715189	180	4	0.00819672131147541	488	10287	5698,9700,5699,5721	PSMB9,ESPL1,PSMB10,PSME2
R-HSA-427389	ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression	0.975461554723175	-0.0248445305380646	76	1	0.00204918032786885	488	10287	723790	HIST2H2AA4
R-HSA-69275	G2/M Transition	0.975974643064338	-0.0243186733734098	182	4	0.00819672131147541	488	10287	5698,5699,5721,8900	PSMB9,PSMB10,PSME2,CCNA1
R-HSA-5663220	RHO GTPases Activate Formins	0.977367412594081	-0.022892635612399	117	2	0.00409836065573771	488	10287	91010,23002	FMNL3,DAAM1
R-HSA-453274	Mitotic G2-G2/M phases	0.977584419462282	-0.0226706282303918	184	4	0.00819672131147541	488	10287	5698,8900,5699,5721	PSMB9,CCNA1,PSMB10,PSME2
R-HSA-162587	HIV Life Cycle	0.977768076523482	-0.0224827776386274	152	3	0.00614754098360656	488	10287	7852,3159,23327	CXCR4,HMGA1,NEDD4L
R-HSA-1221632	Meiotic synapsis	0.978814600093578	-0.0214130312053148	79	1	0.00204918032786885	488	10287	723790	HIST2H2AA4
R-HSA-112315	Transmission across Chemical Synapses	0.979156944657827	-0.0210633381072155	217	5	0.0102459016393443	488	10287	6616,6580,80852,6506,2903	SNAP25,SLC22A1,GRIP2,SLC1A2,GRIN2A
R-HSA-392499	Metabolism of proteins	0.983225320747572	-0.0169169676571526	1619	61	0.125	488	10287	3576,50614,330,5698,9507,154064,10071,150,3624,8876,5277,64135,7295,56999,10517,79931,10318,60676,5721,4586,8975,467,6484,6347,8313,116372,6708,1604,10164,51301,79623,8900,6288,4792,23586,374,90865,4121,84101,1294,124872,9628,7128,286,8767,4312,3484,10471,5069,8875,64127,9945,219333,27076,6482,5699,1080,135,5329,723790,1540	CXCL8,GALNT9,BIRC3,PSMB9,ADAMTS4,RAET1L,MUC12,ADRA2A,INHBA,VNN1,PIGA,IFIH1,TXN,ADAMTS9,FBXW10,TNIP3,TNIP1,PAPPA2,PSME2,MUC5AC,USP13,ATF3,ST3GAL4,CCL2,AXIN2,LYPD1,SPTA1,CD55,CHST4,GCNT4,GALNT14,CCNA1,SAA1,NFKBIA,DDX58,AREG,IL33,MAN1A1,USP44,COL7A1,B4GALNT2,RGS6,TNFAIP3,ANK1,RIPK2,MMP1,IGFBP1,PFDN6,PAPPA,VNN2,NOD2,GFPT2,USP12,LYPD3,ST3GAL1,PSMB10,CFTR,ADORA2A,PLAUR,HIST2H2AA4,CYLD
R-HSA-194315	Signaling by Rho GTPases	0.984853828847605	-0.0152620459310195	427	12	0.0245901639344262	488	10287	644150,83478,1080,723790,116984,91010,5880,4688,4629,26230,9938,23002	WIPF3,ARHGAP24,CFTR,HIST2H2AA4,ARAP2,FMNL3,RAC2,NCF2,MYH11,TIAM2,ARHGAP25,DAAM1
R-HSA-912446	Meiotic recombination	0.986370178769275	-0.0137235599802563	88	1	0.00204918032786885	488	10287	723790	HIST2H2AA4
R-HSA-8876198	RAB GEFs exchange GTP for GDP on RABs	0.987022336120868	-0.0130626094897548	89	1	0.00204918032786885	488	10287	23258	DENND5A
R-HSA-428157	Sphingolipid metabolism	0.987643350049717	-0.0124336281349137	90	1	0.00204918032786885	488	10287	130367	SGPP2
R-HSA-73777	RNA Polymerase I Chain Elongation	0.98823470488392	-0.0118350538955951	91	1	0.00204918032786885	488	10287	723790	HIST2H2AA4
R-HSA-2980736	Peptide hormone metabolism	0.98823470488392	-0.0118350538955951	91	1	0.00204918032786885	488	10287	3624	INHBA
R-HSA-69481	G2/M Checkpoints	0.988389569223921	-0.0116783581164863	169	3	0.00614754098360656	488	10287	5698,5699,5721	PSMB9,PSMB10,PSME2
R-HSA-5250924	B-WICH complex positively regulates rRNA expression	0.989334024896353	-0.0107232643439948	93	1	0.00204918032786885	488	10287	723790	HIST2H2AA4
R-HSA-3214815	HDACs deacetylate histones	0.989844618957323	-0.0102072987196857	94	1	0.00204918032786885	488	10287	723790	HIST2H2AA4
R-HSA-211000	Gene Silencing by RNA	0.99028965740574	-0.0097577954095083	137	2	0.00409836065573771	488	10287	723790,54514	HIST2H2AA4,DDX4
R-HSA-8856828	Clathrin-mediated endocytosis	0.99028965740574	-0.0097577954095083	137	2	0.00409836065573771	488	10287	1080,7474	CFTR,WNT5A
R-HSA-5693607	Processing of DNA double-strand break ends	0.991654402641443	-0.00838061683124876	98	1	0.00204918032786885	488	10287	8900	CCNA1
R-HSA-112314	Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell	0.993405827809569	-0.00661600979743675	146	2	0.00409836065573771	488	10287	2903,80852	GRIN2A,GRIP2
R-HSA-2132295	MHC class II antigen presentation	0.993470789189568	-0.00655061934544189	103	1	0.00204918032786885	488	10287	1520	CTSS
R-HSA-5578749	Transcriptional regulation by small RNAs	0.994365220852732	-0.0056507144045842	106	1	0.00204918032786885	488	10287	723790	HIST2H2AA4
R-HSA-427413	NoRC negatively regulates rRNA expression	0.994635309465639	-0.00537913215968261	107	1	0.00204918032786885	488	10287	723790	HIST2H2AA4
R-HSA-5250913	Positive epigenetic regulation of rRNA expression	0.994892477359187	-0.00512061061835713	108	1	0.00204918032786885	488	10287	723790	HIST2H2AA4
R-HSA-73854	RNA Polymerase I Promoter Clearance	0.995370489098622	-0.00464026027603369	110	1	0.00204918032786885	488	10287	723790	HIST2H2AA4
R-HSA-5250941	Negative epigenetic regulation of rRNA expression	0.995370489098622	-0.00464026027603369	110	1	0.00204918032786885	488	10287	723790	HIST2H2AA4
R-HSA-73864	RNA Polymerase I Transcription	0.995803846915483	-0.00420498164084265	112	1	0.00204918032786885	488	10287	723790	HIST2H2AA4
R-HSA-2408522	Selenoamino acid metabolism	0.997304323279983	-0.00269931659927029	121	1	0.00204918032786885	488	10287	7296	TXNRD1
R-HSA-1500620	Meiosis	0.997304323279983	-0.00269931659927029	121	1	0.00204918032786885	488	10287	723790	HIST2H2AA4
R-HSA-4839726	Chromatin organization	0.997568528154989	-0.00243443267309797	279	5	0.0102459016393443	488	10287	4791,23135,723790,4790,595	NFKB2,KDM6B,HIST2H2AA4,NFKB1,CCND1
R-HSA-3247509	Chromatin modifying enzymes	0.997568528154989	-0.00243443267309797	279	5	0.0102459016393443	488	10287	4790,595,723790,4791,23135	NFKB1,CCND1,HIST2H2AA4,NFKB2,KDM6B
R-HSA-212436	Generic Transcription Pathway	0.998341329506336	-0.00166004761056655	865	25	0.0512295081967213	488	10287	3725,163732,7296,27113,8900,7832,637,25946,10308,4929,6446,85441,4435,1030,10769,7295,54541,23327,10046,639,1263,90874,8626,8013,5366	JUN,CITED4,TXNRD1,BBC3,CCNA1,BTG2,BID,ZNF385A,ZNF267,NR4A2,SGK1,HELZ2,CITED1,CDKN2B,PLK2,TXN,DDIT4,NEDD4L,MAMLD1,PRDM1,PLK3,ZNF697,TP63,NR4A3,PMAIP1
R-HSA-5693567	HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA)	0.998431300073737	-0.00156993162427036	132	1	0.00204918032786885	488	10287	8900	CCNA1
R-HSA-5693538	Homology Directed Repair	0.998832711443793	-0.00116797036812645	138	1	0.00204918032786885	488	10287	8900	CCNA1
R-HSA-162599	Late Phase of HIV Life Cycle	0.99888883882946	-0.00111177896780435	139	1	0.00204918032786885	488	10287	23327	NEDD4L
R-HSA-68875	Mitotic Prophase	0.99899314198569	-0.0010073652363358	141	1	0.00204918032786885	488	10287	723790	HIST2H2AA4
R-HSA-3214847	HATs acetylate histones	0.999087672535501	-0.000912743888496599	143	1	0.00204918032786885	488	10287	723790	HIST2H2AA4
R-HSA-68886	M Phase	0.999168598517621	-0.000831747288273642	308	5	0.0102459016393443	488	10287	5698,723790,9700,5721,5699	PSMB9,HIST2H2AA4,ESPL1,PSME2,PSMB10
R-HSA-504046	RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription	0.9993213491854	-0.000678881202305186	149	1	0.00204918032786885	488	10287	723790	HIST2H2AA4
R-HSA-212165	Epigenetic regulation of gene expression	0.999385114489521	-0.000615074630102842	151	1	0.00204918032786885	488	10287	723790	HIST2H2AA4
R-HSA-168254	Influenza Infection	0.99954271611869	-0.000457388467468469	157	1	0.00204918032786885	488	10287	9636	ISG15
R-HSA-5693532	DNA Double-Strand Break Repair	0.99972096095079	-0.000279077987848996	167	1	0.00204918032786885	488	10287	8900	CCNA1
R-HSA-69278	Cell Cycle, Mitotic	0.999802559426349	-0.000197460067606608	514	10	0.0204918032786885	488	10287	5699,595,8900,723790,9700,5721,23649,64785,5698,1030	PSMB10,CCND1,CCNA1,HIST2H2AA4,ESPL1,PSME2,POLA2,GINS3,PSMB9,CDKN2B
R-HSA-6811442	Intra-Golgi and retrograde Golgi-to-ER traffic	0.999845846694156	-0.000154165188686263	179	1	0.00204918032786885	488	10287	4121	MAN1A1
R-HSA-5617833	Cilium Assembly	0.999919013898591	-8.098938096042e-05	192	1	0.00204918032786885	488	10287	2847	MCHR1
R-HSA-5653656	Vesicle-mediated transport	0.999950718334777	-4.92828796042416e-05	650	13	0.0266393442622951	488	10287	8578,1294,4121,374,2706,6288,23258,1080,286,7474,2495,1604,6708	SCARF1,COL7A1,MAN1A1,AREG,GJB2,SAA1,DENND5A,CFTR,ANK1,WNT5A,FTH1,CD55,SPTA1
R-HSA-199991	Membrane Trafficking	0.999977811722421	-2.21885237422136e-05	610	11	0.0225409836065574	488	10287	1294,4121,374,2706,286,1080,7474,2495,23258,6708,1604	COL7A1,MAN1A1,AREG,GJB2,ANK1,CFTR,WNT5A,FTH1,DENND5A,SPTA1,CD55
R-HSA-1640170	Cell Cycle	0.999984908255507	-1.50918583746748e-05	621	11	0.0225409836065574	488	10287	5698,1030,64785,23649,25946,5721,8900,9700,723790,5699,595	PSMB9,CDKN2B,GINS3,POLA2,ZNF385A,PSME2,CCNA1,ESPL1,HIST2H2AA4,PSMB10,CCND1
R-HSA-72203	Processing of Capped Intron-Containing Pre-mRNA	0.999994732159407	-5.26785446778991e-06	247	1	0.00204918032786885	488	10287	9589	WTAP
R-HSA-73894	DNA Repair	0.999997113721809	-2.88628235608837e-06	316	2	0.00409836065573771	488	10287	8900,9636	CCNA1,ISG15
R-HSA-1852241	Organelle biogenesis and maintenance	0.9999990715988	-9.28401630597444e-07	340	2	0.00409836065573771	488	10287	2847,85441	MCHR1,HELZ2
R-HSA-381753	Olfactory Signaling Pathway	0.999999918633992	-8.13660113387021e-08	391	2	0.00409836065573771	488	10287	64108,283365	RTP4,OR6C6
R-HSA-74160	Gene Expression	0.999999999923135	-7.68644821828091e-11	1821	32	0.0655737704918033	488	10287	637,723790,7296,5699,10769,4435,54514,4929,1263,9589,5366,5452,8626,90874,7832,27113,8900,3725,163732,1030,85441,10308,6446,5721,25946,10046,639,54541,23327,7295,5698,8013	BID,HIST2H2AA4,TXNRD1,PSMB10,PLK2,CITED1,DDX4,NR4A2,PLK3,WTAP,PMAIP1,POU2F2,TP63,ZNF697,BTG2,BBC3,CCNA1,JUN,CITED4,CDKN2B,HELZ2,ZNF267,SGK1,PSME2,ZNF385A,MAMLD1,PRDM1,DDIT4,NEDD4L,TXN,PSMB9,NR4A3
R-HSA-5688849	Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5)	0.999999999988021	-1.19791725864989e-11	8	0	0	488	10287
R-HSA-3656534	Loss of Function of TGFBR1 in Cancer	0.999999999988021	-1.19791725864989e-11	8	0	0	488	10287
R-HSA-70921	Histidine catabolism	0.999999999988021	-1.19791725864989e-11	8	0	0	488	10287
R-HSA-6787450	tRNA modification in the mitochondrion	0.999999999988021	-1.19791725864989e-11	8	0	0	488	10287
R-HSA-72731	Recycling of eIF2:GDP	0.999999999988021	-1.19791725864989e-11	8	0	0	488	10287
R-HSA-389397	Orexin and neuropeptides FF and QRFP bind to their respective receptors	0.999999999988021	-1.19791725864989e-11	8	0	0	488	10287
R-HSA-73928	Depyrimidination	0.999999999988021	-1.19791725864989e-11	8	0	0	488	10287
R-HSA-5688890	Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4)	0.999999999988021	-1.19791725864989e-11	8	0	0	488	10287
R-HSA-8937144	Aryl hydrocarbon receptor signalling	0.999999999988021	-1.19791725864989e-11	8	0	0	488	10287
R-HSA-5362798	Release of Hh-Np from the secreting cell	0.999999999988021	-1.19791725864989e-11	8	0	0	488	10287
R-HSA-450520	HuR (ELAVL1) binds and stabilizes mRNA	0.999999999988021	-1.19791725864989e-11	8	0	0	488	10287
R-HSA-1253288	Downregulation of ERBB4 signaling	0.999999999988021	-1.19791725864989e-11	8	0	0	488	10287
R-HSA-110329	Cleavage of the damaged pyrimidine	0.999999999988021	-1.19791725864989e-11	8	0	0	488	10287
R-HSA-210747	Regulation of gene expression in early pancreatic precursor cells	0.999999999988021	-1.19791725864989e-11	8	0	0	488	10287
R-HSA-196783	Coenzyme A biosynthesis	0.999999999988021	-1.19791725864989e-11	8	0	0	488	10287
R-HSA-194313	VEGF ligand-receptor interactions	0.999999999988021	-1.19791725864989e-11	8	0	0	488	10287
R-HSA-177128	Conjugation of salicylate with glycine	0.999999999988021	-1.19791725864989e-11	8	0	0	488	10287
R-HSA-804914	Transport of fatty acids	0.999999999988021	-1.19791725864989e-11	8	0	0	488	10287
R-HSA-5632681	Ligand-receptor interactions	0.999999999988021	-1.19791725864989e-11	8	0	0	488	10287
R-HSA-1483115	Hydrolysis of LPC	0.999999999988021	-1.19791725864989e-11	8	0	0	488	10287
R-HSA-5358493	Synthesis of diphthamide-EEF2	0.999999999988021	-1.19791725864989e-11	8	0	0	488	10287
R-HSA-2142789	Ubiquinol biosynthesis	0.999999999988021	-1.19791725864989e-11	8	0	0	488	10287
R-HSA-446388	Regulation of cytoskeletal remodeling and cell spreading by IPP complex components	0.999999999988021	-1.19791725864989e-11	8	0	0	488	10287
R-HSA-3656532	TGFBR1 KD Mutants in Cancer	0.999999999988021	-1.19791725864989e-11	8	0	0	488	10287
R-HSA-2408508	Metabolism of ingested SeMet, Sec, MeSec into H2Se	0.999999999988021	-1.19791725864989e-11	8	0	0	488	10287
R-HSA-195399	VEGF binds to VEGFR leading to receptor dimerization	0.999999999988021	-1.19791725864989e-11	8	0	0	488	10287
R-HSA-400451	Free fatty acids regulate insulin secretion	0.999999999988021	-1.19791725864989e-11	8	0	0	488	10287
R-HSA-193634	Axonal growth inhibition (RHOA activation)	0.999999999988021	-1.19791725864989e-11	8	0	0	488	10287
R-HSA-163680	AMPK inhibits chREBP transcriptional activation activity	0.999999999988021	-1.19791725864989e-11	8	0	0	488	10287
R-HSA-2142670	Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)	0.999999999988021	-1.19791725864989e-11	8	0	0	488	10287
R-HSA-434316	Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion	0.999999999988021	-1.19791725864989e-11	8	0	0	488	10287
R-HSA-73942	DNA Damage Reversal	0.999999999988021	-1.19791725864989e-11	8	0	0	488	10287
R-HSA-77111	Synthesis of Ketone Bodies	0.999999999988021	-1.19791725864989e-11	8	0	0	488	10287
R-HSA-977347	Serine biosynthesis	0.999999999988021	-1.19791725864989e-11	8	0	0	488	10287
R-HSA-1483148	Synthesis of PG	0.999999999988021	-1.19791725864989e-11	8	0	0	488	10287
R-HSA-444821	Relaxin receptors	0.999999999988021	-1.19791725864989e-11	8	0	0	488	10287
R-HSA-110328	Recognition and association of DNA glycosylase with site containing an affected pyrimidine	0.999999999988021	-1.19791725864989e-11	8	0	0	488	10287
R-HSA-399954	Sema3A PAK dependent Axon repulsion	0.999999999991759	-8.24116933972458e-12	16	0	0	488	10287
R-HSA-163615	PKA activation	0.999999999991759	-8.24116933972458e-12	16	0	0	488	10287
R-HSA-8866910	TFAP2 (AP-2) family regulates transcription of growth factors and their receptors	0.999999999991759	-8.24116933972458e-12	16	0	0	488	10287
R-HSA-1834941	STING mediated induction of host immune responses	0.999999999991759	-8.24116933972458e-12	16	0	0	488	10287
R-HSA-1170546	Prolactin receptor signaling	0.999999999991759	-8.24116933972458e-12	16	0	0	488	10287
R-HSA-372708	p130Cas linkage to MAPK signaling for integrins	0.999999999991759	-8.24116933972458e-12	16	0	0	488	10287
R-HSA-446353	Cell-extracellular matrix interactions	0.999999999991759	-8.24116933972458e-12	16	0	0	488	10287
R-HSA-110312	Translesion synthesis by REV1	0.999999999991759	-8.24116933972458e-12	16	0	0	488	10287
R-HSA-1295596	Spry regulation of FGF signaling	0.999999999991759	-8.24116933972458e-12	16	0	0	488	10287
R-HSA-163210	Formation of ATP by chemiosmotic coupling	0.999999999991759	-8.24116933972458e-12	16	0	0	488	10287
R-HSA-399956	CRMPs in Sema3A signaling	0.999999999991759	-8.24116933972458e-12	16	0	0	488	10287
R-HSA-354194	GRB2:SOS provides linkage to MAPK signaling for Integrins	0.999999999991759	-8.24116933972458e-12	16	0	0	488	10287
R-HSA-5637810	Constitutive Signaling by EGFRvIII	0.999999999991759	-8.24116933972458e-12	16	0	0	488	10287
R-HSA-5637812	Signaling by EGFRvIII in Cancer	0.999999999991759	-8.24116933972458e-12	16	0	0	488	10287
R-HSA-264870	Caspase-mediated cleavage of cytoskeletal proteins	0.999999999992003	-7.99685690210275e-12	13	0	0	488	10287
R-HSA-375281	Hormone ligand-binding receptors	0.999999999992003	-7.99685690210275e-12	13	0	0	488	10287
R-HSA-400511	Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)	0.999999999992003	-7.99685690210275e-12	13	0	0	488	10287
R-HSA-2995410	Nuclear Envelope Reassembly	0.999999999992003	-7.99685690210275e-12	13	0	0	488	10287
R-HSA-391160	Signal regulatory protein (SIRP) family interactions	0.999999999992003	-7.99685690210275e-12	13	0	0	488	10287
R-HSA-1663150	The activation of arylsulfatases	0.999999999992003	-7.99685690210275e-12	13	0	0	488	10287
R-HSA-381033	ATF6 (ATF6-alpha) activates chaperones	0.999999999992003	-7.99685690210275e-12	13	0	0	488	10287
R-HSA-1358803	Downregulation of ERBB2:ERBB3 signaling	0.999999999992003	-7.99685690210275e-12	13	0	0	488	10287
R-HSA-5210891	Uptake and function of anthrax toxins	0.999999999992003	-7.99685690210275e-12	13	0	0	488	10287
R-HSA-198323	AKT phosphorylates targets in the cytosol	0.999999999992003	-7.99685690210275e-12	13	0	0	488	10287
R-HSA-171007	p38MAPK events	0.999999999992003	-7.99685690210275e-12	13	0	0	488	10287
R-HSA-2564830	Cytosolic iron-sulfur cluster assembly	0.999999999992003	-7.99685690210275e-12	13	0	0	488	10287
R-HSA-2995383	Initiation of Nuclear Envelope Reformation	0.999999999992003	-7.99685690210275e-12	13	0	0	488	10287
R-HSA-2408517	SeMet incorporation into proteins	0.999999999992003	-7.99685690210275e-12	13	0	0	488	10287
R-HSA-5626467	RHO GTPases activate IQGAPs	0.999999999992003	-7.99685690210275e-12	13	0	0	488	10287
R-HSA-175474	Assembly Of The HIV Virion	0.999999999992003	-7.99685690210275e-12	13	0	0	488	10287
R-HSA-112308	Depolarization of the Presynaptic Terminal Triggers the Opening of Calcium Channels	0.999999999992003	-7.99685690210275e-12	13	0	0	488	10287
R-HSA-2168880	Scavenging of heme from plasma	0.999999999992003	-7.99685690210275e-12	13	0	0	488	10287
R-HSA-3270619	IRF3-mediated induction of type I IFN	0.999999999992003	-7.99685690210275e-12	13	0	0	488	10287
R-HSA-977441	GABA A receptor activation	0.999999999992003	-7.99685690210275e-12	13	0	0	488	10287
R-HSA-202040	G-protein activation	0.999999999993794	-6.20637448350584e-12	29	0	0	488	10287
R-HSA-390918	Peroxisomal lipid metabolism	0.999999999993794	-6.20637448350584e-12	29	0	0	488	10287
R-HSA-72086	mRNA Capping	0.999999999993794	-6.20637448350584e-12	29	0	0	488	10287
R-HSA-1482839	Acyl chain remodelling of PE	0.999999999993794	-6.20637448350584e-12	29	0	0	488	10287
R-HSA-176407	Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase	0.999999999995655	-4.34516100583228e-12	19	0	0	488	10287
R-HSA-202430	Translocation of ZAP-70 to Immunological synapse	0.999999999995655	-4.34516100583228e-12	19	0	0	488	10287
R-HSA-422085	Synthesis, secretion, and deacylation of Ghrelin	0.999999999995655	-4.34516100583228e-12	19	0	0	488	10287
R-HSA-392851	Prostacyclin signalling through prostacyclin receptor	0.999999999995655	-4.34516100583228e-12	19	0	0	488	10287
R-HSA-8876725	Protein methylation	0.999999999995655	-4.34516100583228e-12	19	0	0	488	10287
R-HSA-450604	KSRP (KHSRP) binds and destabilizes mRNA	0.999999999995655	-4.34516100583228e-12	19	0	0	488	10287
R-HSA-5223345	Miscellaneous transport and binding events	0.999999999995655	-4.34516100583228e-12	19	0	0	488	10287
R-HSA-110320	Translesion Synthesis by POLH	0.999999999995655	-4.34516100583228e-12	19	0	0	488	10287
R-HSA-71403	Citric acid cycle (TCA cycle)	0.999999999995655	-4.34516100583228e-12	19	0	0	488	10287
R-HSA-5576886	Phase 4 - resting membrane potential	0.999999999995655	-4.34516100583228e-12	19	0	0	488	10287
R-HSA-1660514	Synthesis of PIPs at the Golgi membrane	0.999999999995655	-4.34516100583228e-12	19	0	0	488	10287
R-HSA-176412	Phosphorylation of the APC/C	0.999999999995655	-4.34516100583228e-12	19	0	0	488	10287
R-HSA-5358749	S37 mutants of beta-catenin aren't phosphorylated	0.999999999997455	-2.54482962189321e-12	15	0	0	488	10287
R-HSA-997269	Inhibition of adenylate cyclase pathway	0.999999999997455	-2.54482962189321e-12	15	0	0	488	10287
R-HSA-156581	Methylation	0.999999999997455	-2.54482962189321e-12	15	0	0	488	10287
R-HSA-5358751	S45 mutants of beta-catenin aren't phosphorylated	0.999999999997455	-2.54482962189321e-12	15	0	0	488	10287
R-HSA-3371568	Attenuation phase	0.999999999997455	-2.54482962189321e-12	15	0	0	488	10287
R-HSA-69298	Association of licensing factors with the pre-replicative complex	0.999999999997455	-2.54482962189321e-12	15	0	0	488	10287
R-HSA-2046104	alpha-linolenic (omega3) and linoleic (omega6) acid metabolism	0.999999999997455	-2.54482962189321e-12	15	0	0	488	10287
R-HSA-391903	Eicosanoid ligand-binding receptors	0.999999999997455	-2.54482962189321e-12	15	0	0	488	10287
R-HSA-3134975	Regulation of innate immune responses to cytosolic DNA	0.999999999997455	-2.54482962189321e-12	15	0	0	488	10287
R-HSA-4839743	phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex	0.999999999997455	-2.54482962189321e-12	15	0	0	488	10287
R-HSA-5358508	Mismatch Repair	0.999999999997455	-2.54482962189321e-12	15	0	0	488	10287
R-HSA-5339716	Misspliced GSK3beta mutants stabilize beta-catenin	0.999999999997455	-2.54482962189321e-12	15	0	0	488	10287
R-HSA-4419969	Depolymerisation of the Nuclear Lamina	0.999999999997455	-2.54482962189321e-12	15	0	0	488	10287
R-HSA-170670	Adenylate cyclase inhibitory pathway	0.999999999997455	-2.54482962189321e-12	15	0	0	488	10287
R-HSA-211935	Fatty acids	0.999999999997455	-2.54482962189321e-12	15	0	0	488	10287
R-HSA-68884	Mitotic Telophase/Cytokinesis	0.999999999997455	-2.54482962189321e-12	15	0	0	488	10287
R-HSA-2046106	alpha-linolenic acid (ALA) metabolism	0.999999999997455	-2.54482962189321e-12	15	0	0	488	10287
R-HSA-5358747	S33 mutants of beta-catenin aren't phosphorylated	0.999999999997455	-2.54482962189321e-12	15	0	0	488	10287
R-HSA-3322077	Glycogen synthesis	0.999999999997455	-2.54482962189321e-12	15	0	0	488	10287
R-HSA-430039	mRNA decay by 5' to 3' exoribonuclease	0.999999999997455	-2.54482962189321e-12	15	0	0	488	10287
R-HSA-5358752	T41 mutants of beta-catenin aren't phosphorylated	0.999999999997455	-2.54482962189321e-12	15	0	0	488	10287
R-HSA-418885	DCC mediated attractive signaling	0.999999999997632	-2.36836453966811e-12	14	0	0	488	10287
R-HSA-181431	Acetylcholine Binding And Downstream Events	0.999999999997632	-2.36836453966811e-12	14	0	0	488	10287
R-HSA-2024101	CS/DS degradation	0.999999999997632	-2.36836453966811e-12	14	0	0	488	10287
R-HSA-419408	Lysosphingolipid and LPA receptors	0.999999999997632	-2.36836453966811e-12	14	0	0	488	10287
R-HSA-1660516	Synthesis of PIPs at the early endosome membrane	0.999999999997632	-2.36836453966811e-12	14	0	0	488	10287
R-HSA-5467337	APC truncation mutants have impaired AXIN binding	0.999999999997632	-2.36836453966811e-12	14	0	0	488	10287
R-HSA-4839735	AXIN mutants destabilize the destruction complex, activating WNT signaling	0.999999999997632	-2.36836453966811e-12	14	0	0	488	10287
R-HSA-4839744	truncated APC mutants destabilize the destruction complex	0.999999999997632	-2.36836453966811e-12	14	0	0	488	10287
R-HSA-204174	Regulation of pyruvate dehydrogenase (PDH) complex	0.999999999997632	-2.36836453966811e-12	14	0	0	488	10287
R-HSA-4839748	AMER1 mutants destabilize the destruction complex	0.999999999997632	-2.36836453966811e-12	14	0	0	488	10287
R-HSA-1483213	Synthesis of PE	0.999999999997632	-2.36836453966811e-12	14	0	0	488	10287
R-HSA-5467348	Truncations of AMER1 destabilize the destruction complex	0.999999999997632	-2.36836453966811e-12	14	0	0	488	10287
R-HSA-5358606	Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)	0.999999999997632	-2.36836453966811e-12	14	0	0	488	10287
R-HSA-5358565	Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)	0.999999999997632	-2.36836453966811e-12	14	0	0	488	10287
R-HSA-5467340	AXIN missense mutants destabilize the destruction complex	0.999999999997632	-2.36836453966811e-12	14	0	0	488	10287
R-HSA-629602	Activation of Nicotinic Acetylcholine Receptors	0.999999999997632	-2.36836453966811e-12	14	0	0	488	10287
R-HSA-162658	Golgi Cisternae Pericentriolar Stack Reorganization	0.999999999997632	-2.36836453966811e-12	14	0	0	488	10287
R-HSA-622327	Postsynaptic nicotinic acetylcholine receptors	0.999999999997632	-2.36836453966811e-12	14	0	0	488	10287
R-HSA-6811434	COPI-dependent Golgi-to-ER retrograde traffic	0.999999999998429	-1.57136865024143e-12	82	0	0	488	10287
R-HSA-380287	Centrosome maturation	0.999999999998429	-1.57136865024143e-12	82	0	0	488	10287
R-HSA-380270	Recruitment of mitotic centrosome proteins and complexes	0.999999999998429	-1.57136865024143e-12	82	0	0	488	10287
R-HSA-77595	Processing of Intronless Pre-mRNAs	0.999999999998445	-1.55489570809006e-12	22	0	0	488	10287
R-HSA-901032	ER Quality Control Compartment (ERQC)	0.999999999998445	-1.55489570809006e-12	22	0	0	488	10287
R-HSA-202427	Phosphorylation of CD3 and TCR zeta chains	0.999999999998445	-1.55489570809006e-12	22	0	0	488	10287
R-HSA-166208	mTORC1-mediated signalling	0.999999999998445	-1.55489570809006e-12	22	0	0	488	10287
R-HSA-373753	Nephrin interactions	0.999999999998445	-1.55489570809006e-12	22	0	0	488	10287
R-HSA-5620916	VxPx cargo-targeting to cilium	0.999999999998445	-1.55489570809006e-12	22	0	0	488	10287
R-HSA-77289	Mitochondrial Fatty Acid Beta-Oxidation	0.999999999998445	-1.55489570809006e-12	22	0	0	488	10287
R-HSA-164938	Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters	0.999999999998445	-1.55489570809006e-12	22	0	0	488	10287
R-HSA-169131	Inhibition of PKR	0.999999999998641	-1.35854522076428e-12	1	0	0	488	10287
R-HSA-1839128	FGFR4 mutant receptor activation	0.999999999998641	-1.35854522076428e-12	1	0	0	488	10287
R-HSA-1222352	Latent infection of Homo sapiens with Mycobacterium tuberculosis	0.999999999998641	-1.35854522076428e-12	1	0	0	488	10287
R-HSA-2142696	Synthesis of Hepoxilins (HX) and Trioxilins (TrX)	0.999999999998641	-1.35854522076428e-12	1	0	0	488	10287
R-HSA-5083628	Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3	0.999999999998641	-1.35854522076428e-12	1	0	0	488	10287
R-HSA-5467333	APC truncation mutants are not K63 polyubiquitinated	0.999999999998641	-1.35854522076428e-12	1	0	0	488	10287
R-HSA-2023837	Signaling by FGFR2 amplification mutants	0.999999999998641	-1.35854522076428e-12	1	0	0	488	10287
R-HSA-162585	Uncoating of the HIV Virion	0.999999999998641	-1.35854522076428e-12	1	0	0	488	10287
R-HSA-5083633	Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1	0.999999999998641	-1.35854522076428e-12	1	0	0	488	10287
R-HSA-5619058	Defective SLCO1B3 causes hyperbilirubinemia, Rotor type (HBLRR)	0.999999999998641	-1.35854522076428e-12	1	0	0	488	10287
R-HSA-3359457	Defective GIF causes intrinsic factor deficiency	0.999999999998641	-1.35854522076428e-12	1	0	0	488	10287
R-HSA-1839120	Signaling by FGFR1 amplification mutants	0.999999999998641	-1.35854522076428e-12	1	0	0	488	10287
R-HSA-2033515	t(4;14) translocations of FGFR3	0.999999999998641	-1.35854522076428e-12	1	0	0	488	10287
R-HSA-5602415	UNC93B1 deficiency - HSE	0.999999999998641	-1.35854522076428e-12	1	0	0	488	10287
R-HSA-1222499	Response of Mtb to phagocytosis	0.999999999998641	-1.35854522076428e-12	1	0	0	488	10287
R-HSA-1483196	PI and PC transport between ER and Golgi membranes	0.999999999998641	-1.35854522076428e-12	1	0	0	488	10287
R-HSA-5657655	MGMT-mediated DNA damage reversal	0.999999999998641	-1.35854522076428e-12	1	0	0	488	10287
R-HSA-163316	Mitochondrial transcription termination	0.999999999998641	-1.35854522076428e-12	1	0	0	488	10287
R-HSA-3248023	Regulation by TREX1	0.999999999998641	-1.35854522076428e-12	1	0	0	488	10287
R-HSA-190840	Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane	0.999999999998641	-1.35854522076428e-12	1	0	0	488	10287
R-HSA-171286	Synthesis and processing of ENV and VPU	0.999999999998641	-1.35854522076428e-12	1	0	0	488	10287
R-HSA-8853333	Signaling by FGFR2 fusions	0.999999999998641	-1.35854522076428e-12	1	0	0	488	10287
R-HSA-2466712	Biosynthesis of A2E, implicated in retinal degradation	0.999999999998641	-1.35854522076428e-12	1	0	0	488	10287
R-HSA-389542	NADPH regeneration	0.999999999998641	-1.35854522076428e-12	1	0	0	488	10287
R-HSA-975574	Reactions specific to the hybrid N-glycan synthesis pathway	0.999999999998641	-1.35854522076428e-12	1	0	0	488	10287
R-HSA-2534343	Interaction With Cumulus Cells	0.999999999998641	-1.35854522076428e-12	1	0	0	488	10287
R-HSA-168330	Viral RNP Complexes in the Host Cell Nucleus	0.999999999998641	-1.35854522076428e-12	1	0	0	488	10287
R-HSA-112122	ALKBH2 mediated reversal of alkylation damage	0.999999999998641	-1.35854522076428e-12	1	0	0	488	10287
R-HSA-1222449	Mtb iron assimilation by chelation	0.999999999998641	-1.35854522076428e-12	1	0	0	488	10287
R-HSA-2408552	Methylation of MeSeH for excretion	0.999999999998641	-1.35854522076428e-12	1	0	0	488	10287
R-HSA-6809583	Retinoid metabolism disease events	0.999999999998641	-1.35854522076428e-12	1	0	0	488	10287
R-HSA-164525	Plus-strand DNA synthesis	0.999999999998641	-1.35854522076428e-12	1	0	0	488	10287
R-HSA-5250982	Toxicity of tetanus toxin (TeNT)	0.999999999998641	-1.35854522076428e-12	1	0	0	488	10287
R-HSA-3359454	Defective TCN2 causes hereditary megaloblastic anemia	0.999999999998641	-1.35854522076428e-12	1	0	0	488	10287
R-HSA-3359474	Defective MMACHC causes methylmalonic aciduria and homocystinuria type cblC	0.999999999998641	-1.35854522076428e-12	1	0	0	488	10287
R-HSA-1299287	Tandem pore domain halothane-inhibited K+ channel (THIK)	0.999999999998641	-1.35854522076428e-12	1	0	0	488	10287
R-HSA-5619110	Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR)	0.999999999998641	-1.35854522076428e-12	1	0	0	488	10287
R-HSA-140180	COX reactions	0.999999999998641	-1.35854522076428e-12	1	0	0	488	10287
R-HSA-164516	Minus-strand DNA synthesis	0.999999999998641	-1.35854522076428e-12	1	0	0	488	10287
R-HSA-162589	Reverse Transcription of HIV RNA	0.999999999998641	-1.35854522076428e-12	1	0	0	488	10287
R-HSA-211957	Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2	0.999999999998641	-1.35854522076428e-12	1	0	0	488	10287
R-HSA-1483076	Synthesis of CL	0.999999999998641	-1.35854522076428e-12	1	0	0	488	10287
R-HSA-2978092	Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate	0.999999999998641	-1.35854522076428e-12	1	0	0	488	10287
R-HSA-5602410	TLR3 deficiency - HSE	0.999999999998641	-1.35854522076428e-12	1	0	0	488	10287
R-HSA-1300645	Acrosome Reaction	0.999999999998641	-1.35854522076428e-12	1	0	0	488	10287
R-HSA-1299344	TWIK-related spinal cord K+ channel (TRESK)	0.999999999998641	-1.35854522076428e-12	1	0	0	488	10287
R-HSA-5083629	Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2	0.999999999998641	-1.35854522076428e-12	1	0	0	488	10287
R-HSA-5340573	WNT ligand secretion is abrogated by the PORCN inhibitor LGK974	0.999999999998641	-1.35854522076428e-12	1	0	0	488	10287
R-HSA-1855231	Synthesis of IPs in the ER lumen	0.999999999998641	-1.35854522076428e-12	1	0	0	488	10287
R-HSA-165054	Rev-mediated nuclear export of HIV RNA	0.999999999998813	-1.18718547192489e-12	34	0	0	488	10287
R-HSA-159227	Transport of the SLBP independent Mature mRNA	0.999999999998813	-1.18718547192489e-12	34	0	0	488	10287
R-HSA-1483166	Synthesis of PA	0.999999999998813	-1.18718547192489e-12	34	0	0	488	10287
R-HSA-5693568	Resolution of D-loop Structures through Holliday Junction Intermediates	0.999999999998813	-1.18718547192489e-12	34	0	0	488	10287
R-HSA-420029	Tight junction interactions	0.999999999999357	-6.43014593661664e-13	30	0	0	488	10287
R-HSA-8866652	Synthesis of active ubiquitin: roles of E1 and E2 enzymes	0.999999999999357	-6.43014593661664e-13	30	0	0	488	10287
R-HSA-110314	Recognition of DNA damage by PCNA-containing replication complex	0.999999999999357	-6.43014593661664e-13	30	0	0	488	10287
R-HSA-111996	Ca-dependent events	0.999999999999357	-6.43014593661664e-13	30	0	0	488	10287
R-HSA-3323169	Defects in biotin (Btn) metabolism	0.999999999999602	-3.97575003775843e-13	6	0	0	488	10287
R-HSA-3065679	SUMO is proteolytically processed	0.999999999999602	-3.97575003775843e-13	6	0	0	488	10287
R-HSA-5693548	Sensing of DNA Double Strand Breaks	0.999999999999602	-3.97575003775843e-13	6	0	0	488	10287
R-HSA-177135	Conjugation of benzoate with glycine	0.999999999999602	-3.97575003775843e-13	6	0	0	488	10287
R-HSA-166662	Lectin pathway of complement activation	0.999999999999602	-3.97575003775843e-13	6	0	0	488	10287
R-HSA-6793080	rRNA modification in the mitochondrion	0.999999999999602	-3.97575003775843e-13	6	0	0	488	10287
R-HSA-1566977	Fibronectin matrix formation	0.999999999999602	-3.97575003775843e-13	6	0	0	488	10287
R-HSA-390247	Beta-oxidation of very long chain fatty acids	0.999999999999602	-3.97575003775843e-13	6	0	0	488	10287
R-HSA-5674499	Negative feedback regulation of MAPK pathway	0.999999999999602	-3.97575003775843e-13	6	0	0	488	10287
R-HSA-77288	mitochondrial fatty acid beta-oxidation of unsaturated fatty acids	0.999999999999602	-3.97575003775843e-13	6	0	0	488	10287
R-HSA-6798163	Choline catabolism	0.999999999999602	-3.97575003775843e-13	6	0	0	488	10287
R-HSA-193993	Mineralocorticoid biosynthesis	0.999999999999602	-3.97575003775843e-13	6	0	0	488	10287
R-HSA-5626978	TNFR1-mediated ceramide production	0.999999999999602	-3.97575003775843e-13	6	0	0	488	10287
R-HSA-6787639	GDP-fucose biosynthesis	0.999999999999602	-3.97575003775843e-13	6	0	0	488	10287
R-HSA-442717	CREB phosphorylation through the activation of CaMKK	0.999999999999602	-3.97575003775843e-13	6	0	0	488	10287
R-HSA-176417	Phosphorylation of Emi1	0.999999999999602	-3.97575003775843e-13	6	0	0	488	10287
R-HSA-2187335	The retinoid cycle in cones (daylight vision)	0.999999999999602	-3.97575003775843e-13	6	0	0	488	10287
R-HSA-947581	Molybdenum cofactor biosynthesis	0.999999999999602	-3.97575003775843e-13	6	0	0	488	10287
R-HSA-2142700	Synthesis of Lipoxins (LX)	0.999999999999602	-3.97575003775843e-13	6	0	0	488	10287
R-HSA-173623	Classical antibody-mediated complement activation	0.999999999999602	-3.97575003775843e-13	6	0	0	488	10287
R-HSA-68616	Assembly of the ORC complex at the origin of replication	0.999999999999602	-3.97575003775843e-13	6	0	0	488	10287
R-HSA-5579029	Metabolic disorders of biological oxidation enzymes	0.999999999999602	-3.97575003775843e-13	6	0	0	488	10287
R-HSA-444257	RSK activation	0.999999999999602	-3.97575003775843e-13	6	0	0	488	10287
R-HSA-6782861	Synthesis of wybutosine at G37 of tRNA(Phe)	0.999999999999602	-3.97575003775843e-13	6	0	0	488	10287
R-HSA-500753	Pyrimidine biosynthesis	0.999999999999602	-3.97575003775843e-13	6	0	0	488	10287
R-HSA-1237112	Methionine salvage pathway	0.999999999999602	-3.97575003775843e-13	6	0	0	488	10287
R-HSA-3134973	LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production	0.999999999999602	-3.97575003775843e-13	6	0	0	488	10287
R-HSA-5624138	Trafficking of myristoylated proteins to the cilium	0.999999999999602	-3.97575003775843e-13	6	0	0	488	10287
R-HSA-446199	Synthesis of Dolichyl-phosphate	0.999999999999602	-3.97575003775843e-13	6	0	0	488	10287
R-HSA-3371599	Defective HLCS causes multiple carboxylase deficiency	0.999999999999602	-3.97575003775843e-13	6	0	0	488	10287
R-HSA-3304356	SMAD2/3 Phosphorylation Motif Mutants in Cancer	0.999999999999602	-3.97575003775843e-13	6	0	0	488	10287
R-HSA-1482798	Acyl chain remodeling of CL	0.999999999999602	-3.97575003775843e-13	6	0	0	488	10287
R-HSA-111957	Cam-PDE 1 activation	0.999999999999602	-3.97575003775843e-13	6	0	0	488	10287
R-HSA-5368598	Negative regulation of TCF-dependent signaling by DVL-interacting proteins	0.999999999999602	-3.97575003775843e-13	6	0	0	488	10287
R-HSA-3785653	Myoclonic epilepsy of Lafora	0.999999999999619	-3.81280127172563e-13	10	0	0	488	10287
R-HSA-74749	Signal attenuation	0.999999999999619	-3.81280127172563e-13	10	0	0	488	10287
R-HSA-6811555	PI5P Regulates TP53 Acetylation	0.999999999999619	-3.81280127172563e-13	10	0	0	488	10287
R-HSA-8853334	Signaling by FGFR3 fusions in cancer	0.999999999999619	-3.81280127172563e-13	10	0	0	488	10287
R-HSA-8868766	rRNA processing in the mitochondrion	0.999999999999619	-3.81280127172563e-13	10	0	0	488	10287
R-HSA-389887	Beta-oxidation of pristanoyl-CoA	0.999999999999619	-3.81280127172563e-13	10	0	0	488	10287
R-HSA-164940	Nef mediated downregulation of MHC class I complex cell surface expression	0.999999999999619	-3.81280127172563e-13	10	0	0	488	10287
R-HSA-975578	Reactions specific to the complex N-glycan synthesis pathway	0.999999999999619	-3.81280127172563e-13	10	0	0	488	10287
R-HSA-430116	GP1b-IX-V activation signalling	0.999999999999619	-3.81280127172563e-13	10	0	0	488	10287
R-HSA-201688	WNT mediated activation of DVL	0.999999999999619	-3.81280127172563e-13	10	0	0	488	10287
R-HSA-3215018	Processing and activation of SUMO	0.999999999999619	-3.81280127172563e-13	10	0	0	488	10287
R-HSA-170660	Adenylate cyclase activating pathway	0.999999999999619	-3.81280127172563e-13	10	0	0	488	10287
R-HSA-167590	Nef Mediated CD4 Down-regulation	0.999999999999619	-3.81280127172563e-13	10	0	0	488	10287
R-HSA-2465910	MASTL Facilitates Mitotic Progression	0.999999999999619	-3.81280127172563e-13	10	0	0	488	10287
R-HSA-727802	Transport of nucleotide sugars	0.999999999999619	-3.81280127172563e-13	10	0	0	488	10287
R-HSA-5663084	Diseases of carbohydrate metabolism	0.999999999999619	-3.81280127172563e-13	10	0	0	488	10287
R-HSA-209968	Thyroxine biosynthesis	0.999999999999619	-3.81280127172563e-13	10	0	0	488	10287
R-HSA-159740	Gamma-carboxylation of protein precursors	0.999999999999619	-3.81280127172563e-13	10	0	0	488	10287
R-HSA-8866904	Negative regulation of activity of TFAP2 (AP-2) family transcription factors	0.999999999999619	-3.81280127172563e-13	10	0	0	488	10287
R-HSA-2046105	Linoleic acid (LA) metabolism	0.999999999999619	-3.81280127172563e-13	10	0	0	488	10287
R-HSA-70635	Urea cycle	0.999999999999619	-3.81280127172563e-13	10	0	0	488	10287
R-HSA-174437	Removal of the Flap Intermediate from the C-strand	0.999999999999619	-3.81280127172563e-13	10	0	0	488	10287
R-HSA-5687613	Diseases associated with surfactant metabolism	0.999999999999619	-3.81280127172563e-13	10	0	0	488	10287
R-HSA-390450	Folding of actin by CCT/TriC	0.999999999999619	-3.81280127172563e-13	10	0	0	488	10287
R-HSA-418890	Role of second messengers in netrin-1 signaling	0.999999999999619	-3.81280127172563e-13	10	0	0	488	10287
R-HSA-77286	mitochondrial fatty acid beta-oxidation of saturated fatty acids	0.999999999999619	-3.81280127172563e-13	10	0	0	488	10287
R-HSA-3229121	Glycogen storage diseases	0.999999999999619	-3.81280127172563e-13	10	0	0	488	10287
R-HSA-2151209	Activation of PPARGC1A (PGC-1alpha) by phosphorylation	0.999999999999619	-3.81280127172563e-13	10	0	0	488	10287
R-HSA-190873	Gap junction degradation	0.999999999999619	-3.81280127172563e-13	10	0	0	488	10287
R-HSA-428643	Organic anion transporters	0.999999999999619	-3.81280127172563e-13	10	0	0	488	10287
R-HSA-2562578	TRIF-mediated programmed cell death	0.999999999999619	-3.81280127172563e-13	10	0	0	488	10287
R-HSA-159782	Removal of aminoterminal propeptides from gamma-carboxylated proteins	0.999999999999619	-3.81280127172563e-13	10	0	0	488	10287
R-HSA-419812	Calcitonin-like ligand receptors	0.999999999999619	-3.81280127172563e-13	10	0	0	488	10287
R-HSA-111367	SLBP independent Processing of Histone Pre-mRNAs	0.999999999999619	-3.81280127172563e-13	10	0	0	488	10287
R-HSA-113507	E2F-enabled inhibition of pre-replication complex formation	0.999999999999619	-3.81280127172563e-13	10	0	0	488	10287
R-HSA-73929	Base-Excision Repair, AP Site Formation	0.999999999999619	-3.81280127172563e-13	10	0	0	488	10287
R-HSA-3371378	Regulation by c-FLIP	1.00000000000219	2.18712897958346e-12	11	0	0	488	10287
R-HSA-5218900	CASP8 activity is inhibited	1.00000000000219	2.18712897958346e-12	11	0	0	488	10287
R-HSA-2514853	Condensation of Prometaphase Chromosomes	1.00000000000219	2.18712897958346e-12	11	0	0	488	10287
R-HSA-75072	mRNA Editing	1.00000000000219	2.18712897958346e-12	11	0	0	488	10287
R-HSA-2485179	Activation of the phototransduction cascade	1.00000000000219	2.18712897958346e-12	11	0	0	488	10287
R-HSA-211999	CYP2E1 reactions	1.00000000000219	2.18712897958346e-12	11	0	0	488	10287
R-HSA-5685939	HDR through MMEJ (alt-NHEJ)	1.00000000000219	2.18712897958346e-12	11	0	0	488	10287
R-HSA-380320	Recruitment of NuMA to mitotic centrosomes	1.00000000000219	2.18712897958346e-12	11	0	0	488	10287
R-HSA-1855183	Synthesis of IP2, IP, and Ins in the cytosol	1.00000000000219	2.18712897958346e-12	11	0	0	488	10287
R-HSA-68689	CDC6 association with the ORC:origin complex	1.00000000000219	2.18712897958346e-12	11	0	0	488	10287
R-HSA-159854	Gamma-carboxylation, transport, and amino-terminal cleavage of proteins	1.00000000000219	2.18712897958346e-12	11	0	0	488	10287
R-HSA-69416	Dimerization of procaspase-8	1.00000000000219	2.18712897958346e-12	11	0	0	488	10287
R-HSA-975144	IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation	1.00000000000219	2.18712897958346e-12	11	0	0	488	10287
R-HSA-376172	DSCAM interactions	1.00000000000219	2.18712897958346e-12	11	0	0	488	10287
R-HSA-189451	Heme biosynthesis	1.00000000000219	2.18712897958346e-12	11	0	0	488	10287
R-HSA-2470946	Cohesin Loading onto Chromatin	1.00000000000219	2.18712897958346e-12	11	0	0	488	10287
R-HSA-174414	Processive synthesis on the C-strand of the telomere	1.00000000000219	2.18712897958346e-12	11	0	0	488	10287
R-HSA-196780	Biotin transport and metabolism	1.00000000000219	2.18712897958346e-12	11	0	0	488	10287
R-HSA-629594	Highly calcium permeable postsynaptic nicotinic acetylcholine receptors	1.00000000000219	2.18712897958346e-12	11	0	0	488	10287
R-HSA-937039	IRAK1 recruits IKK complex	1.00000000000219	2.18712897958346e-12	11	0	0	488	10287
R-HSA-2022923	Dermatan sulfate biosynthesis	1.00000000000219	2.18712897958346e-12	11	0	0	488	10287
R-HSA-174495	Synthesis And Processing Of GAG, GAGPOL Polyproteins	1.00000000000219	2.18712897958346e-12	11	0	0	488	10287
R-HSA-3296469	Defects in cobalamin (B12) metabolism	1.00000000000219	2.18712897958346e-12	11	0	0	488	10287
R-HSA-5625970	RHO GTPases activate KTN1	1.00000000000219	2.18712897958346e-12	11	0	0	488	10287
R-HSA-418889	Ligand-independent caspase activation via DCC	1.00000000000219	2.18712897958346e-12	11	0	0	488	10287
R-HSA-381183	ATF6 (ATF6-alpha) activates chaperone genes	1.00000000000219	2.18712897958346e-12	11	0	0	488	10287
R-HSA-200425	Import of palmitoyl-CoA into the mitochondrial matrix	1.00000000000219	2.18712897958346e-12	11	0	0	488	10287
R-HSA-174490	Membrane binding and targetting of GAG proteins	1.00000000000219	2.18712897958346e-12	11	0	0	488	10287
R-HSA-5655291	Signaling by FGFR4 in disease	1.00000000000219	2.18712897958346e-12	11	0	0	488	10287
R-HSA-77588	SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs	1.00000000000219	2.18712897958346e-12	11	0	0	488	10287
R-HSA-5688031	Defective pro-SFTPB causes pulmonary surfactant metabolism dysfunction 1 (SMDP1) and respiratory distress syndrome (RDS)	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-1296067	Potassium transport channels	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-173599	Formation of the active cofactor, UDP-glucuronate	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-1307965	betaKlotho-mediated ligand binding	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-844615	The AIM2 inflammasome	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-73927	Depurination	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-165181	Inhibition of TSC complex formation by PKB	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-1299308	Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK)	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-180897	Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-1483248	Synthesis of PIPs at the ER membrane	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-2892245	POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-427589	Type II Na+/Pi cotransporters	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-1234162	Oxygen-dependent asparagine hydroxylation of Hypoxia-inducible Factor Alpha	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-5658034	HHAT G278V abrogates palmitoylation of Hh-Np	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-3249367	STAT6-mediated induction of chemokines	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-110331	Cleavage of the damaged purine	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-5250958	Toxicity of botulinum toxin type B (BoNT/B)	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-217271	FMO oxidises nucleophiles	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-191647	c-src mediated regulation of Cx43 function and closure of gap junctions	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-379397	Enzymatic degradation of dopamine by COMT	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-111446	Activation of BIM and translocation to mitochondria	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-5602680	MyD88 deficiency (TLR5)	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-77305	Beta oxidation of palmitoyl-CoA to myristoyl-CoA	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-6806664	Metabolism of vitamin K	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-3304347	Loss of Function of SMAD4 in Cancer	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-5602571	TRAF3 deficiency - HSE	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-3296197	Hydroxycarboxylic acid-binding receptors	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-5250989	Toxicity of botulinum toxin type G (BoNT/G)	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-5635851	GLI proteins bind promoters of Hh responsive genes to promote transcription	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-77108	Utilization of Ketone Bodies	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-265473	Trafficking of dietary sterols	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-110330	Recognition and association of DNA glycosylase with site containing an affected purine	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-428359	Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-844455	The NLRP1 inflammasome	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-190374	FGFR1c and Klotho ligand binding and activation	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-1299503	TWIK related potassium channel (TREK)	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-5339700	TCF7L2 mutants don't bind CTBP	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-5357572	Lysosomal glycogen catabolism	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-880009	Interconversion of 2-oxoglutarate and 2-hydroxyglutarate	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-1368071	NR1D1 (REV-ERBA) represses gene expression	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-3359462	Defective AMN causes hereditary megaloblastic anemia 1	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-77285	Beta oxidation of myristoyl-CoA to lauroyl-CoA	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-350864	Regulation of thyroid hormone activity	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-8849472	PTK6 Down-Regulation	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-380615	Serotonin clearance from the synaptic cleft	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-139910	Activation of BMF and translocation to mitochondria	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-964975	Vitamins B6 activation to pyridoxal phosphate	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-162699	Synthesis of dolichyl-phosphate mannose	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-352238	Breakdown of the nuclear lamina	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-163282	Mitochondrial transcription initiation	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-2395516	Electron transport from NADPH to Ferredoxin	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-3359463	Defective CUBN causes hereditary megaloblastic anemia 1	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-111458	Formation of apoptosome	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-5624958	ARL13B-mediated ciliary trafficking of INPP5E	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-8853336	Signaling by plasma membrane FGFR1 fusions	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-191650	Regulation of gap junction activity	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-977442	GABA A (rho) receptor activation	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-379398	Enzymatic degradation of Dopamine by monoamine oxidase	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-3311021	SMAD4 MH2 Domain Mutants in Cancer	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-73843	5-Phosphoribose 1-diphosphate biosynthesis	1.00000000000278	2.77810021894528e-12	3	0	0	488	10287
R-HSA-204626	Hypusine synthesis from eIF5A-lysine	1.00000000000322	3.2178021488002e-12	4	0	0	488	10287
R-HSA-888593	Reuptake of GABA	1.00000000000322	3.2178021488002e-12	4	0	0	488	10287
R-HSA-428776	Class II GLUTs	1.00000000000322	3.2178021488002e-12	4	0	0	488	10287
R-HSA-112126	ALKBH3 mediated reversal of alkylation damage	1.00000000000322	3.2178021488002e-12	4	0	0	488	10287
R-HSA-5579026	Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)	1.00000000000322	3.2178021488002e-12	4	0	0	488	10287
R-HSA-165158	Activation of AKT2	1.00000000000322	3.2178021488002e-12	4	0	0	488	10287
R-HSA-5619099	Defective AVP causes neurohypophyseal diabetes insipidus (NDI)	1.00000000000322	3.2178021488002e-12	4	0	0	488	10287
R-HSA-399710	Activation of AMPA receptors	1.00000000000322	3.2178021488002e-12	4	0	0	488	10287
R-HSA-176034	Interactions of Tat with host cellular proteins	1.00000000000322	3.2178021488002e-12	4	0	0	488	10287
R-HSA-110381	Resolution of AP sites via the single-nucleotide replacement pathway	1.00000000000322	3.2178021488002e-12	4	0	0	488	10287
R-HSA-8935690	Miscellaneous digestion events	1.00000000000322	3.2178021488002e-12	4	0	0	488	10287
R-HSA-69200	Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes	1.00000000000322	3.2178021488002e-12	4	0	0	488	10287
R-HSA-6807047	Cholesterol biosynthesis via desmosterol	1.00000000000322	3.2178021488002e-12	4	0	0	488	10287
R-HSA-8847453	Synthesis of PIPs in the nucleus	1.00000000000322	3.2178021488002e-12	4	0	0	488	10287
R-HSA-6807062	Cholesterol biosynthesis via lathosterol	1.00000000000322	3.2178021488002e-12	4	0	0	488	10287
R-HSA-1855191	Synthesis of IPs in the nucleus	1.00000000000322	3.2178021488002e-12	4	0	0	488	10287
R-HSA-1296025	ATP sensitive Potassium channels	1.00000000000322	3.2178021488002e-12	4	0	0	488	10287
R-HSA-75944	Transcription from mitochondrial promoters	1.00000000000322	3.2178021488002e-12	4	0	0	488	10287
R-HSA-6803544	Ion influx/efflux at host-pathogen interface	1.00000000000322	3.2178021488002e-12	4	0	0	488	10287
R-HSA-379401	Dopamine clearance from the synaptic cleft	1.00000000000322	3.2178021488002e-12	4	0	0	488	10287
R-HSA-4551638	SUMOylation of chromatin organization proteins	1.00000000000322	3.2178021488002e-12	4	0	0	488	10287
R-HSA-5603037	IRAK4 deficiency (TLR5)	1.00000000000322	3.2178021488002e-12	4	0	0	488	10287
R-HSA-6802953	RAS signaling downstream of NF1 loss-of-function variants	1.00000000000322	3.2178021488002e-12	4	0	0	488	10287
R-HSA-3000497	Scavenging by Class H Receptors	1.00000000000322	3.2178021488002e-12	4	0	0	488	10287
R-HSA-1251932	PLCG1 events in ERBB2 signaling	1.00000000000322	3.2178021488002e-12	4	0	0	488	10287
R-HSA-5083630	Defective LFNG causes SCDO3	1.00000000000322	3.2178021488002e-12	4	0	0	488	10287
R-HSA-5221030	TET1,2,3 and TDG demethylate DNA	1.00000000000322	3.2178021488002e-12	4	0	0	488	10287
R-HSA-211163	AKT-mediated inactivation of FOXO1A	1.00000000000322	3.2178021488002e-12	4	0	0	488	10287
R-HSA-8848584	Wax biosynthesis	1.00000000000322	3.2178021488002e-12	4	0	0	488	10287
R-HSA-8866906	TFAP2 (AP-2) family regulates transcription of other transcription factors	1.00000000000322	3.2178021488002e-12	4	0	0	488	10287
R-HSA-8849474	PTK6 Activates STAT3	1.00000000000322	3.2178021488002e-12	4	0	0	488	10287
R-HSA-1369007	Mitochondrial ABC transporters	1.00000000000322	3.2178021488002e-12	4	0	0	488	10287
R-HSA-390650	Histamine receptors	1.00000000000322	3.2178021488002e-12	4	0	0	488	10287
R-HSA-1296053	Classical Kir channels	1.00000000000322	3.2178021488002e-12	4	0	0	488	10287
R-HSA-3878781	Glycogen storage disease type IV (GBE1)	1.00000000000322	3.2178021488002e-12	4	0	0	488	10287
R-HSA-1296061	HCN channels	1.00000000000322	3.2178021488002e-12	4	0	0	488	10287
R-HSA-442745	Activation of CaMK IV	1.00000000000322	3.2178021488002e-12	4	0	0	488	10287
R-HSA-446343	Localization of the PINCH-ILK-PARVIN complex to focal adhesions	1.00000000000322	3.2178021488002e-12	4	0	0	488	10287
R-HSA-6783984	Glycine degradation	1.00000000000322	3.2178021488002e-12	4	0	0	488	10287
R-HSA-8868773	rRNA processing in the nucleus and cytosol	1.00000000000396	3.95702734717435e-12	191	0	0	488	10287
R-HSA-6811436	COPI-independent Golgi-to-ER retrograde traffic	1.00000000000463	4.63061875056625e-12	28	0	0	488	10287
R-HSA-70268	Pyruvate metabolism	1.00000000000463	4.63061875056625e-12	28	0	0	488	10287
R-HSA-6803529	FGFR2 alternative splicing	1.00000000000463	4.63061875056625e-12	28	0	0	488	10287
R-HSA-380972	Energy dependent regulation of mTOR by LKB1-AMPK	1.00000000000463	4.63061875056625e-12	28	0	0	488	10287
R-HSA-437239	Recycling pathway of L1	1.00000000000463	4.63061875056625e-12	28	0	0	488	10287
R-HSA-1855204	Synthesis of IP3 and IP4 in the cytosol	1.00000000000463	4.63061875056625e-12	28	0	0	488	10287
R-HSA-264876	Insulin processing	1.00000000000463	4.63061875056625e-12	28	0	0	488	10287
R-HSA-76061	RNA Polymerase III Transcription Initiation From Type 1 Promoter	1.00000000000463	4.63061875056625e-12	28	0	0	488	10287
R-HSA-111933	Calmodulin induced events	1.00000000000463	4.63061875056625e-12	28	0	0	488	10287
R-HSA-5357769	Caspase activation via extrinsic apoptotic signalling pathway	1.00000000000463	4.63061875056625e-12	28	0	0	488	10287
R-HSA-111997	CaM pathway	1.00000000000463	4.63061875056625e-12	28	0	0	488	10287
R-HSA-76071	RNA Polymerase III Transcription Initiation From Type 3 Promoter	1.00000000000463	4.63061875056625e-12	28	0	0	488	10287
R-HSA-917729	Endosomal Sorting Complex Required For Transport (ESCRT)	1.00000000000463	4.63061875056625e-12	28	0	0	488	10287
R-HSA-73780	RNA Polymerase III Chain Elongation	1.00000000000486	4.85585739440605e-12	18	0	0	488	10287
R-HSA-936964	Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon	1.00000000000486	4.85585739440605e-12	18	0	0	488	10287
R-HSA-450385	Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA	1.00000000000486	4.85585739440605e-12	18	0	0	488	10287
R-HSA-1839117	Signaling by cytosolic FGFR1 fusion mutants	1.00000000000486	4.85585739440605e-12	18	0	0	488	10287
R-HSA-2022377	Metabolism of Angiotensinogen to Angiotensins	1.00000000000486	4.85585739440605e-12	18	0	0	488	10287
R-HSA-1482925	Acyl chain remodelling of PG	1.00000000000486	4.85585739440605e-12	18	0	0	488	10287
R-HSA-5635838	Activation of SMO	1.00000000000486	4.85585739440605e-12	18	0	0	488	10287
R-HSA-450513	Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA	1.00000000000486	4.85585739440605e-12	18	0	0	488	10287
R-HSA-5689877	Josephin domain DUBs	1.00000000000573	5.73471389663326e-12	12	0	0	488	10287
R-HSA-417957	P2Y receptors	1.00000000000573	5.73471389663326e-12	12	0	0	488	10287
R-HSA-166786	Creation of C4 and C2 activators	1.00000000000573	5.73471389663326e-12	12	0	0	488	10287
R-HSA-622323	Presynaptic nicotinic acetylcholine receptors	1.00000000000573	5.73471389663326e-12	12	0	0	488	10287
R-HSA-5578768	Physiological factors	1.00000000000573	5.73471389663326e-12	12	0	0	488	10287
R-HSA-1433617	Regulation of signaling by NODAL	1.00000000000573	5.73471389663326e-12	12	0	0	488	10287
R-HSA-211979	Eicosanoids	1.00000000000573	5.73471389663326e-12	12	0	0	488	10287
R-HSA-390666	Serotonin receptors	1.00000000000573	5.73471389663326e-12	12	0	0	488	10287
R-HSA-975110	TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling	1.00000000000573	5.73471389663326e-12	12	0	0	488	10287
R-HSA-75035	Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex	1.00000000000573	5.73471389663326e-12	12	0	0	488	10287
R-HSA-2022857	Keratan sulfate degradation	1.00000000000573	5.73471389663326e-12	12	0	0	488	10287
R-HSA-3371511	HSF1 activation	1.00000000000573	5.73471389663326e-12	12	0	0	488	10287
R-HSA-1296346	Tandem pore domain potassium channels	1.00000000000573	5.73471389663326e-12	12	0	0	488	10287
R-HSA-211958	Miscellaneous substrates	1.00000000000573	5.73471389663326e-12	12	0	0	488	10287
R-HSA-71064	Lysine catabolism	1.00000000000573	5.73471389663326e-12	12	0	0	488	10287
R-HSA-71384	Ethanol oxidation	1.00000000000573	5.73471389663326e-12	12	0	0	488	10287
R-HSA-2468052	Establishment of Sister Chromatid Cohesion	1.00000000000573	5.73471389663326e-12	12	0	0	488	10287
R-HSA-451308	Activation of Ca-permeable Kainate Receptor	1.00000000000573	5.73471389663326e-12	12	0	0	488	10287
R-HSA-73817	Purine ribonucleoside monophosphate biosynthesis	1.00000000000573	5.73471389663326e-12	12	0	0	488	10287
R-HSA-1234158	Regulation of gene expression by Hypoxia-inducible Factor	1.00000000000573	5.73471389663326e-12	12	0	0	488	10287
R-HSA-451306	Ionotropic activity of Kainate Receptors	1.00000000000573	5.73471389663326e-12	12	0	0	488	10287
R-HSA-8866427	VLDLR internalisation and degradation	1.00000000000573	5.73471389663326e-12	12	0	0	488	10287
R-HSA-6784531	tRNA processing in the nucleus	1.00000000000586	5.8595864490235e-12	60	0	0	488	10287
R-HSA-168271	Transport of Ribonucleoproteins into the Host Nucleus	1.0000000000061	6.0994657643179e-12	31	0	0	488	10287
R-HSA-73772	RNA Polymerase I Promoter Escape	1.0000000000061	6.0994657643179e-12	31	0	0	488	10287
R-HSA-75067	Processing of Capped Intronless Pre-mRNA	1.0000000000061	6.0994657643179e-12	31	0	0	488	10287
R-HSA-6804758	Regulation of TP53 Activity through Acetylation	1.0000000000061	6.0994657643179e-12	31	0	0	488	10287
R-HSA-70614	Amino acid synthesis and interconversion (transamination)	1.0000000000061	6.0994657643179e-12	31	0	0	488	10287
R-HSA-1296065	Inwardly rectifying K+ channels	1.0000000000061	6.0994657643179e-12	31	0	0	488	10287
R-HSA-170822	Regulation of Glucokinase by Glucokinase Regulatory Protein	1.0000000000061	6.0994657643179e-12	31	0	0	488	10287
R-HSA-168333	NEP/NS2 Interacts with the Cellular Export Machinery	1.0000000000061	6.0994657643179e-12	31	0	0	488	10287
R-HSA-171052	LDL-mediated lipid transport	1.00000000000651	6.51294361929822e-12	24	0	0	488	10287
R-HSA-191273	Cholesterol biosynthesis	1.00000000000651	6.51294361929822e-12	24	0	0	488	10287
R-HSA-156588	Glucuronidation	1.00000000000651	6.51294361929822e-12	24	0	0	488	10287
R-HSA-70895	Branched-chain amino acid catabolism	1.00000000000651	6.51294361929822e-12	24	0	0	488	10287
R-HSA-110373	Resolution of AP sites via the multiple-nucleotide patch replacement pathway	1.00000000000651	6.51294361929822e-12	24	0	0	488	10287
R-HSA-5651801	PCNA-Dependent Long Patch Base Excision Repair	1.00000000000657	6.56573117096202e-12	21	0	0	488	10287
R-HSA-1181150	Signaling by NODAL	1.00000000000657	6.56573117096202e-12	21	0	0	488	10287
R-HSA-69618	Mitotic Spindle Checkpoint	1.00000000000657	6.56573117096202e-12	21	0	0	488	10287
R-HSA-210745	Regulation of gene expression in beta cells	1.00000000000657	6.56573117096202e-12	21	0	0	488	10287
R-HSA-500657	Presynaptic function of Kainate receptors	1.00000000000657	6.56573117096202e-12	21	0	0	488	10287
R-HSA-445144	Signal transduction by L1	1.00000000000657	6.56573117096202e-12	21	0	0	488	10287
R-HSA-379716	Cytosolic tRNA aminoacylation	1.00000000000944	9.43908388418154e-12	26	0	0	488	10287
R-HSA-975298	Ligand-gated ion channel transport	1.00000000000944	9.43908388418154e-12	26	0	0	488	10287
R-HSA-389960	Formation of tubulin folding intermediates by CCT/TriC	1.00000000000944	9.43908388418154e-12	26	0	0	488	10287
R-HSA-3359473	Defective MMADHC causes methylmalonic aciduria and homocystinuria type cblD	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-75896	Plasmalogen biosynthesis	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-5602566	TICAM1 deficiency - HSE	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-5683177	Defective ABCC8 can cause hypoglycemias and hyperglycemias	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-1483101	Synthesis of PS	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-5638303	Inhibition of Signaling by Overexpressed EGFR	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-203754	NOSIP mediated eNOS trafficking	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-5545619	XAV939 inhibits tankyrase, stabilizing AXIN	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-3814836	Glycogen storage disease type XV (GYG1)	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-1483152	Hydrolysis of LPE	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-888568	GABA synthesis	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-70688	Proline catabolism	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-5638302	Signaling by Overexpressed Wild-Type EGFR in Cancer	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-198765	Signalling to ERK5	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-168277	Influenza Virus Induced Apoptosis	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-156582	Acetylation	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-8854521	Interaction between PHLDA1 and AURKA	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-77042	Formation of editosomes by ADAR proteins	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-1614603	Cysteine formation from homocysteine	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-73930	Abasic sugar-phosphate removal via the single-nucleotide replacement pathway	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-165160	PDE3B signalling	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-75064	mRNA Editing: A to I Conversion	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-8849175	Threonine catabolism	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-166020	Transfer of LPS from LBP carrier to CD14	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-211736	Stimulation of the cell death response by PAK-2p34	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-351143	Agmatine biosynthesis	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-916853	Degradation of GABA	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-3858516	Glycogen storage disease type 0 (liver GYS2)	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-3359478	Defective MUT causes methylmalonic aciduria mut type	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-168268	Virus Assembly and Release	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-211728	Regulation of PAK-2p34 activity by PS-GAP/RHG10	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-168275	Entry of Influenza Virion into Host Cell via Endocytosis	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-3359475	Defective MMAA causes methylmalonic aciduria type cblA	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-3359467	Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-71737	Pyrophosphate hydrolysis	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-211994	Sterols are 12-hydroxylated by CYP8B1	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-844623	The IPAF inflammasome	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-141444	Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-5602636	IKBKB deficiency causes SCID	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-3642279	TGFBR2 MSI Frameshift Mutants in Cancer	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-5688354	Defective pro-SFTPC causes pulmonary surfactant metabolism dysfunction 2 (SMDP2) and respiratory distress syndrome (RDS)	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-480985	Synthesis of dolichyl-phosphate-glucose	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-380612	Metabolism of serotonin	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-163754	Insulin effects increased synthesis of Xylulose-5-Phosphate	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-141424	Amplification of signal from the kinetochores	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-192905	vRNP Assembly	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-1299316	TWIK-releated acid-sensitive K+ channel (TASK)	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-5357609	Glycogen storage disease type II (GAA)	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-451307	Activation of Na-permeable Kainate Receptors	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-111457	Release of apoptotic factors from the mitochondria	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-168315	Inhibition of Host mRNA Processing and RNA Silencing	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-5687868	Defective SFTPA2 causes idiopathic pulmonary fibrosis (IPF)	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-428559	Proton-coupled neutral amino acid transporters	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-141333	Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-3359485	Defective CD320 causes methylmalonic aciduria	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-68881	Mitotic Metaphase/Anaphase Transition	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-111995	phospho-PLA2 pathway	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-75102	C6 deamination of adenosine	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-177162	Conjugation of phenylacetate with glutamine	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-3828062	Glycogen storage disease type 0 (muscle GYS1)	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-8942233	Intestinal infectious diseases	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-168316	Assembly of Viral Components at the Budding Site	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-5579031	Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-3359469	Defective MTR causes methylmalonic aciduria and homocystinuria type cblG	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-1299361	TWIK-related alkaline pH activated K+ channel (TALK)	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-5619107	Defective TRP may confer susceptibility towards thyroid papillary carcinoma (TPC)	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-164939	Nef mediated downregulation of CD28 cell surface expression	1.00000000000972	9.7238146354317e-12	2	0	0	488	10287
R-HSA-167246	Tat-mediated elongation of the HIV-1 transcript	1.00000000000974	9.74461877999177e-12	50	0	0	488	10287
R-HSA-6802949	Signaling by RAS mutants	1.00000000000974	9.74461877999177e-12	50	0	0	488	10287
R-HSA-167200	Formation of HIV-1 elongation complex containing HIV-1 Tat	1.00000000000974	9.74461877999177e-12	50	0	0	488	10287
R-HSA-167169	HIV Transcription Elongation	1.00000000000974	9.74461877999177e-12	50	0	0	488	10287
R-HSA-4615885	SUMOylation of DNA replication proteins	1.00000000001043	1.04265338421997e-11	46	0	0	488	10287
R-HSA-1660662	Glycosphingolipid metabolism	1.00000000001043	1.04265338421997e-11	46	0	0	488	10287
R-HSA-3108214	SUMOylation of DNA damage response and repair proteins	1.00000000001047	1.046881539914e-11	78	0	0	488	10287
R-HSA-156842	Eukaryotic Translation Elongation	1.00000000001071	1.07121102060929e-11	96	0	0	488	10287
R-HSA-72764	Eukaryotic Translation Termination	1.00000000001071	1.07121102060929e-11	96	0	0	488	10287
R-HSA-429947	Deadenylation of mRNA	1.00000000001117	1.11738274727379e-11	25	0	0	488	10287
R-HSA-5696397	Gap-filling DNA repair synthesis and ligation in GG-NER	1.00000000001117	1.11738274727379e-11	25	0	0	488	10287
R-HSA-997272	Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits	1.00000000001117	1.11738274727379e-11	25	0	0	488	10287
R-HSA-179409	APC-Cdc20 mediated degradation of Nek2A	1.00000000001117	1.11738274727379e-11	25	0	0	488	10287
R-HSA-5673000	RAF activation	1.00000000001117	1.11738274727379e-11	25	0	0	488	10287
R-HSA-1296059	G protein gated Potassium channels	1.00000000001117	1.11738274727379e-11	25	0	0	488	10287
R-HSA-167242	Abortive elongation of HIV-1 transcript in the absence of Tat	1.00000000001117	1.11738274727379e-11	25	0	0	488	10287
R-HSA-418592	ADP signalling through P2Y purinoceptor 1	1.00000000001117	1.11738274727379e-11	25	0	0	488	10287
R-HSA-203927	MicroRNA (miRNA) biogenesis	1.00000000001117	1.11738274727379e-11	25	0	0	488	10287
R-HSA-5674400	Constitutive Signaling by AKT1 E17K in Cancer	1.00000000001117	1.11738274727379e-11	25	0	0	488	10287
R-HSA-1296041	Activation of G protein gated Potassium channels	1.00000000001117	1.11738274727379e-11	25	0	0	488	10287
R-HSA-389661	Glyoxylate metabolism and glycine degradation	1.00000000001117	1.11738274727379e-11	25	0	0	488	10287
R-HSA-3304351	Signaling by TGF-beta Receptor Complex in Cancer	1.00000000001118	1.11751532588217e-11	9	0	0	488	10287
R-HSA-74182	Ketone body metabolism	1.00000000001118	1.11751532588217e-11	9	0	0	488	10287
R-HSA-1462054	Alpha-defensins	1.00000000001118	1.11751532588217e-11	9	0	0	488	10287
R-HSA-8849469	PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1	1.00000000001118	1.11751532588217e-11	9	0	0	488	10287
R-HSA-419771	Opsins	1.00000000001118	1.11751532588217e-11	9	0	0	488	10287
R-HSA-163765	ChREBP activates metabolic gene expression	1.00000000001118	1.11751532588217e-11	9	0	0	488	10287
R-HSA-166665	Terminal pathway of complement	1.00000000001118	1.11751532588217e-11	9	0	0	488	10287
R-HSA-156587	Amino Acid conjugation	1.00000000001118	1.11751532588217e-11	9	0	0	488	10287
R-HSA-159763	Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus	1.00000000001118	1.11751532588217e-11	9	0	0	488	10287
R-HSA-8876493	InlA-mediated entry of Listeria monocytogenes into host cells	1.00000000001118	1.11751532588217e-11	9	0	0	488	10287
R-HSA-198693	AKT phosphorylates targets in the nucleus	1.00000000001118	1.11751532588217e-11	9	0	0	488	10287
R-HSA-5340588	RNF mutants show enhanced WNT signaling and proliferation	1.00000000001118	1.11751532588217e-11	9	0	0	488	10287
R-HSA-2142816	Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)	1.00000000001118	1.11751532588217e-11	9	0	0	488	10287
R-HSA-2243919	Crosslinking of collagen fibrils	1.00000000001118	1.11751532588217e-11	9	0	0	488	10287
R-HSA-75094	Formation of the Editosome	1.00000000001118	1.11751532588217e-11	9	0	0	488	10287
R-HSA-196025	Formation of annular gap junctions	1.00000000001118	1.11751532588217e-11	9	0	0	488	10287
R-HSA-71336	Pentose phosphate pathway (hexose monophosphate shunt)	1.00000000001118	1.11751532588217e-11	9	0	0	488	10287
R-HSA-391908	Prostanoid ligand receptors	1.00000000001118	1.11751532588217e-11	9	0	0	488	10287
R-HSA-2428933	SHC-related events triggered by IGF1R	1.00000000001118	1.11751532588217e-11	9	0	0	488	10287
R-HSA-2142688	Synthesis of 5-eicosatetraenoic acids	1.00000000001118	1.11751532588217e-11	9	0	0	488	10287
R-HSA-1300642	Sperm Motility And Taxes	1.00000000001118	1.11751532588217e-11	9	0	0	488	10287
R-HSA-110357	Displacement of DNA glycosylase by APEX1	1.00000000001118	1.11751532588217e-11	9	0	0	488	10287
R-HSA-5666185	RHO GTPases Activate Rhotekin and Rhophilins	1.00000000001118	1.11751532588217e-11	9	0	0	488	10287
R-HSA-159424	Conjugation of carboxylic acids	1.00000000001118	1.11751532588217e-11	9	0	0	488	10287
R-HSA-1247673	Erythrocytes take up oxygen and release carbon dioxide	1.00000000001118	1.11751532588217e-11	9	0	0	488	10287
R-HSA-189085	Digestion of dietary carbohydrate	1.00000000001118	1.11751532588217e-11	9	0	0	488	10287
R-HSA-426486	Small interfering RNA (siRNA) biogenesis	1.00000000001118	1.11751532588217e-11	9	0	0	488	10287
R-HSA-425986	Sodium/Proton exchangers	1.00000000001118	1.11751532588217e-11	9	0	0	488	10287
R-HSA-72200	mRNA Editing: C to U Conversion	1.00000000001118	1.11751532588217e-11	9	0	0	488	10287
R-HSA-629597	Highly calcium permeable nicotinic acetylcholine receptors	1.00000000001118	1.11751532588217e-11	9	0	0	488	10287
R-HSA-674695	RNA Polymerase II Pre-transcription Events	1.00000000001189	1.18861294858236e-11	88	0	0	488	10287
R-HSA-5389840	Mitochondrial translation elongation	1.00000000001189	1.18861294858236e-11	88	0	0	488	10287
R-HSA-210744	Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells	1.00000000001212	1.2120057893393e-11	7	0	0	488	10287
R-HSA-5649702	APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway	1.00000000001212	1.2120057893393e-11	7	0	0	488	10287
R-HSA-2393930	Phosphate bond hydrolysis by NUDT proteins	1.00000000001212	1.2120057893393e-11	7	0	0	488	10287
R-HSA-174362	Transport and synthesis of PAPS	1.00000000001212	1.2120057893393e-11	7	0	0	488	10287
R-HSA-442720	CREB phosphorylation through the activation of Adenylate Cyclase	1.00000000001212	1.2120057893393e-11	7	0	0	488	10287
R-HSA-73943	Reversal of alkylation damage by DNA dioxygenases	1.00000000001212	1.2120057893393e-11	7	0	0	488	10287
R-HSA-3595177	Defective CHSY1 causes TPBS	1.00000000001212	1.2120057893393e-11	7	0	0	488	10287
R-HSA-6814848	Glycerophospholipid catabolism	1.00000000001212	1.2120057893393e-11	7	0	0	488	10287
R-HSA-426496	Post-transcriptional silencing by small RNAs	1.00000000001212	1.2120057893393e-11	7	0	0	488	10287
R-HSA-182218	Nef Mediated CD8 Down-regulation	1.00000000001212	1.2120057893393e-11	7	0	0	488	10287
R-HSA-110362	POLB-Dependent Long Patch Base Excision Repair	1.00000000001212	1.2120057893393e-11	7	0	0	488	10287
R-HSA-171319	Telomere Extension By Telomerase	1.00000000001212	1.2120057893393e-11	7	0	0	488	10287
R-HSA-3065678	SUMO is transferred from E1 to E2 (UBE2I, UBC9)	1.00000000001212	1.2120057893393e-11	7	0	0	488	10287
R-HSA-163767	PP2A-mediated dephosphorylation of key metabolic factors	1.00000000001212	1.2120057893393e-11	7	0	0	488	10287
R-HSA-3595172	Defective CHST3 causes SEDCJD	1.00000000001212	1.2120057893393e-11	7	0	0	488	10287
R-HSA-5576894	Phase 1 - inactivation of fast Na+ channels	1.00000000001212	1.2120057893393e-11	7	0	0	488	10287
R-HSA-2993913	Clearance of Nuclear Envelope Membranes from Chromatin	1.00000000001212	1.2120057893393e-11	7	0	0	488	10287
R-HSA-3304349	Loss of Function of SMAD2/3 in Cancer	1.00000000001212	1.2120057893393e-11	7	0	0	488	10287
R-HSA-426117	Cation-coupled Chloride cotransporters	1.00000000001212	1.2120057893393e-11	7	0	0	488	10287
R-HSA-3656225	Defective CHST6 causes MCDC1	1.00000000001212	1.2120057893393e-11	7	0	0	488	10287
R-HSA-435368	Zinc efflux and compartmentalization by the SLC30 family	1.00000000001212	1.2120057893393e-11	7	0	0	488	10287
R-HSA-433692	Proton-coupled monocarboxylate transport	1.00000000001212	1.2120057893393e-11	7	0	0	488	10287
R-HSA-629587	Highly sodium permeable acetylcholine nicotinic receptors	1.00000000001212	1.2120057893393e-11	7	0	0	488	10287
R-HSA-199920	CREB phosphorylation	1.00000000001212	1.2120057893393e-11	7	0	0	488	10287
R-HSA-2980767	Activation of NIMA Kinases NEK9, NEK6, NEK7	1.00000000001212	1.2120057893393e-11	7	0	0	488	10287
R-HSA-3315487	SMAD2/3 MH2 Domain Mutants in Cancer	1.00000000001212	1.2120057893393e-11	7	0	0	488	10287
R-HSA-3656244	Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)	1.00000000001212	1.2120057893393e-11	7	0	0	488	10287
R-HSA-1912399	Pre-NOTCH Processing in the Endoplasmic Reticulum	1.00000000001212	1.2120057893393e-11	7	0	0	488	10287
R-HSA-3656243	Defective ST3GAL3 causes MCT12 and EIEE15	1.00000000001212	1.2120057893393e-11	7	0	0	488	10287
R-HSA-196843	Vitamin B2 (riboflavin) metabolism	1.00000000001212	1.2120057893393e-11	7	0	0	488	10287
R-HSA-111471	Apoptotic factor-mediated response	1.00000000001212	1.2120057893393e-11	7	0	0	488	10287
R-HSA-3595174	Defective CHST14 causes EDS, musculocontractural type	1.00000000001212	1.2120057893393e-11	7	0	0	488	10287
R-HSA-5619102	SLC transporter disorders	1.00000000001212	1.2120057893393e-11	7	0	0	488	10287
R-HSA-75158	TRAIL  signaling	1.00000000001212	1.2120057893393e-11	7	0	0	488	10287
R-HSA-168273	Influenza Viral RNA Transcription and Replication	1.00000000001238	1.23812656019194e-11	137	0	0	488	10287
R-HSA-418217	G beta:gamma signalling through PLC beta	1.00000000001285	1.28546817404185e-11	20	0	0	488	10287
R-HSA-6804760	Regulation of TP53 Activity through Methylation	1.00000000001285	1.28546817404185e-11	20	0	0	488	10287
R-HSA-141405	Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components	1.00000000001285	1.28546817404185e-11	20	0	0	488	10287
R-HSA-194223	HDL-mediated lipid transport	1.00000000001285	1.28546817404185e-11	20	0	0	488	10287
R-HSA-381771	Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)	1.00000000001285	1.28546817404185e-11	20	0	0	488	10287
R-HSA-141430	Inactivation of APC/C via direct inhibition of the APC/C complex	1.00000000001285	1.28546817404185e-11	20	0	0	488	10287
R-HSA-1643713	Signaling by EGFR in Cancer	1.00000000001285	1.28546817404185e-11	20	0	0	488	10287
R-HSA-1236382	Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants	1.00000000001285	1.28546817404185e-11	20	0	0	488	10287
R-HSA-5637815	Signaling by Ligand-Responsive EGFR Variants in Cancer	1.00000000001285	1.28546817404185e-11	20	0	0	488	10287
R-HSA-749476	RNA Polymerase III Abortive And Retractive Initiation	1.00000000001297	1.29684723036996e-11	41	0	0	488	10287
R-HSA-5620924	Intraflagellar transport	1.00000000001297	1.29684723036996e-11	41	0	0	488	10287
R-HSA-5696400	Dual Incision in GG-NER	1.00000000001297	1.29684723036996e-11	41	0	0	488	10287
R-HSA-74158	RNA Polymerase III Transcription	1.00000000001297	1.29684723036996e-11	41	0	0	488	10287
R-HSA-3371571	HSF1-dependent transactivation	1.0000000000134	1.34031612725435e-11	23	0	0	488	10287
R-HSA-174048	APC/C:Cdc20 mediated degradation of Cyclin B	1.0000000000134	1.34031612725435e-11	23	0	0	488	10287
R-HSA-5205685	Pink/Parkin Mediated Mitophagy	1.0000000000134	1.34031612725435e-11	23	0	0	488	10287
R-HSA-8855121	VLDL interactions	1.0000000000134	1.34031612725435e-11	23	0	0	488	10287
R-HSA-389977	Post-chaperonin tubulin folding pathway	1.0000000000134	1.34031612725435e-11	23	0	0	488	10287
R-HSA-73980	RNA Polymerase III Transcription Termination	1.0000000000134	1.34031612725435e-11	23	0	0	488	10287
R-HSA-428930	Thromboxane signalling through TP receptor	1.0000000000134	1.34031612725435e-11	23	0	0	488	10287
R-HSA-379726	Mitochondrial tRNA aminoacylation	1.0000000000134	1.34031612725435e-11	23	0	0	488	10287
R-HSA-392170	ADP signalling through P2Y purinoceptor 12	1.0000000000134	1.34031612725435e-11	23	0	0	488	10287
R-HSA-400508	Incretin synthesis, secretion, and inactivation	1.0000000000134	1.34031612725435e-11	23	0	0	488	10287
R-HSA-5205647	Mitophagy	1.0000000000134	1.34031612725435e-11	23	0	0	488	10287
R-HSA-77075	RNA Pol II CTD phosphorylation and interaction with CE	1.00000000001367	1.3670298149149e-11	27	0	0	488	10287
R-HSA-1482788	Acyl chain remodelling of PC	1.00000000001367	1.3670298149149e-11	27	0	0	488	10287
R-HSA-76066	RNA Polymerase III Transcription Initiation From Type 2 Promoter	1.00000000001367	1.3670298149149e-11	27	0	0	488	10287
R-HSA-901042	Calnexin/calreticulin cycle	1.00000000001367	1.3670298149149e-11	27	0	0	488	10287
R-HSA-5693554	Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)	1.00000000001367	1.3670298149149e-11	27	0	0	488	10287
R-HSA-167160	RNA Pol II CTD phosphorylation and interaction with CE during HIV infection	1.00000000001367	1.3670298149149e-11	27	0	0	488	10287
R-HSA-8849471	PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases	1.00000000001367	1.3670298149149e-11	27	0	0	488	10287
R-HSA-70263	Gluconeogenesis	1.00000000001367	1.36719240875406e-11	32	0	0	488	10287
R-HSA-73863	RNA Polymerase I Transcription Termination	1.00000000001367	1.36719240875406e-11	32	0	0	488	10287
R-HSA-451326	Activation of Kainate Receptors upon glutamate binding	1.00000000001367	1.36719240875406e-11	32	0	0	488	10287
R-HSA-168274	Export of Viral Ribonucleoproteins from Nucleus	1.00000000001367	1.36719240875406e-11	32	0	0	488	10287
R-HSA-5620912	Anchoring of the basal body to the plasma membrane	1.00000000001393	1.39282137583144e-11	100	0	0	488	10287
R-HSA-6802948	Signaling by high-kinase activity BRAF mutants	1.00000000001438	1.43775195848707e-11	35	0	0	488	10287
R-HSA-159230	Transport of the SLBP Dependant Mature mRNA	1.00000000001438	1.43775195848707e-11	35	0	0	488	10287
R-HSA-5693537	Resolution of D-Loop Structures	1.00000000001438	1.43775195848707e-11	35	0	0	488	10287
R-HSA-113418	Formation of the Early Elongation Complex	1.00000000001438	1.43775195848707e-11	35	0	0	488	10287
R-HSA-167158	Formation of the HIV-1 Early Elongation Complex	1.00000000001438	1.43775195848707e-11	35	0	0	488	10287
R-HSA-3301854	Nuclear Pore Complex (NPC) Disassembly	1.00000000001438	1.43775195848707e-11	35	0	0	488	10287
R-HSA-111932	CaMK IV-mediated phosphorylation of CREB	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-1300652	Sperm:Oocyte Membrane Binding	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-77348	Beta oxidation of octanoyl-CoA to hexanoyl-CoA	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-8849468	PTK6 Regulates Proteins Involved in RNA Processing	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-166187	Mitochondrial Uncoupling Proteins	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-2855086	Ficolins bind to repetitive carbohydrate structures on the target cell surface	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-77346	Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-391906	Leukotriene receptors	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-446205	Synthesis of GDP-mannose	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-390648	Muscarinic acetylcholine receptors	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-8853383	Lysosomal oligosaccharide catabolism	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-71262	Carnitine synthesis	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-75157	FasL/ CD95L signaling	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-163358	PKA-mediated phosphorylation of key metabolic factors	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-8866423	VLDL biosynthesis	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-71032	Propionyl-CoA catabolism	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-427652	Sodium-coupled phosphate cotransporters	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-380095	Tachykinin receptors bind tachykinins	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-8866376	Reelin signalling pathway	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-111461	Cytochrome c-mediated apoptotic response	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-2161541	Abacavir metabolism	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-8866911	TFAP2 (AP-2) family regulates transcription of cell cycle factors	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-5662702	Melanin biosynthesis	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-77350	Beta oxidation of hexanoyl-CoA to butanoyl-CoA	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-196819	Vitamin B1 (thiamin) metabolism	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-74713	IRS activation	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-444209	Free fatty acid receptors	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-77310	Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-3645790	TGFBR2 Kinase Domain Mutants in Cancer	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-5661270	Catabolism of glucuronate to xylulose-5-phosphate	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-390651	Dopamine receptors	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-2644605	FBXW7 Mutants and NOTCH1 in Cancer	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-8849473	PTK6 Expression	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-1606341	IRF3 mediated activation of type 1 IFN	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-3065676	SUMO is conjugated to E1 (UBA2:SAE1)	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-5683678	Defective ABCA3 causes pulmonary surfactant metabolism dysfunction type 3 (SMDP3)	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-210746	Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-3642278	Loss of Function of TGFBR2 in Cancer	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-111463	SMAC binds to IAPs	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-69478	G2/M DNA replication checkpoint	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-5250955	Toxicity of botulinum toxin type D (BoNT/D)	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-111459	Activation of caspases through apoptosome-mediated cleavage	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-561048	Organic anion transport	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-114516	Disinhibition of SNARE formation	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-77352	Beta oxidation of butanoyl-CoA to acetyl-CoA	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-8852405	Signaling by MST1	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-167826	The fatty acid cycling model	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-111464	SMAC-mediated dissociation of IAP:caspase complexes	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-6785470	tRNA processing in the mitochondrion	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-389599	Alpha-oxidation of phytanate	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-8869496	TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-167827	The proton buffering model	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-1483226	Synthesis of PI	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-111469	SMAC-mediated apoptotic response	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-2644607	Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-70370	Galactose catabolism	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-70350	Fructose catabolism	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-157881	Cyclin B2 mediated events	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-3656535	TGFBR1 LBD Mutants in Cancer	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-5250981	Toxicity of botulinum toxin type F (BoNT/F)	1.00000000001476	1.47608907166003e-11	5	0	0	488	10287
R-HSA-5693571	Nonhomologous End-Joining (NHEJ)	1.00000000001484	1.48392091468223e-11	69	0	0	488	10287
R-HSA-73776	RNA Polymerase II Promoter Escape	1.00000000001574	1.57354586027941e-11	47	0	0	488	10287
R-HSA-73779	RNA Polymerase II Transcription Pre-Initiation And Promoter Opening	1.00000000001574	1.57354586027941e-11	47	0	0	488	10287
R-HSA-76042	RNA Polymerase II Transcription Initiation And Promoter Clearance	1.00000000001574	1.57354586027941e-11	47	0	0	488	10287
R-HSA-167162	RNA Polymerase II HIV Promoter Escape	1.00000000001574	1.57354586027941e-11	47	0	0	488	10287
R-HSA-5576892	Phase 0 - rapid depolarisation	1.00000000001574	1.57354586027941e-11	47	0	0	488	10287
R-HSA-75953	RNA Polymerase II Transcription Initiation	1.00000000001574	1.57354586027941e-11	47	0	0	488	10287
R-HSA-167161	HIV Transcription Initiation	1.00000000001574	1.57354586027941e-11	47	0	0	488	10287
R-HSA-4570464	SUMOylation of RNA binding proteins	1.00000000001609	1.6094650648957e-11	48	0	0	488	10287
R-HSA-73762	RNA Polymerase I Transcription Initiation	1.00000000001609	1.6094650648957e-11	48	0	0	488	10287
R-HSA-975956	Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)	1.0000000000161	1.61033885055668e-11	99	0	0	488	10287
R-HSA-5419276	Mitochondrial translation termination	1.00000000001707	1.70649691649786e-11	87	0	0	488	10287
R-HSA-72202	Transport of Mature Transcript to Cytoplasm	1.00000000001707	1.70649691649786e-11	87	0	0	488	10287
R-HSA-5368286	Mitochondrial translation initiation	1.00000000001707	1.70649691649786e-11	87	0	0	488	10287
R-HSA-167152	Formation of HIV elongation complex in the absence of HIV Tat	1.0000000000174	1.73954849081708e-11	52	0	0	488	10287
R-HSA-2980766	Nuclear Envelope Breakdown	1.0000000000174	1.73954849081708e-11	52	0	0	488	10287
R-HSA-3371556	Cellular response to heat stress	1.00000000001818	1.81801564825864e-11	89	0	0	488	10287
R-HSA-72662	Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S	1.00000000001852	1.85202014807266e-11	63	0	0	488	10287
R-HSA-1632852	Macroautophagy	1.00000000001886	1.88579053663874e-11	67	0	0	488	10287
R-HSA-3371453	Regulation of HSF1-mediated heat shock response	1.00000000001905	1.90529267080163e-11	70	0	0	488	10287
R-HSA-8873719	RAB geranylgeranylation	1.00000000001973	1.97281322108903e-11	64	0	0	488	10287
R-HSA-72702	Ribosomal scanning and start codon recognition	1.00000000001975	1.97522803745822e-11	61	0	0	488	10287
R-HSA-6802952	Signaling by BRAF and RAF fusions	1.00000000001975	1.97522803745822e-11	61	0	0	488	10287
R-HSA-3108232	SUMO E3 ligases SUMOylate target proteins	1.00000000002023	2.02293358526892e-11	104	0	0	488	10287
R-HSA-1428517	The citric acid (TCA) cycle and respiratory electron transport	1.00000000002031	2.03091971441467e-11	158	0	0	488	10287
R-HSA-196299	Beta-catenin phosphorylation cascade	1.00000000002032	2.03180858595741e-11	17	0	0	488	10287
R-HSA-3296482	Defects in vitamin and cofactor metabolism	1.00000000002032	2.03180858595741e-11	17	0	0	488	10287
R-HSA-2173791	TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)	1.00000000002032	2.03180858595741e-11	17	0	0	488	10287
R-HSA-164378	PKA activation in glucagon signalling	1.00000000002032	2.03180858595741e-11	17	0	0	488	10287
R-HSA-429958	mRNA decay by 3' to 5' exoribonuclease	1.00000000002032	2.03180858595741e-11	17	0	0	488	10287
R-HSA-1482922	Acyl chain remodelling of PI	1.00000000002032	2.03180858595741e-11	17	0	0	488	10287
R-HSA-70221	Glycogen breakdown (glycogenolysis)	1.00000000002032	2.03180858595741e-11	17	0	0	488	10287
R-HSA-111931	PKA-mediated phosphorylation of CREB	1.00000000002032	2.03180858595741e-11	17	0	0	488	10287
R-HSA-156711	Polo-like kinase mediated events	1.00000000002032	2.03180858595741e-11	17	0	0	488	10287
R-HSA-3232118	SUMOylation of transcription factors	1.00000000002032	2.03180858595741e-11	17	0	0	488	10287
R-HSA-5655862	Translesion synthesis by POLK	1.00000000002032	2.03180858595741e-11	17	0	0	488	10287
R-HSA-5656121	Translesion synthesis by POLI	1.00000000002032	2.03180858595741e-11	17	0	0	488	10287
R-HSA-140534	Ligand-dependent caspase activation	1.00000000002032	2.03180858595741e-11	17	0	0	488	10287
R-HSA-159234	Transport of Mature mRNAs Derived from Intronless Transcripts	1.00000000002156	2.15596738208923e-11	45	0	0	488	10287
R-HSA-8854214	TBC/RABGAPs	1.00000000002156	2.15596738208923e-11	45	0	0	488	10287
R-HSA-379724	tRNA Aminoacylation	1.00000000002156	2.15596738208923e-11	45	0	0	488	10287
R-HSA-380259	Loss of Nlp from mitotic centrosomes	1.00000000002276	2.27611018717811e-11	72	0	0	488	10287
R-HSA-380284	Loss of proteins required for interphase microtubule organization from the centrosome	1.00000000002276	2.27611018717811e-11	72	0	0	488	10287
R-HSA-76046	RNA Polymerase III Transcription Initiation	1.00000000002281	2.2806236815628e-11	36	0	0	488	10287
R-HSA-177243	Interactions of Rev with host cellular proteins	1.00000000002281	2.2806236815628e-11	36	0	0	488	10287
R-HSA-432720	Lysosome Vesicle Biogenesis	1.00000000002281	2.2806236815628e-11	36	0	0	488	10287
R-HSA-532668	N-glycan trimming in the ER and Calnexin/Calreticulin cycle	1.00000000002281	2.2806236815628e-11	36	0	0	488	10287
R-HSA-6799198	Complex I biogenesis	1.00000000002293	2.29342032543617e-11	51	0	0	488	10287
R-HSA-176187	Activation of ATR in response to replication stress	1.00000000002354	2.35419820028043e-11	37	0	0	488	10287
R-HSA-73884	Base Excision Repair	1.00000000002354	2.35419820028043e-11	37	0	0	488	10287
R-HSA-73933	Resolution of Abasic Sites (AP sites)	1.00000000002354	2.35419820028043e-11	37	0	0	488	10287
R-HSA-168325	Viral Messenger RNA Synthesis	1.00000000002369	2.36944448601374e-11	43	0	0	488	10287
R-HSA-5696395	Formation of Incision Complex in GG-NER	1.00000000002369	2.36944448601374e-11	43	0	0	488	10287
R-HSA-5693579	Homologous DNA Pairing and Strand Exchange	1.00000000002369	2.36944448601374e-11	43	0	0	488	10287
R-HSA-73857	RNA Polymerase II Transcription	1.00000000002377	2.37704195553703e-11	159	0	0	488	10287
R-HSA-167172	Transcription of the HIV genome	1.00000000002382	2.38154168720135e-11	77	0	0	488	10287
R-HSA-180746	Nuclear import of Rev protein	1.00000000002413	2.41291040755897e-11	33	0	0	488	10287
R-HSA-186712	Regulation of beta-cell development	1.00000000002413	2.41291040755897e-11	33	0	0	488	10287
R-HSA-392518	Signal amplification	1.00000000002413	2.41291040755897e-11	33	0	0	488	10287
R-HSA-5696399	Global Genome Nucleotide Excision Repair (GG-NER)	1.00000000002441	2.44121539387086e-11	85	0	0	488	10287
R-HSA-2565942	Regulation of PLK1 Activity at G2/M Transition	1.00000000002451	2.45124359365935e-11	90	0	0	488	10287
R-HSA-72312	rRNA processing	1.00000000002479	2.47855801984762e-11	201	0	0	488	10287
R-HSA-2500257	Resolution of Sister Chromatid Cohesion	1.0000000000252	2.51997462310296e-11	103	0	0	488	10287
R-HSA-5696394	DNA Damage Recognition in GG-NER	1.00000000002552	2.55151542613061e-11	39	0	0	488	10287
R-HSA-5674135	MAP2K and MAPK activation	1.00000000002552	2.55151542613061e-11	39	0	0	488	10287
R-HSA-163841	Gamma carboxylation, hypusine formation and arylsulfatase activation	1.00000000002552	2.55151542613061e-11	39	0	0	488	10287
R-HSA-6802955	Paradoxical activation of RAF signaling by kinase inactive BRAF	1.00000000002552	2.55151542613061e-11	39	0	0	488	10287
R-HSA-6783310	Fanconi Anemia Pathway	1.00000000002552	2.55151542613061e-11	39	0	0	488	10287
R-HSA-165159	mTOR signalling	1.00000000002552	2.55151542613061e-11	39	0	0	488	10287
R-HSA-6802946	Signaling by moderate kinase activity BRAF mutants	1.00000000002552	2.55151542613061e-11	39	0	0	488	10287
R-HSA-72172	mRNA Splicing	1.00000000002554	2.55436214587443e-11	195	0	0	488	10287
R-HSA-194441	Metabolism of non-coding RNA	1.00000000002604	2.60377374433514e-11	53	0	0	488	10287
R-HSA-72695	Formation of the ternary complex, and subsequently, the 43S complex	1.00000000002604	2.60377374433514e-11	53	0	0	488	10287
R-HSA-191859	snRNP Assembly	1.00000000002604	2.60377374433514e-11	53	0	0	488	10287
R-HSA-72165	mRNA Splicing - Minor Pathway	1.00000000002604	2.60377374433514e-11	53	0	0	488	10287
R-HSA-977443	GABA receptor activation	1.00000000002636	2.63644167392579e-11	56	0	0	488	10287
R-HSA-381038	XBP1(S) activates chaperone genes	1.00000000002636	2.63644167392579e-11	56	0	0	488	10287
R-HSA-5668914	Diseases of metabolism	1.0000000000265	2.64979598947656e-11	44	0	0	488	10287
R-HSA-159231	Transport of Mature mRNA Derived from an Intronless Transcript	1.0000000000265	2.64979598947656e-11	44	0	0	488	10287
R-HSA-977444	GABA B receptor activation	1.00000000002653	2.65273518617872e-11	40	0	0	488	10287
R-HSA-991365	Activation of GABAB receptors	1.00000000002653	2.65273518617872e-11	40	0	0	488	10287
R-HSA-5693616	Presynaptic phase of homologous DNA pairing and strand exchange	1.00000000002653	2.65273518617872e-11	40	0	0	488	10287
R-HSA-167290	Pausing and recovery of HIV elongation	1.00000000002653	2.65273518617872e-11	40	0	0	488	10287
R-HSA-109703	PKB-mediated events	1.00000000002653	2.65273518617872e-11	40	0	0	488	10287
R-HSA-167287	HIV elongation arrest and recovery	1.00000000002653	2.65273518617872e-11	40	0	0	488	10287
R-HSA-8866654	E3 ubiquitin ligases ubiquitinate target proteins	1.00000000002672	2.67160976607207e-11	42	0	0	488	10287
R-HSA-983189	Kinesins	1.00000000002672	2.67160976607207e-11	42	0	0	488	10287
R-HSA-6782315	tRNA modification in the nucleus and cytosol	1.00000000002672	2.67160976607207e-11	42	0	0	488	10287
R-HSA-168255	Influenza Life Cycle	1.00000000002677	2.67726055014351e-11	146	0	0	488	10287
R-HSA-109688	Cleavage of Growing Transcript in the Termination Region	1.00000000002681	2.68107295702916e-11	71	0	0	488	10287
R-HSA-73856	RNA Polymerase II Transcription Termination	1.00000000002681	2.68107295702916e-11	71	0	0	488	10287
R-HSA-71406	Pyruvate metabolism and Citric Acid (TCA) cycle	1.00000000002693	2.69316759341474e-11	49	0	0	488	10287
R-HSA-6811440	Retrograde transport at the Trans-Golgi-Network	1.00000000002693	2.69316759341474e-11	49	0	0	488	10287
R-HSA-72689	Formation of a pool of free 40S subunits	1.00000000002703	2.70264696744248e-11	105	0	0	488	10287
R-HSA-2990846	SUMOylation	1.00000000002747	2.74681139954098e-11	110	0	0	488	10287
R-HSA-8856688	Golgi-to-ER retrograde transport	1.00000000002747	2.74681139954098e-11	110	0	0	488	10287
R-HSA-6781823	Formation of TC-NER Pre-Incision Complex	1.00000000002781	2.78083364506538e-11	54	0	0	488	10287
R-HSA-5368287	Mitochondrial translation	1.00000000002808	2.80802754733109e-11	94	0	0	488	10287
R-HSA-429914	Deadenylation-dependent mRNA decay	1.00000000002869	2.86855368948422e-11	57	0	0	488	10287
R-HSA-163200	Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.	1.00000000002908	2.90752891292342e-11	113	0	0	488	10287
R-HSA-156902	Peptide chain elongation	1.00000000002928	2.92805419640735e-11	92	0	0	488	10287
R-HSA-611105	Respiratory electron transport	1.00000000002928	2.92805419640735e-11	92	0	0	488	10287
R-HSA-192823	Viral mRNA Translation	1.00000000002928	2.92805419640735e-11	92	0	0	488	10287
R-HSA-5696398	Nucleotide Excision Repair	1.00000000003003	3.00275826286443e-11	112	0	0	488	10287
R-HSA-1445148	Translocation of GLUT4 to the plasma membrane	1.00000000003024	3.02439668389863e-11	62	0	0	488	10287
R-HSA-8852135	Protein ubiquitination	1.00000000003024	3.02439668389863e-11	62	0	0	488	10287
R-HSA-72649	Translation initiation complex formation	1.00000000003024	3.02439668389863e-11	62	0	0	488	10287
R-HSA-72187	mRNA 3'-end processing	1.00000000003024	3.02439668389863e-11	62	0	0	488	10287
R-HSA-1268020	Mitochondrial protein import	1.00000000003024	3.02439668389863e-11	62	0	0	488	10287
R-HSA-6790901	rRNA modification in the nucleus and cytosol	1.00000000003024	3.02439668389863e-11	62	0	0	488	10287
R-HSA-72766	Translation	1.00000000003049	3.04902834981709e-11	162	0	0	488	10287
R-HSA-69473	G2/M DNA damage checkpoint	1.00000000003217	3.21655397935177e-11	95	0	0	488	10287
R-HSA-2408557	Selenocysteine synthesis	1.00000000003217	3.21655397935177e-11	95	0	0	488	10287
R-HSA-5693565	Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks	1.00000000003219	3.218637532503e-11	75	0	0	488	10287
R-HSA-159236	Transport of Mature mRNA derived from an Intron-Containing Transcript	1.00000000003219	3.218637532503e-11	75	0	0	488	10287
R-HSA-6802957	Oncogenic MAPK signaling	1.00000000003219	3.218637532503e-11	75	0	0	488	10287
R-HSA-8854518	AURKA Activation by TPX2	1.00000000003219	3.218637532503e-11	75	0	0	488	10287
R-HSA-1799339	SRP-dependent cotranslational protein targeting to membrane	1.0000000000322	3.21963965452733e-11	115	0	0	488	10287
R-HSA-6782210	Gap-filling DNA repair synthesis and ligation in TC-NER	1.00000000003254	3.25362963082184e-11	65	0	0	488	10287
R-HSA-112382	Formation of RNA Pol II elongation complex	1.00000000003254	3.25362963082184e-11	65	0	0	488	10287
R-HSA-75955	RNA Polymerase II Transcription Elongation	1.00000000003254	3.25362963082184e-11	65	0	0	488	10287
R-HSA-381070	IRE1alpha activates chaperones	1.00000000003266	3.26571327003793e-11	58	0	0	488	10287
R-HSA-927802	Nonsense-Mediated Decay (NMD)	1.00000000003271	3.27064499782783e-11	120	0	0	488	10287
R-HSA-975957	Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)	1.00000000003271	3.27064499782783e-11	120	0	0	488	10287
R-HSA-6782135	Dual incision in TC-NER	1.00000000003471	3.47113609753435e-11	66	0	0	488	10287
R-HSA-72706	GTP hydrolysis and joining of the 60S ribosomal subunit	1.00000000003664	3.66425891323106e-11	117	0	0	488	10287
R-HSA-156827	L13a-mediated translational silencing of Ceruloplasmin expression	1.00000000003664	3.66425891323106e-11	117	0	0	488	10287
R-HSA-72306	tRNA processing	1.00000000003679	3.67858193635614e-11	109	0	0	488	10287
R-HSA-6781827	Transcription-Coupled Nucleotide Excision Repair (TC-NER)	1.00000000003837	3.83720911803143e-11	79	0	0	488	10287
R-HSA-72737	Cap-dependent Translation Initiation	1.00000000003894	3.89408225081103e-11	125	0	0	488	10287
R-HSA-72613	Eukaryotic Translation Initiation	1.00000000003894	3.89408225081103e-11	125	0	0	488	10287
R-HSA-5693606	DNA Double Strand Break Response	1.00000000003895	3.894989180781e-11	76	0	0	488	10287
R-HSA-6791226	Major pathway of rRNA processing in the nucleolus and cytosol	1.00000000004085	4.08533500224658e-11	179	0	0	488	10287
R-HSA-68877	Mitotic Prometaphase	1.00000000004102	4.10227560898999e-11	111	0	0	488	10287
R-HSA-72163	mRNA Splicing - Major Pathway	1.00000000004123	4.12310251822888e-11	187	0	0	488	10287
R-HSA-5685942	HDR through Homologous Recombination (HRR)	1.00000000004203	4.20269084067121e-11	68	0	0	488	10287
R-HSA-167243	Tat-mediated HIV elongation arrest and recovery	1.00000000004785	4.78473493253264e-11	38	0	0	488	10287
R-HSA-5685938	HDR through Single Strand Annealing (SSA)	1.00000000004785	4.78473493253264e-11	38	0	0	488	10287
R-HSA-167238	Pausing and recovery of Tat-mediated HIV elongation	1.00000000004785	4.78473493253264e-11	38	0	0	488	10287
